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Abstract 
 Current orthopaedics treatments of bone defects often involve the use of 
implanted fixatives and/or autograft procedures to restore function to the afflicted area 
following injury.  Fixatives and implants are usually temporary solutions, since they are 
intrinsically prone to failure. In addition to this, replacing implants involve expensive and 
invasive procedures that cause great hardship to patients. Whilst autografts can provide 
an excellent outcome in healing of the initial injury site, donor site morbidity from the 
autologous bone graft can lead to complications such as infection, chronic pain and an 
abnormal walking gait.  Bone tissue engineering is a field of science aiming to address 
these limitations by providing in vitro manufactured bone to replace autografts, and also 
limit the use of temporary fixatives. Hydrostatic force bioreactors are currently being 
developed within this field to attempt improve the outcome of the tissue engineered bone 
by mimicking the forces typically experienced by cells in the native bone niche. Based on 
this principle, it is hoped that such systems will aid the translation of research in bone 
tissue engineering from the lab to the clinic. 
This research aims to investigate and validate the use of a hydrostatic force bioreactor 
for improving the outcome of in vitro manufactured bone using a clinically relative 
strategy employing human mesenchymal stem cells seeded in 3D scaffolds. The research 
first describes a validation process to determine the initial response of cells to hydrostatic 
pressure in monolayer cultures. The outcome of this study indicated that mechanical 
responsiveness in cells can vary according to cell phenotype and the integrity of the f-
actin cytoskeleton.  Next it was demonstrated that hydrostatic pressure can improve the 
outcome of in vitro bone formation by MG-63 human osteoblast like cells, validating the 
bioreactor as a potential preconditioning platform. Following this, a model of bone 
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formation in hMSCs/collagen scaffolds was described, whereby a predictable rate of bone 
formation was determined by adjusting cellular distribution and protein concentration in 
collagen type-1 scaffolds.  
Finally, an organotypic fracture repair model was established using explanted 
embryonic chick femurs to test the hypothesis that hydrostatic preconditioning of 
hMSC/collagen hydrogels can improve the outcome of fracture repair. The results of this 
study showed that bioreactor stimulation could enhance the outcome of repair using a 
combination of undifferentiated hMSC/collagen type-1 scaffolds, and global mechanical 
signalling (stimulation of entire femur constructs).  It was then shown that hydrostatic 
preconditioning of hMSC seeded hydrogels prior to implantation did not increase the rate 
of in vitro bone formation. Following implantation of the hydrogels into the fracture 
repair model, it was demonstrated that highly mineralised preconditioned implants 
actually inhibited the fracture repair process. In addition to this, it was shown that 
preconditioned implants with a lower level of mineralisation allowed invasion and bone 
formation by native cells from the host tissue. Collectively, the results implied that the 
outcome of repair using this model relied on three main factors: the presence of global 
hydrostatic stimulation; the lineage commitment of hMSCs in collagen scaffolds at the 
time of implantation; and the permeability and cell invasion capacity of the implant.  
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1.1. Introduction 
Regenerative medicine (RM) is an emerging field in science that explores aspects of 
translational research in order to restore normal function to diseased or injured regions of 
the body. The field itself encompasses broad multidisciplinary practises that aim to 
address growing concerns for public health in the years to come. With an aging 
population and increasing trends in both childhood and adult obesity, the challenges 
facing orthopaedics to effectively treat patients will quickly become impracticable using 
current treatments (Wills 2004)(Lawrence et al. 2008). Bone tissue engineering (BTE) is 
a branch of RM that utilises developments in biomedical science to treat orthopaedic 
injuries that are incapable of self-regeneration such as massive traumatic bone loss or 
tumour resection (Lichte et al,. 2011). Bone tissue engineering aims to overcome 
limitations facing current orthopaedic practises, and in practise should incorporate 
clinical safety, predictability and  reproducibility in the outcome of potential treatments 
(Shrivats et al. 2014).   
 Engineering bone tissue in vitro translates our biological understanding of in vivo 
osteogenesis and applies it to bioengineering concepts that aim to grow replacement bone 
tissue in the lab. Osteogenesis is defined as the process by which osteoprogenitor cells 
recruit, and/or differentiate into bone forming osteoblasts to mineralise the surrounding 
extracellular matrix (Orlando et al. 2013). Bone has remarkable capacity for self-renewal 
relative to other tissue types. Throughout the life of a person, the mechanical integrity of 
the skeleton is maintained by a constant rate of turnover known as bone homeostasis 
(Kalfas 2001). Adult bone healing during fracture repair recapitulates many pathways of 
normal foetal skeletal development such as intramembranous and endochondral 
ossification (Ferguson et al. 1999) . Thus, there exists very real opportunity to address a 
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growing health concern by translating our ever increasing understanding of biological 
events into useful clinical applications.  
1.2. Limitations in current orthopaedic gold standards 
As mentioned previously, bone has a relatively good regenerative capacity after injury 
and many orthopaedic injuries such as stress fractures and minor trauma heal with minimal 
intervention and without complication. It is the more complex and more severe injuries 
which require review of the gold standard, currently utilising temporary fixation, or 
autografts harvested directly from the patient. Both of these methods have significant 
limitations, particularly in addressing a larger scale clinical need. Fixation techniques 
employ metal and ceramic implants and are intrinsically prone to failure. Implant failure 
can cause severe pain to the patient and great expense and hardship in their removal and 
replacement (Sivakumar et al. 1995). Autologous bone grafts usually involve removal of 
bone from the iliac crest and have a number of associated complications such as pain, 
sensory disturbances, gait abnormality, or post-operative infection (Ahlmann et al. 2002). 
One patient follow up study found that in certain cases as much as 18% of patients 
experienced major complications as a result of the autograft procedure (Younger & 
Chapman 1989). The cumulative cost of osteoporotic fractures alone in the UK was 
estimated at £20.3 billion between 2000 and 2010, and is set to increase by 20% by 2020 
(Burge et al. 2008). If BTE engineering can emerge as a new gold standard in orthopaedics 
it could have significant positive impact on both the patient and the healthcare economy 
through a growing RM industry.  
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1.3. Orthopaedic applications from bone tissue engineering 
1.3.1.  Pathological abnormalities 
Pathological abnormalities occur due to an underlying disease state and can lead 
multiple complications that require surgical intervention. There are a number of 
pathological abnormalities that occur in bones, each of which carry different levels of 
risk. As an example, unicameral bone cysts (UBCS) are benign bone lesions that 
commonly occur in children and young adults but are not generally considered to pose a 
serious health risk. However,  if large enough, they introduce an increased risk of 
pathological fracture due to mechanical instability (Weinman et al. 2013). Bone grafts are 
one of the current gold standards in the treatment of this affliction (Kadhim et al. 2014), 
however  as discussed previously, these procedures arguably represent the current 
limitations in orthopaedic practise. Concepts that have emerged from  understanding of 
basic biology have seen the implementation of aspiration and percutaneous autogenous 
bone marrow injections (ABMI) into the injury site (Delloye et al. 1998). The use of 
ABMI is now considered to provide an excellent alternative treatment for UBCs over 
autografts, with one study demonstrating an 82% success rate of healing using ABMI 
(Zamzam et al. 2009).  
Other approaches in targeting pathological bone abnormalities include the 
enrichment of isolated skeletal stem cell (SSC) populations which can then be 
reintroduced into the body to target the injury site (Oreffo et al. 2005). It is hoped that 
techniques such as SSC isolation and enrichment might be effective in treating 
osteogenesis imperfecta (OI), a genetic disorder which results in abnormal collagen type 
1 production by native osteoblasts. This disorder can lead to recurrent multiple fractures 
and growth abnormalities that commonly result in a  shortened stature (Undale et al. 
2009). Current gold standards for OI involve ongoing and intensive surgical procedures 
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to correct abnormalities, or treatment with bisphosphonate therapy, for which the long 
term clinical outcome is currently unknown (Rauch & Glorieux 2004). Allogeneic 
mesenchymal stromal cell (MSC) transplantations have recently shown increased efficacy 
in the treatment of OI in a number of studies (Horwitz et al. 2002)(Le Blanc et al. 
2005)(Götherström et al. 2014), demonstrating how we can utilise concepts from  BTE to 
address currently limited procedures to heal pathologies in bone tissue.  
1.3.2.  Delayed healing during fracture repair 
The nature of orthopaedic treatment will depend on the type and severity of the injury 
or abnormality. Fractures for example are generally categorised into three types; Traumatic 
fracture, pathological fracture, and fracture by fatigue (Dhillon & Dhatt 2012). Traumatic 
fractures are caused by excessive force, which can incorporate a variety of fracture subsets, 
for example, compression, torsion or blunt trauma. Pathological fractures have underlying 
causes such as bone diseases or prolonged disuse. Finally fatigue fractures are usually a 
result of repetitive stress, leading to a cumulative excess in force that leads to stress 
fractures (Packer & Colditz 1986). An accurate understanding of the nature of injury 
facilitates the correct prognosis and treatment type. A compression fracture resulting from 
low bone density (a common injury among elderly women suffering with osteoporosis) 
typically would employ a form of injectable bone cement to the fracture site (Klazen et al. 
2010). By contrast a non-union caused by blunt trauma in a young male patient could 
require fixation of an autograft to facilitate bone repair (Sen & Miclau 2007).   
The general stance on using BTE for restoring function to bone that do not heal, is to 
exploit the correct combination of stem cell derived cell phenotypes, 3D scaffolds, and 
external cues that then improve vascularised bone formation after implantation (Dawson et 
al. 2014)(Figure 1).  Whilst BTE has shown some success in producing large bone 
6 
 
volumes suitable for transplantation (Stevens et al. 2005), there remain limitations in 
translating BTE from in vitro to in vivo,  such as the poor predictability of clinical 
outcomes from  rodent models of vascularised bone tissue formation, into human bone 
defects (Stevens 2008). We must not overlook early successes demonstrating the potential 
of BTE in long term clinical outcomes in large bone defects (Marcacci et al. 2007). 
However, existing evidence implementing clinical therapies derived from BTE does not 
yet offer orthopaedic surgeons enough proven efficacy to take the place of autografts as the 
gold standard (Amini et al. 2012). For BTE to become the new gold standard, scientists 
must utilise the increasingly interdisciplinary field of RM to develop novel concepts that 
overcome the current limitations facing the field such as reproducibility and predictability, 
and preclinical models that adequately translate into use in humans.  
 
 
 
 
 
 
 
 
 
 
Figure 1.  Concept in bone tissue engineering of stem cell isolation and differentiation 
on 3D scaffolds prior to implantation to promote bone regeneration. Adapted from 
(Dawson et al. 2014), reprinted with permission of John Wiley and Sons [license 
number:3791881189997]  
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1.3.3. Commercially available artificial bone substitutes ‘from bench to bedside’ 
Orthopaedic surgeons already employ a wide range of artificial bone substitutes to 
treat a range of injuries such large defects, craniofacial abnormalities and spinal fusion. 
There are an increasing number of industry based efforts to develop and commercialising 
materials for orthopaedic tissue repair, such as the university spin out venture Apatech, 
who develop porous synthetic hydroxyapatite based bone grafts, which have shown 
success in a number of clinical case studies (McNamara et al. 2010) (Lerner & Liljenqvist 
2013). To date, Apatech are estimated to have successfully treated over ½ million people 
across 30 countries and in 2012 occupied around 10% of a market worth over $500 
million (source: National Centre for University and Business, 
http://www.ncub.co.uk/apatech-development-synthetic-bone-grafts-2.html). Apatech  is 
just one example of the clinical and commercial successes of the bench to bedside 
strategy, and these successes continually drive research activity to find lower cost, 
minimally invasive and more effective ways of treating bone abnormalities. Since many 
artificial bone substitutes employ cell free approaches, they can avoid many regulatory 
issues associated with using cell based therapies.  With artificial bone substitutes already 
so widely and successfully employed, it is then tempting to ask why so many are seeking 
to develop cell based strategies to treat bone abnormalities. The main drawback of using 
artificial bone substitutes is that they are unsuitable for treating pathological 
abnormalities such as OI, discussed previously.  A cells unique ability to actively adapt to 
an in vivo environment can allow the treatment of OI with allogeneic an MSC 
transplantation (Götherström et al. 2014). Hence there are distinct limitations in the use of 
artificial bone substitutes which continue to inspire new approaches to treating bone 
abnormalities with more widely applicable techniques. A combination of the correct 
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cell/scaffold environment could potentially address many of the limitations which 
commercially available treatment options face.  
1.4. Bone anatomy 
1.4.1. Structure and function 
Bone is a dynamic tissue that plays a role in structure, stability and protection of the body. Its 
functions include maintaining blood calcium levels, providing mechanical support to soft tissue and 
levering muscle action, supporting haematopoiesis, and housing the brain and spinal cord (Harada 
& Rodan 2003). Bone consists of two main types; compact or cortical bone and cancellous or 
spongy bone. Compact bone forms a dense cylinder around the mid diaphysis of long bones and 
comprises highly aligned collagen fibrils which form lamella. Within this lamella are embedded 
osteocytes interconnected via dendritic processes extending through channels called canaliculi. 
These channels act as a mass transfer system, delivering nutrients and exporting waste, and are also 
believed to mediate mechanical signals through interstitial fluid, allowing cells to detect and 
process external mechanical stimuli (Kamioka et al. 2001). Cancellous bone is present at load 
bearing sites toward the epiphysis of long bones and comprises porous, randomly oriented bone 
matrix called trabeculae. Cancellous bone has evolved to allow optimal load transfer, by pairing 
suitable strength and stiffness to minimal weight according to rules of mathematical design 
(Huiskes et al. 2000).  
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Figure 2: Schematic showing the structure of compact and cancellous bone. 
Within a typical femur there is both compact and cancellous bone in different regions. 
Compact bone forms a dense bone collar extending the femur diaphysis consisting of 
mineralised collagen in a highly ordered lamella structure. Cancellous bone is present 
toward the femoral head or epiphysis, providing a lightweight, robust structure ideal for 
load bearing. 
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1.4.2. Formation in vivo 
Bone is carefully regulated by a constant flux of remodelling and resorption, 
involving a delicate balance of bone resorbing osteoclasts and bone forming osteoblasts. 
The mechanisms that control bone homeostasis are complex and there is a large body of 
literature on the many potential candidate cues for regulating bone mass. There are various 
ways in which bone forms and maintains itself. During embryonic development 
endochondral ossification (Figure 3A) controls the formation of most long and irregular 
bones. Endochondral ossification involves the formation of a cartilage like matrix that is 
then mineralised to form mature bone tissue (Mackie et al. 2011). Most flat bones such as 
the calvaria (skull) are formed via the process of intramembranous ossification (Figure 
3B). Intramembranous ossification occurs by first recruiting progenitor cells to the site of 
interest via chemotaxis. These progenitor cells then differentiate into matrix secreting 
osteoblasts which subsequently mineralise surrounding fibrous tissue, forming distinct 
mineralised nodules (Cooper et al. 2006). These nodules grow in size and interconnect 
with surrounding nodules to form new bone. Both intramembranous and endochondral 
ossification are present in embryonic development, fracture healing and adult bone 
homeostasis, however there is debate as to which process is more favourable for generating 
bone tissue in vitro. Evidence suggests that bone formation via these mechanisms is 
dictated by the cell-matrix environment and the lineage commitment of cells present within 
these bone forming regions (Tortelli et al. 2010).  
During bone remodelling, cells will exhibit a number of different phenotypes as 
they progress from a dormant or ‘quiescent’ state to becoming embedded osteocytes. 
Osteoclasts are first recruited to deliver hydrochloric acid and proteases to degrade old 
bone, releasing factors contained in the matrix which encourage recruitment of osteoblasts 
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Figure 3: Picture representation of the different stages of endochondral (A) and 
intramembranous bone formation (B).  
A) Endochondral ossification 
B)  Intramembranous ossification 
ossification 
Vascularisation 
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1.4.3. Bone homeostasis  
During bone remodelling and homeostasis, native bone cells will exhibit a number 
of different phenotypes as they progress from a dormant or ‘quiescent’ state to becoming 
embedded osteocytes. Osteoclasts (OC) are first recruited to deliver hydrochloric acid and 
proteases to degrade old bone, releasing factors contained in the matrix which encourage 
recruitment of osteoblasts (Väänänen et al. 2000)(Rucci 2008). Osteoblasts (OB) then 
invade the site and either undergo apoptosis or encapsulate themselves in mineralised 
matrix, the latter process completing terminal differentiation into osteocytes (OS)  
(Manolagas 2000) (Figure4).  
 
 
 
 
 
 
The mechanisms involved in regulating native osteoblast and osteoclast populations 
that are required for a healthy rate of bone remodelling are currently not well defined. 
Osteoclasts are thought to differentiate from haematopoietic derived macrophages 
(Udagawa et al. 1990) via proximal signalling of receptor activator of nuclear factor kappa-
β ligand (RANKL) from osteoblast lineage cells (Yasuda et al. 1998). Proximal signalling 
mechanisms play an important part in regulating both recruitment and cell functionality of 
osteoclasts. OBs have been shown to influence OC differentiation  by negatively regulating 
Figure 4. Cartoon depiction describing bone formation in the context of bone cell 
turnover (Long 2011) . Reprinted with permission of Nature publishing group [license 
number: 3791991136324] 
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RANKL expression via paracrine signalling (Udagawa et al. 1990). Sclerostin is a soluble 
factor secreted by OSs and interestingly has recently been shown to regulate bone 
resorption by interacting with RANKL production (Wijenayaka et al. 2011)(Xiong & 
O'Brien 2012), highlighting a complex multiparameter system that is to date, poorly 
correlated. In addition to that previously discussed, an increases in nitric oxide (NO) 
signalling has also been shown to regulate OC differentiation in vitro and in the developing 
chick embryo (Collin-Osdoby et al. 2000). NO signalling, an early mediator of bone 
formation induced by mechanical loading (Fox et al. 1996),  has also been shown to 
regulate RANKL and osteoprotegerin (OPG) in osteoprogenitor cells (Fan et al. 2004), 
again highlighting the broad interplay of signalling events involved in bone remodelling. 
OC recruitment has also shown to be sensitive to surface topography, whereby a smooth 
surface rather than a rough surface promoted  tartrate-resistant acid phosphatase (TRAP) 
expression (Costa et al. 2013). Age is another important factor that influences OC, shown 
by a positive correlation between increased age and OC differentiation (Chung et al. 2014).   
OBs are thought to derive from MSC progenitors residing in the bone marrow 
(Pittenger et al. 1999). MSCs differentiate into osteoblasts via transcription of  Runt-
related transcription factor 2 (Runx2), which when abrogated in mice results in a complete 
lack of ossification of the developing skeletal system (Komori et al. 1997). Runx2 is often 
referred to as the ‘master switch’ for osteogenic differentiation in MSCs and has a number 
of upstream effectors such as; bone morphogenetic protein (BMP) (Gori et al. 1999), the 
int/Wingless family (Wnt) (Ling et al. 2009) which has also been shown to interact with 
the BMP during osteogenic differentiation (Bain et al. 2003), and external mechanical 
stimuli (Sittichokechaiwut et al. 2010)(Chenyu & Rei 2012b) which again can influence 
the behaviour of intermediate pathways of Runx2 through Wnt (Yu et al. 2010) and BMP 
(Sumanasinghe et al. 2006) signalling.  
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Whilst the molecular mechanisms that govern the process of MSC to osteoblast 
differentiation are complex, the behaviour of osteoblasts is distinct from other bone cell 
types.  Functional responses of osteoblasts in vitro are easily identified through the 
production of proteins such as; osteocalcin, non-collagenous protein secreted by 
osteoblasts which is thought to be involved regulating of bone metabolism (Long 2011), 
and alkaline phosphatase, which is thought to assist bone mineralisation by cells(E. E. 
Golub & Boesze-Battaglia 2007). The physical environment also plays an important role in 
regulating OB behaviour. For example, in contrast to OCs, OB functionality is favoured by 
rough surfaces. This has been shown by a number of groups to promote bone formation 
and osteogenic gene expression (Costa et al. 2013) (Gough et al. 2004)(Cheng et al. 2014). 
As mentioned previously, when OBs become encased in mineralised matrix they 
are considered to have become terminally differentiated osteocytes (OS) (Chan et al. 
2009). During this process there is a shift in gene expression from markers such Runx2 and 
osteocalcin (OCN) in bone lining osteoblasts, to markers such as E11 (Schwab et al. 1999), 
which is believed to play a role in the formation of dendritic processes characteristic of 
osteocyte formation (Bonewald 2011) (Zhang et al. 2006). OSs contribute the largest 
population of cells in bone tissue relative to OBs and OCs, and play an important role in 
regulating bone remodelling by OBs and OCs via the transport of signalling molecules 
such as dentin matrix protein 1 (DMP-1) and fibroblast growth factor 23 (FGF23) 
(Bonewald 2007). Osteocytes are interconnected via dendritic processes that span the 
canaliculi in bone. These canaliculi are filled with interstitial fluid, which as mentioned 
previously, allows mass transport to occur, and importantly for this research the 
transduction of fluid pressures, resulting from external mechanical stimuli, into biophysical 
processes that determine cell behaviour (Chen et al. 2010). Munrow and Piekaeski were 
the first to conclusively demonstrate that the loading of bone results in the changes in 
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interstitial fluid pressure in the canaliculi of bone (Munrow & Piekarski 1977). There has 
since been an incentive, particularly in the context of BTE, to understand the process of 
loading of bone and cell signalling between osteocytes, osteoblasts and osteoclasts. It is 
hoped that by understanding what mechanical signalling events manage bone remodelling, 
we can design in vitro growth environments that promote bone tissue constructs to be used 
as substitutes for autografts and/or temporary implants.  
1.4.4. Protein and mineral composition of bone 
The mineralised inorganic phase of bone is comprised primarily of a crystal 
structure of  calcium hydroxyapatite (Hall & Guyton 2006), and constitutes between 60-
70%of the dry weight of bone. The remaining organic phase of bone contains in the 
region of 10-20% water and collagen type-1, comprising about 90% of proteins 
constituting bone tissue (Hadjidakis & Androulakis 2006).  Collagen provides an elastic, 
highly ordered lamellar structure that is made stiff by the presence of calcium phosphate 
and hydroxyapatite mineral phases on the collagen fibres themselves (Olszta et al. 2007). 
Bone matrix also contains a number of different non-collagenous proteins (5%) and lipids 
(2%)  (Young 2003). Non collagenous proteins play numerous roles in the formation and 
regulation of bone, however their specific roles in regulating bone homeostasis is still 
debated. Alkaline phosphatase (ALP) is a metalloenzyme that is highly expressed in 
mineralised bone. Although the mechanism of action of ALP is not fully understood, it is 
believed to increase the local concentration of inorganic phosphates involved in bone 
mineralisation (Ellis E Golub & Boesze-Battaglia 2007)(Harmey et al. 2004). OCN is a 
non-collagenous protein secreted by OBs which, as mentioned previously, is thought to 
be involved in the regulation of bone metabolism (Long 2011), but has also been shown 
to facilitate the orientation of calcium ions within the mineralising hydroxyapatite lattice 
(Hoang et al. 2003). Both ALP and OCN are positively expressed by differentiating 
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MSCs, with expression of both ALP (Jaiswal et al. 1997) and OCN (Nakamura et al. 
2009) considered representative of the  early osteogenic phenotype. The process of 
controlled mineralisation during bone development is at present unclear. Recent evidence 
has suggested that the presence of collagen in a hierarchical assembly, often cited as the 
formation of a collagen liquid crystal phase (Giraud-Guille et al. 2003)(Giraud Guille et 
al. 2005)(Giraud-Guille et al. 2008), can initiate and orientate the formation of the apatite 
minerals that form bone(Wang et al. 2012).  
1.4.5. Bone fracture healing 
During normal fracture healing there are three main processes that occur; the 
inflammatory phase, the repair phase, and the remodelling phase (Figure 5). During the 
initial stage prior to injury a haematoma forms, followed rapidly by the inflammatory 
phase. The inflammatory phase involves neovascularisation and invasion of collagen 
secreting fibroblasts to form a vascularised soft callus. After this the reparative phase sees 
recruitment of osteoblasts which lay down new osteoid, forming a spongy woven bone 
matrix bridging the fracture. The reparative phase see’s the formation of both 
endochondral bone, providing a soft cartilaginous template (Figure 3C), and also 
mesenchymal condensation via intramembranous ossification, leading to the formation of 
a hard callus (Figure 3D)(Marsell & Einhorn 2011). The remodelling phase then sees a 
balance of OBs and OCs resorbing and relaying new bone matrix until the injury site is 
fully healed (Oryan et al. 2013). Multipotent stem cells are believed to be involved in the 
healing process, first being recruited to the injury site by different cytokines, and 
subsequently differentiating to form new bone in the injury site(Liu et al. 2009).   The 
first two stages cumulatively last around 4-7 days whilst the remodelling phase can last 
anywhere between 6 weeks and 12 months (Tsiridis et al. 2007).  
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Figure 5: Cartoon depiction of the different stages of fracture healing  
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1.5. Tissue engineered bone 
1.5.1. Primary cell sources in bone tissue engineering  
In vitro research of bone formation utilises a range of established bone cell lines to 
probe the underlying biological phenomena that regulate both developmental bone 
formation as well as adult bone homeostasis. Human primary cells are most desirable 
since they are both clinically relevant and lack interspecies differences. There has been a 
large body of research in recent years investigating different cell phenotypes for 
engineering bone tissue. There are two main branches of stem cell that are utilised in the 
BTE, pluripotent stem cells (PSCs) and multipotent stem cells.  
 PSCs were originally extracted in the form of embryonic stem cells (ESCs) from 
the blastocyst stage of embryonic development (Reubinoff et al. 2000). PSCs possess the 
unique ability to differentiate into any cell type in the body and are often considered to be 
one of the clinical milestones for RM therapies.  This is in part due to recent developments 
in the production of induced pluripotent stem cells (iPSCs), which possess the same 
characteristics as ESCs, but have the added advantage of originating from adult somatic  
cells that have undergone genetic modification to unlock their multi lineage potential 
(Takahashi & Yamanaka 2006). Evidence has demonstrated the potential for both ESCs 
and iPSCs for in vitro production of tissue engineered bone (Marolt et al. 2012) (de Peppo 
et al. 2013). Promisingly, ESC therapies have already made their way into phase I/II 
clinical trials. Advanced cell therapies sponsored a trial investigating the effect of ESC 
transplantation on patients with Stargardts’s macular dystrophy, demonstrating improved 
ocular function after a 22 month patient follow up study with little adverse reaction to the 
treatment (Schwartz et al. 2015). However, there are still some major concerns for ESC 
and iPSC derived cell therapies that have recently come to light. There was initially hope 
that ESCs would overcome complications of immune rejection due to their limited 
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expression of histocompatable antigens (Drukker 2004). However, more recent evidence 
has shown that ESC derived tissue lineages express histocompatibility antigens that 
potentially make them unsuitable for allogeneic therapies (Nussbaum et al. 2007). Coupled 
with this,  whilst autologous iPSCs overcome the barriers set by the immune system, 
current technologies lack the ability to efficiently produce iPSC derived tissue lineages 
without introducing the risk of malignant tumour formation (Herberts et al. 
2011)(Geoghegan & Byrnes 2008).  
 
Mesenchymal stromal cells (MSCs) are were first recognised in their current 
definition by a Russian scientist, who observed adherent cell populations isolated from 
rodent bone marrow (Friedenstein et al. 1970) that were capable of forming ectopic bone 
in vivo after transplantation (Friedenstein et al. 1966). The definition of MSCs is 
generally characterised by their ability to differentiate toward derivatives of the 
mesodermal germ layer, which contributes to the formation of tissues such as bone, 
cartilage, fat, and muscle. Hence, MSCs are considered multipotent stem cell derivatives  
with a rapid proliferation potential (Piertenella et al, 2003), making them a good choice 
of cell for large scale production of cells for RM therapies. They can also be isolated in 
adults from a number different tissues in the body such as adipose tissue (Zuk et al. 
2002), dental pulp (Shi & Gronthos 2003), tendon (Salingcarnboriboon et al. 2003), 
umbilical cord blood (Secco et al. 2008), and synovial tissue (Secco et al. 2008). Since 
MSCs from bone marrow and adipose tissue can be easily isolated using low cost, 
minimally invasive procedures, and yield a high population of MSCs relative to other 
tissue sources such as umbilical cord blood (Lee et al. 2004), they have occupied much of 
the focus in research aiming to use MSCs in BTE.  
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 Bone marrow derived stem cells (BMSCs) and adipose derived stem cells (ADSCs) 
have been shown to have somewhat ostensible similarities (Zuk et al. 2001), nonetheless 
they share numerous distinct positive and negative surface markers characteristic of 
MSCs; positive: CD29, CD44, CD90, SH2/CD105 and negative: CD11b, CD14, CD45 
(Zuk et al. 2001)(Dominici et al. 2006). MSCs are shown to have potent 
immunomodulatory properties such as supressing the proliferation of T-cells 
(Klyushnenkova et al. 2005) and secretion of cytokines that can reduce inflammation at 
the site of injury (Guo et al. 2007). Interestingly, it has been shown that BMSCs and 
ADSCs also share similar immunosuppressive properties after osteogenic differentiation 
in vitro, suggesting both cell types could be suitable for allogeneic as well as autologous 
cell therapies (Niemeyer et al. 2007). However, there is conflicting evidence regarding 
the immunomodulatory properties of allogeneic MSCs, in which T-cell responses are not 
fully silenced, resulting in rejection of the allogeneic graft (Nauta et al. 2006).  
There has been a relatively large body of research  aiming to determine the efficacy of 
MSCs for BTE when sourced from different tissue types (Dragoo et al. 2005)(Niemeyer 
et al. 2010)(Niemeyer et al. 2007). An in vivo study by Niemeyer et al. use radiographic 
evaluation to compare newly formed bone in critically sized defected sheep tibia treated 
with ADSC and BMSC collagen sponges (Niemeyer et al. 2010). The results showed that 
sheep tibia treated with BMSC seeded sponges had significantly higher bone formation 
over both ADSC groups and unseeded controls, suggesting a more relevant use for 
BMSC in the clinic. However, subcutaneous fat has been found to contain up to 50-100 
times as many stem cells per gram of tissue than bone marrow aspirates (Orbay et al. 
2012),  highlighting the need for future clarity of the true efficacy in using BMSCs over 
ADSCs or vice versa.  
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1.5.2. Established cell lines for studying in vitro bone formation 
Limited availability, donor variation, and labour intensive isolation procedures are 
some key motives for substituting primary human cell lines for animal derived and 
immortalised cell lines for in vitro research. Consideration of the most suitable cell type for 
a particular experiment can maximise both output and the significance of the end result. 
Cell lines such as Mouse long bone osteocyte-A5 (MLO-A5) are useful in studying the 
transition from late OB to early OSs. This transition typically occurs when differentiating 
OBs encase themselves in mineralised matrix (Bonewald 2011). They are highly 
expressive of bone markers such as ALP and OCN (Bonewald et al. 2006), and maintain a 
high proliferative potential and consistent phenotype over multiple passages. Since they so 
readily mineralise in culture, MLO-A5s also provide a useful tool for studying 
mechanotransduction. MLO-A5s have been shown to undergo physiological changes 
during application of fluid shear in monolayer(Delaine-Smith et al. 2014)(Siller-Jackson et 
al. 2008), which leads to increased calcium deposition in both 2D (Delaine-Smith et al. 
2014) and 3D growth environments (Sittichockechaiwut et al. 2009).  
There are pros and cons of using different cell lines for different studies, reviewed 
extensively by Czenkanska et al (Czekanska et al. 2012). Czenkanska highlights that whilst 
mouse cell lines such as MLO-A5s are useful for studying bone cell behaviour, they also 
possess interspecies and genomic differences that introduce translational complications for 
BTE therapies. Coupled with this, the response of MLOA5s is not representative of less 
committed cell phenotypes such as stem cells or osteoprogenitors. Human osteoblast-like 
cells (MG-63s) provide useful insights into bone cell function. Like MLO-A5 cells they 
exhibit high proliferative potential and no loss of phenotype during extended culture. 
Unlike MLO-A5, MG-63s are thought to represent a relatively early stage of OB 
differentiation (Pautke et al. 2004). They have also been shown to exhibit a profile of 
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expression similar to primary human OBs for the mineralisation marker OCN (Czekanska 
et al. 2014). The response of MG-63s to mechanical loading has been widely reported, 
demonstrating active responses to strain (D.-Y. Lee et al. 2010), fluid flow (Su et al. 2014), 
and to a lesser extent hydrostatic pressure (Kubo et al. 1998)(Haskin & Athanasiou 1993). 
Thus MG-63s appear to represent a useful model for evaluating mechanical 
preconditioning tools that is cost effective and comparable to a large body of literature. 
Furthermore, established  protocols  for studying events that commonly occur in OBs 
exposed to mechanical loading such as increased collagen and calcium deposition (Michael 
Delaine-Smith et al. 2015) are readily available in the literature. Utilising these protocols 
could provide useful validation techniques to identify mechanotransduction events using 
our bioreactor system. Whilst primary human cell lines will be necessary to establish a 
clinical benchmark for developing BTE therapies, the range of alternative cell lines from 
other sources can generate valuable data that is cost effective and applicable across the 
scope of literature that characterise mechanical force bioreactors.  
1.6. Tissue engineering scaffolds  
Selecting the appropriate scaffold material to provide an optimal growth environment 
for in vitro bone formation encompasses in itself an entire field of biomaterials research 
in BTE. From a TE perspective, scaffolds should incorporate: an interconnected porous 
structure that allows cell migration; appropriate diffusion characteristics that enable  
efficient mass transport process; appropriate biocompatibility that supports the function 
of a desired cell phenotype; and  suitable architecture that best promotes integration and 
tissue regeneration after transplantation (Liu et al. 2007). In the context of BTE, and more 
specifically for fracture healing, scaffolds should provide adequate mechanical stability to 
the fracture site, and promoting the biological activity of bone and the surrounding tissue 
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(Babis & Soucacos 2005) (Schatzker et al. 2005). Generally the biological potential of 
BTE scaffolds is characterised by three main principles: osteoconductivity, which allow 
both implanted and native cells to proliferate and populate the scaffold (Rupani et al. 
2012); osteoinductive, to induce differentiation of osteoprogenitor cells into bone forming 
osteoblasts; and to provide a reservoir of replenishing stem cell progenitors to maintain 
bone tissues innate capacity for self-renewal  (Albrektsson & Johansson 2001)(Rupani et 
al. 2012) (Bueno & Glowacki 2009). Another important factor influencing the 
implementation of scaffolds in BTE is a controlled degradation rate. In principle, this 
would allow native cells to replace the degrading scaffold with newly synthesised extra 
cellular matrix (ECM) without negatively affecting the functionality of the injury site 
(Babensee et al. 1998).  
1.6.1. Targeted strategies in tissue engineered scaffolds 
There are numerous different studies that have attempted to incorporate these 
principles into single scaffolds. A number of groups describe the implementation of 
biomimetic hydrogels with a sustained release of growth factor cocktails to facilitate 
fracture repair (Lienemann et al. 2012)(Smith et al. 2014a)(Smith et al. 2014b)(Gothard 
et al. 2014). However, limitations exist in the use of growth factor laden scaffolds due to 
their relatively short half-life in vivo and suboptimal release kinetics, leading to 
administration of un-physiologically high concentrations of growth factors (Stevens 
2008). Administration of BMP-2 in patients receiving a posterior lumbar interbody fusion 
has been shown to lead to neurological impairment due to ectopic bone formation in the 
lumbar canal (Wong et al. 2008). Other approaches have attempted to overcome the 
safety concerns associated with growth factor loaded scaffolds by utilising techniques 
such as magnetic targeting of cell surface receptors which are thought to regulate stem 
cell differentiation (El Haj et al. 2012)(Henstock et al. 2014). Whilst this approach seems 
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promising in terms of safety versus growth factors, current research is yet to provide 
preclinical data and subsequent evaluation of efficacy in larger animal models that is 
required for clinical translation. 
1.6.2. Synthetic vs natural biomaterials 
The argument of whether to use synthetic versus natural biomaterials for BTE is 
difficult to interpret since both approaches have distinct and numerous advantages over 
the other. For example, synthetic biopolymers are considered to offer an advantage over 
natural biopolymers since they can be tailored to give a wide range of properties and 
more predictable kinetics (Liu et al. 2007). As such, there has been a large research space 
occupied by the development of synthetic biopolymers, particularly those which have 
already obtained FDA approval for use in humans such as poly-lactic acid (PLA), 
polyglycolic acid (PGA), polycaprolactone, (PCL) and poly(lactic-co-glycolic acid) 
(PLGA) (Ma 2004)(Liu et al. 2007)(Pitt et al. 1981). Today, synthetic polymers are 
commonly used in orthopaedic surgery due to their biocompatibility and ability to 
undergo bulk degradation at a predictable rate (Hutmacher 2000)(Rothstein et al. 2009).  
Natural biomaterials possess an intrinsic advantage over synthetic biomaterials in that 
they are in many cases derived from the ECM of native tissue. Collagen for example is 
arguable the most widely used natural biomaterial in TE because it constitutes the 
majority of proteins found in mammals, accounting for over 1/3 of the total protein 
content in the body (Patino et al. 2002). In reference to BTE, collagen type 1 is 
extensively used as a biomaterial, both in its pure form and in composite with many other 
natural and synthetic materials (O’Brien 2011). Many collagen composites have already 
seen clinical approval for use in humans such as: collagen/glycosaminoglycan 
copolymers for skin regeneration  (Yannas et al. 1989); mineralised collagen scaffolds for 
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lumbar spinal fusions (Neen et al. 2006)(Ploumis et al. 2010); collagen tricalcium 
phosphate composites for lumbar spinal fusions (Kraiwattanapong et al. 2005); and 
demineralised bone matrix in a type 1 collagen/sodium alginate carrier for alveolar cleft 
reconstruction (Francis et al. 2013). Interestingly, collagen alginate scaffolds have also 
been developed into a tuneable hydrogel composite to allow user defined initiation of 
human pluripotent stem cell differentiation (Dixon et al. 2014). This suggests future 
research using these clinically approved materials might be adapted to allow controlled 
differentiation and replenishing of the stem cell pool after transplantation. The use of 
collagen in BTE arguable represents one of the more clinically relevant strategies to 
translate research from the bench to the bedside; however certain aspects of its use still 
need addressing such as its poor mechanical properties (O’Brien 2011). 
1.7. Tissue engineering models 
 Since RM ultimately aims to employ translatable research into medical 
treatments, the associated regulatory hurdles make it essential that not only are potential 
treatments safe, but that they demonstrate sufficient efficacy in preclinical testing.  
Muschler and colleagues summarise in detail the challenges facing translational research 
in bone tissue engineering (Muschler et al. 2010). They highlight the use of animal 
models to provide relative clinical efficacy, but also identify gaps in the availability of 
such systems based on three principles. The first discusses the need for assessment of the 
predictive power of such models, taking into account variation between different species 
and how this translates to use in humans. The second considers the need for models that 
mimic the wound healing process; incorporating the healing environment whilst 
considering mass transport conditions in different sized injuries. The third, and perhaps 
the most relevant from a research point of view, is the ability to measure and detect 
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different effects such as cell trafficking events and cell fate during bone remodelling and 
regeneration. Gothard et al. provide an extensive review on the current use of animal 
models and the associated factors one should consider in selecting appropriate models for 
clinical evaluation of BTE therapies (Gothard & Smith 2014). Similar to Muschler and 
colleagues, Gothard et al. describe in some detail the importance of identifying animal 
models in which the interspecies similarities in bone physiology can allow effective 
translation of treatments into humans. For example, pig models could be advantageous in 
this sense, since their anatomy and mineral bone density is not too dissimilar from 
humans (Aerssens et al. 1998). In contrast, rat models whilst being low cost and high 
throughput relative to pig models, their small size and high rate of bone turnover 
introduces translational problems when considering the scale up of vascularised bone 
constructs (Gomes & Fernandes 2011).  By taking into consideration these key aspects of 
animal models, I can review the current basis of research on which animal models best 
suits a translational based evaluation of the hydrostatic force bioreactor.   
 
1.7.1. Live animal models 
 The use of live animal models to evaluate potential treatments for large bone 
defects addresses models that incorporate the wound healing process, whilst considering 
mass transport complications that might arise from massive bone loss, due to for example 
bone tumour resections. Zhu and colleagues modelled repair of critical sized femur 
defects in goats, using autologous bone marrow stromal cells in natural coral scaffolds 
(Zhu et al. 2006). They showed a significant increase in healing of the defect versus 
acellular scaffolds and empty defects, and importantly that the loading bearing capacity in 
the injury site after 4 months was similar to the opposite side normal femurs. Studies 
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have also demonstrated increased healing capacity in defects using autologous based stem 
cell therapies in different animal species including; primate models (Boden et al. 
1998)(Cook et al. 2002) canine models (Luangphakdy et al. 2013); and equine and ovine 
models (Niemeyer et al. 2010) among many others. Smaller animal models can overcome 
some of the time and cost constraints that limit the use of larger animal models. For 
example, preclinical evaluation of autologous cell therapies for bone defect repair has 
shown success in rabbits (Zhang et al. 2012), and mice (Zwingenberger et al. 2013). 
Interestingly clinical translation of rabbit models has been successful, with the use of 
Progenix™ Putty showing efficacy in rabbits (Smucker & Fredericks 2012), and now 
clinically approved for use in humans (Kurd et al. 2015). 
 
1.7.2. Organotypic models of tissue regeneration  
Whilst live animal models are useful from the point of view of preclinical testing, 
Gothard et al. correctly identify that live animal models in any form are inherently 
unethical (Gothard & Smith 2014). Moreover, live animal models do not represent a 
transition in today’s research toward the ‘three Rs’ principle (replacement, refinement 
and reduction). The Animal (Scientific Procedures Act) 1986 incorporates the three R’s 
principle into law (Hollands 1986), rightly urging scientists to approach medical based 
research without relying on live animal models.  Coupled with this, the ability to monitor 
cell trafficking and cell fate (Muschlers 3
rd
 consideration (Muschler et al. 2010)) is made 
complicated by the use of live animal models when compared with recent advances in 
organotypic tissue models.  
Organotypic models of tissue regeneration have been providing researchers with a 
base for addressing the three R’s by trying to recapitulate in vivo niches of both 
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developmental and adult systems. The use of organotypic tissue models has provided a 
platform to study  regeneration of spinal cord lesions (Weightman et al. 2014), skin (Oh 
et al. 2014) and bone, using embryonic chick femurs (Smith et al. 2013)(Kanczler et al. 
2012). The developing chick embryo offer a useful developmental system to study bone 
repair, and has received a revival in recent years due to both time and cost effectiveness, 
and reduced ethical concerns owing to the stage of embryonic development in which the 
chicks are culled. The model has proven effective in studying the developing bone niche 
in a vascularised environment (Gellynck et al. 2013) using the chorioallantoic membrane 
(CAM)  assay. The isolation of chick femurs has been utilised for modelling bone 
formation in response to pharmacological agents (Smith et al. 2015) and to study femoral 
defect repair (Smith et al. 2014a)(Smith et al. 2014b). As mentioned previously, our 
bioreactor system has already proven effective in stimulating new bone formation in 
isolated chick femurs, thus the potential to use this model to study the effect of 
hydrostatic pressure on fracture repair could provide interesting and novel findings. 
Coupled with this, the use of isolated chick femurs is easily compatible with Muschlers 
3
rd
 consideration and can allow accurate tracking of cells, as well as their associated stem 
cell fate.  
1.8. Mechano-active responses in bone cells 
 A mechanically active environment in vivo is crucial in the development and 
maintenance of bone tissue. The effect of increased or reduced mechanical stimulus is 
demonstrated by observations of an average 30% thicker cortical bone in the fore arms of 
elite tennis players (Jones et al. 2007),  to a significant loss in bone mass in people 
exposed to prolonged bed rest (Rubin et al. 2001). In vitro studies have suggested OSs to 
be primary mechanosensors in bone, evidenced by the development of fragile bones and 
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micro fractures in mice when OS function was ablated (Tatsumi et al. 2007).  
Interestingly the same study showed that ablation of osteocyte function also prevented the 
loss of bone mass in mice after prolonged hind leg unloading, suggesting that osteocytes 
may orchestrate both the formation of bone by osteoblasts and the resorption of bone by 
OCs. As mentioned earlier in this chapter, mechanical loading of osteocytes has been 
shown by a number of studies to induce NO production (Fox et al. 1996)(Tjabringa et al. 
2006)(McGarry et al. 2005), which has been reported to inhibit OC function (Tan et al. 
2007)(van’t Hof & Ralston 1997) whilst also stimulating OB function (Mancini et al. 
2000). Other signalling events commonly associated with mechanical loading in bone 
cells include; ion channel activation (el Haj et al. 1999)(Yang et al. 2002), integrin 
mediated gene transcription (Plotkin et al. 2005), and mechanosensing by primary cilia 
(Temiyasathit et al. 2012)(Malone et al. 2007). The overall picture of how these events 
regulate bone remodelling in vivo is complex and to date not fully understood. However, 
a consistent agreement in the literature, first proposed by the surgeon Julius Wolf in the 
19
th
 century (Chen et al. 2010) is that mechanical loading of bone is translated into 
biochemical signals in cells, resulting in adaptive bone remodelling.  
1.8.1. Distinguishing between different types of force 
It is generally accepted that mechanical loading of bone tissue generates: high 
hydrostatic pressures in the interstitial fluid that fills the lacuna network (D. Zhang et al. 
1998); interstitial fluid flow resulting from pressure gradients in the lacuna network of 
bone (Munrow & Piekarski 1977); and strains caused by physical deformation of bone 
ECM(Burr et al. 1996). Hydrostatic -pressure by definition is the force exerted by a fluid 
in a confined space. The force transduction of pressure on an object will depend on the 
compressibility of the object, either leading to deformational stress and strain if the object 
is compressible, or static pressure if the object is incompressible. Since bone is relatively 
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incompressible, and pressure is transduced through interstitial fluid, which is also 
incompressible, the transduction of force from hydrostatic pressure to cells is considered 
to be static and does not induce significant deformational change. By contrast, if 
hydrostatic pressure gradients are generated upon loading, fluid flow in the lacuna space 
can result fluid shear and deformational strain on osteocytes in the lacuna network, hence 
it is important to distinguish the effect of static vs dynamic in the context of changes in 
cell behaviour upon loading.   
1.8.2. Influence of strain 
Strain is an intrinsic consequence of mechanical loading in bone tissue. Estimates 
of strain in human bone during loading have suggested: peak compressive strains of -
(400-600μϵ) when walking and -(500-1000μϵ) when running; a peak tensile strain of 
between 400-500μϵ when walking and 600-700μϵ when running; and peak shear strains 
of 800-1000μϵ when walking, and 900-1600μϵ when running (Burr et al. 1996). Chen and 
colleagues provide an excellent summary of the various mechanical factors that influence 
bone remodelling (Chen et al. 2010). Interestingly, they suggest that hydrostatic pressure 
and fluid flow rather than strain to be the primary stimuli for OSs, and that strains role in 
providing mechanical stimuli is more prominently featured in OB precursors present in 
the softer fibrous tissue of the periosteum, which would deform significantly during 
loading relative to cortical bone.  A number of groups have observed enhanced 
proliferation in MSCs due to applied strains (Song et al. 2007)(Qi et al. 2009)(Subramony 
et al. 2013). The effect of strain has been implicated to be sensitive to the loading regime. 
As an example, Kioke et al. showed that MSC proliferation was enhanced at higher 
strains, whereas osteogenic differentiation was more favoured at low strains (Koike et al. 
2005). Lee et al. also reported changes in response to strain in adipose derived MSCs, 
where strain inhibited both proliferation and cell differentiation. This might imply that 
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responses of MSCs from different cell niches can also affect cellular response to strain 
(Lee et al. 2007). The effect of strain in osteoblast phenotypes is reportedly similar to that 
of MSCs, with increases observed in cell proliferation (Ignatius et al. 2005) and 
osteogenic differentiation  (Ignatius et al. 2005)(Visconti et al. 2004). It should be stated 
however that the Visconti also reported changes in cell behaviour according to the 
characteristics of the applied strain regime. It should be mentioned that Mullender et al. 
discuss in their paper the ambiguity associated with many in vitro systems for applying 
strain, whereby by ‘true strain’ is in fact not present and is in most cases accompanied by 
fluid flow (Mullender et al. 2004). Interestingly they demonstrate that fluid flow and not 
strain was responsible for prostaglandin E2 (PGE2) production in human primary bone 
cells, whereas both strain and fluid flow influences NO production. This demonstrates 
nicely how changes in the nature of the applied force can potentially change the 
behavioural outcome of bone cells. 
1.8.3. Influence of fluid flow 
As mentioned previously, fluid flow in bone occurs due to pressure gradients in the 
canaliculi and lacuna spaces of bone during normal loading (Munrow & Piekarski 1977). 
This fluid flow is sensed by osteocytes as shear force and is translated into biochemical 
signals that regulate bone formation.  Early experiments have shown onset of NO 
signalling in chick osteocytes but not periosteal fibroblasts following just a few minutes 
exposure to fluid flow (Klein-Nulend et al. 1995). Other studies have observed similar 
phenomena, whereby fluid shear induces rapid onset of PGE2 production in MLO-A5 
cells (Delaine-Smith et al. 2014), less committed MC3T3 preosteoblasts (McGarry et al. 
2005) and more recently NO release in MSCs (Lu et al. 2015). It should be mentioned at 
this point that NO and prostaglandins are often used interchangeable when defining 
mechanotransduction in cells responding to fluid flow. This is in part due to the evidence 
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describing NO increasing the activity of cyclooxygenase (COX) enzymes (Salvemini et 
al. 1993), which act as a precursor to the synthesis of prostaglandins (Mollace et al. 
2005). After the onset of NO or PGE2 release, another widely reported phenomena that 
occurs are after mechanical stimulation with fluid flow is stress fibre formation in the 
actin cytoskeleton (Chen et al. 2000) (McGarry et al. 2005)(Gardinier et al. 2009). 
Interestingly, the study by Gardinier et al. directly compared the effect of fluid shear and 
cyclic hydrostatic pressure in osteoblasts, concluding that whilst similarities occurred in 
the levels of COX2 expression, the effects on cytoskeletal remodelling were distinct to 
each stimulus. A recent study suggested that cytoskeletal tensioning is a necessary 
requirement for osteogenic differentiation via Runx2 transcription in murine 
mesenchymal stromal cells exposed to fluid flow (Arnsdorf et al. 2009). It may be that 
changes in cytoskeletal dynamics during mechanical loading contributes to the changes in 
cellular behaviour.    
Our current understanding of fluid flow and its effects on bone cells extends from 
the very earliest responses to flow as discussed above, to its prolonged effect on the 
osteogenic differentiation of stem cells and their ability to produce new bone.   There is a 
large body of research studying the effect of flow perfusion systems that aim to improve 
the outcome of tissue engineered bone. Unlike strain, application of fluid flow in vitro 
possesses the ability to provide a combinatorial stimulus in the form of mechanical 
signalling, and improving the homogeneity of tissue maturation through enhanced 
nutrient diffusion.  This effect has been demonstrated by a number of groups in: synthetic 
biomaterial scaffolds  (Porta et al. 2015); natural biomaterial scaffolds  (Antebi et al. 
2013);  and also trabecular bone explants (Grayson et al. 2008). Other groups have also 
utilised a combination of fluid flow and compression (Hoffmann et al. 2015)(Bouet et al. 
2015),  with earlier reports suggesting that the combination of both compression and fluid 
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flow is a more effective stimulus than fluid flow or compression alone (Bolgen et al. 
2008). 
1.8.4. Influence of Hydrostatic Pressure 
The use of hydrostatic pressure (HP) as a therapeutic tool was first recognised by Lipello 
and co-workers in 1985 when they observed increased metabolic activity in articular 
cartilage segments when exposed to low hydrostatic pressure (Lipello et al. 1985). The 
majority of studies using hydrostatic pressure that have been performed over the last 15 
years regarding hydrostatic preconditioning in cell seeded scaffolds have focussed on 
functional improvements to cartilage tissue (Table1). The functional aspects of cartilage 
are considerable different to bone. For example, hydrostatic pressures have been 
estimated at as high as 18MPa in cartilage tissue present in the hip joint (Afoke et al. 
1987), nearly an order of magnitude higher that pressure estimated in the interstitial fluid 
of bone (D Zhang et al. 1998). In addition to this, whereas the main constituent protein in 
bone is collagen type I, cartilage consists primarily of collagen type II (Sophia Fox et al. 
2009). Despite these functional differences it would not unreasonable to postulate that 
mechanisms of mechantransduction that occur in bone and cartilage are related, 
particularly when we consider the transition from cartilage to bone during the process of 
endochondral ossification. The effectiveness of HP for stimulating in vitro bone 
formation (Table 2) clinically relevant cell types such as hMSCs is not currently well 
defined. Many groups have adopted fluid shear as the primary mechanical stimulus for 
tissue engineered bone, however there have been some interesting findings in the last 10 
years regarding hydrostatically stimulated bone formation (Table 2).  
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Table 1: Key articles published in recent years concerning the effect of HP on cartilage tissue engineering 
 
Study Methods Results 
 
(Angele et 
al. 2003) 
 hMSC aggregates 
 Cyclic HP, 1Hz, 0.55 – 5MPa, 3h/day for 7 days,  
 14-28 day culture, chondrogenic media 
HP resulted in larger constructs and histological staining indicated a 
greater matrix/cell ratio. Stimulated groups showed statistically 
significant increases in proteoglycan and collagen content at day 14 and 
day 28. 
 
(Miyanishi 
et al, 2006) 
 hMSC’s pellet cultures  
 Cyclic HP, 1Hz, 0.1-10MPa  4h/day 
 14 day culture in chondrogenic media 
HP in the presence of growth factors increased chondrogenic gene 
expression up to 3.3 fold by day 14. Extracellular matrix deposition of 
type II collagen and aggrecan increased in cell pellets. 
 
(Meyer et al, 
2011) 
 
 hMSCs multiple donors seeded in agarose gel scaffold,  
 Cyclic (10MPa) 1Hz, 1hr/day) and continuous HP(10MPa)  
 42days culture, chondrogenic media 
 
 
HP increased collagen and GAG accumulation by day 42, resulting in an 
increased dynamic modulus compared to FS controls. Effect variable 
between donors. Static pressure had no effect on either matrix 
accumulation or construct mechanical properties for both donors 
 
(Jeong et al. 
2012) 
 hMSC/chondrocyte co-culture seeded in Alginate gels 
 Continuous HP, 0.02- 0.2MPa 2min HP, 15min rest, 2h/day, 7 days 
 20 day culture, proliferation media. 
HP resulted in higher proliferation of MSCs Gene expression of Collagen 
type II, SOX9, and aggrecan in MSCs under intermittent HP was 
comparable with that in unstimulated MSCs in chondrogenic media. 
 
(Steward et 
al. 2012) 
 hMSC’s seeded in either agarose or fibrin gels 
 10MPa 4hr/day CHP, 1Hz,  
 3 week culture, in chondrogenic media 
Agarose gels better supported tissue maturation.  Significant increase in 
secretion of sGAGs present only in fibrin gels exposed to HP. HP 
decreased ALP activity in both agarose and fibrin. 
 
(Correia et 
al. 2012) 
 hASC seeded  gellan gum  hydrogels 
 Cyclic(0.1-1Hz, 3hr/day) and Sustained(3hr/day) HP 0.4-5MPa 
 3 week culture, chondrogenic media.  
 Cyclic HP resulted in enhanced chondrogenic differentiation and matrix 
deposition at physiological loading (5MPa), indicated by increased gene 
expression of aggrecan, collagen type II, and sox-9. 
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Study Methods Results 
 
(Chenyu & 
Rei 2012a) 
 hMSC seeded hydroxyapatite scaffold.  
 Cyclic HP 0.5Hz, 0 – 500kPa, no rest period. 
 3week culture, osteogenic media 
 
HP resulted in cells distributed evenly throughout the scaffolds. HP 
groups expressed higher levels of osteocalcin, osteopontin, osteonectin 
and collagen type 1 versus controls after three weeks. 
 
(Kim et al. 
2007) 
 hMSC seeded polymeric scaffolds 
 200kPa for 1min under combined with fluid shear, 14mins rest. 
Controls receive fluid shear only 
 21 days culture in osteogenic media 
 
Enhanced expression of osteocalcin in HP treated groups over 21 days. 
Effect of HP was supressed by addition of U0126-MAP kinase inhibitor.  
 
(Maxson & 
Burg 2012) 
 hMSCs seeded in 2% agarose constructs. 
 2.5hrs perfusion followed by 30 mins Cyclic HP, 300 kPa, 0.5Hz, 
4hrs stimulation/day 
 21 day culture in both osteogenic and chondrogenic  conditioned 
media (CM)   
Increase in osteogenic differentiation in HP treated cells cultured in 
chondrogenic conditioned media. Increased chondrogenic 
differentiation in HP treated cells cultured in osteogenic conditioned 
media. 
 
(Henstock et 
al. 2013) 
 Ex vivo culture chick foetal femurs 
 0-280kPa, 1 hr, 0.001-1hz.  
 14 days culture in either basal or osteogenic media 
Increased bone formation and bone density in HP treated femurs - 
linearly dependant of cycling frequency. Increases in bone formation 
only observed in osteogenic but not proliferation media. 
 
(Zhao et al. 
2015) 
 hMSC monolayer cultures  
 30-300kPa 1hour static pressure 
 2 week culture in osteogenic media 
Increased expression of collagen type1 and osteocalcin in HP treated 
cells after 1 week but not after 2 weeks. Increased F-actin stress fibre 
formation immediately after pressure. 
 
(Reinwald et 
al. 2015) 
 Chick skeletal cells seeded in collagen hydrogels 
 280kPa, 1hr, 1Hz, 5days/week 
 2 weak culture in osteogenic media 
Increased matrix mineralisation and density after 14 days in HP treated 
groups. mathematical modelling indicated increased stress and fluid 
shear at hydrogel boundary caused peripheral mineralisation of the 
hydrogels 
Table 2: Key articles published in recent years concerning the effect of HP on bone tissue engineering 
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If we adopt a comprehensive view of evidence encompassing studies performed 
on both cartilage and bone, it becomes clear that the therapeutic effects of HP on tissue 
regeneration are broadly similar. Cyclic but not static pressure appears effective in 
upregulating chondrogenic (Correia et al. 2012)(Meyer et al. 2011) and osteogenic 
(Henstock et al. 2013) gene expression,  which is followed by enhanced tissue 
maturation. It appears too that HP alone improves homogeneity of tissue engineered 
cartilage (Huang et al. 2010) and bone (Chenyu & Rei 2012b). It is interesting to note 
that some studies utilise a combination of HP and fluid flow (Maxson & Burg 2012) 
(Kim et al. 2007) based on evidence demonstrating increased homogeneity in engineered 
bone tissue (Grayson et al. 2008). Whilst there is a broad agreement in the literature on 
the effect of HP as a therapeutics stimulus, the effect of HP appears to highly sensitive to 
the cell matrix environment. Steward et al. reported a reduction in HP induced sulphated 
glycosaminoglycan (sGAG) in hMSC cartilage constructs when changing the ECM 
environment from fibrin to agarose (Steward et al. 2012).  Steward went on to show that 
HP induced changes in agarose cartilage constructs depended on construct stiffness as 
well as the presence of arginylglycylaspartic acid RGD binding sites (Steward et al. 
2013). The effect of substrate stiffness on stem cells has been shown to have a significant 
effect on the lineage commitment of undifferentiated hMSCs (Engler et al. 2006). Based 
on this, it would be interesting to study the effect of substrate stiffness and HP, which has 
not yet been investigated in hMSC undergoing osteogenesis.  
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1.9. Mediators of mechantransduction 
1.9.1. Ion channels  
Ion channels were first shown to mediate mechanotransduction in Escherichia Coli in 
1985 by Sachs et al. (Sachs 1985). There is a large body of literature documenting the 
role of ion channels in mediating cellular function in response to mechanical stimuli. Ion 
channels are macromolecular pores in the cell membrane which function to stabilise 
membrane potentials by allowing the flow of ions across the cell membrane (Figure 6). 
When the cell membrane undergoes conformational change, fluctuations in 
intra/extracellular ion potentials are believed to trigger signal cascades, resulting in 
transcription of genes specific to the applied stimulus (Hille 1984). Ion channels are 
referred to as gated if they can be opened or closed, and stimuli for such gating events 
can be electrical, chemical or mechanical (Garcia 2004). During these gating events, 
different ions pass in and out of the cell such as potassium (K
+
), sodium (Na
+
) and 
calcium (Ca
+
) (Sackin 1995), which in turn will have specific actions on cell behaviour. 
For example, in osteocyte MLO-Y4 is has been shown that three distinct forms of K
+ 
currents are active across the cell membrane during stimulation with different 
pharmacological agents (Gu et al. 2001), and that these characteristics lead to distinct 
functions in OSs versus more osteoblastic phenotypes (Rawlinson et al. 1996). 
Subsequent events following ion channel activation such as NO and PGE2 production 
(Rawlinson et al. 1996) can be induced via application of external mechanical loading. 
NO and PGE2 are widely reported to be produced by bone cells in response to 
mechanical loading (McGarry et al. 2005)(Reher et al. 2002)(Siller-Jackson et al. 2008), 
suggesting ion channels might mediate these signalling events during mechanical loading. 
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Studies investigating ion channel activation under hydrostatic pressure are relatively 
limited. Ulb et al. used patch clamping techniques to observe increased membrane 
potential in opossum kidney cells under hydrostatic pressure  (Ubl et al. 1988). HP was 
also found to stimulate adenosine triphosphate (ATP) release in rat bladder urethral cells, 
which was subsequently completely diminished after inhibiting stretch activated channels 
along with transient receptor protein (TRP) channels  and epithelial sodium channels 
(Olsen et al. 2011). In bone cells,  patch clamping has been used to investigate the effect 
of applied pressure in osteoblast osteosarcoma G292, which showed locally applied 
membrane pressures of 0-50kPa resulted in increased membrane potential (Davidson et 
al. 1990), a phenomena observed in osteocytes after exposure to prostaglandin E2 (Chow, 
1984) . Klein-Nulend et al observed increased PGE2 production in  both osteoblasts and 
osteocytes exposed to 15kPa, 0.3hz HP (Klein-Nulend, 1995), implying a relationship 
between membrane potential, PGE2 and HP that could be mediated through ion channel 
activation. Surprisingly, whilst the influence of HP on NO release has been reported in 
Figure 6: Picture representation of ion channels found on the cell membrane.  A) 
Voltage gated ion channels. B) Stretch activated ion channels (Garcia 2004) reprinted 
with permission of Nature publishing group [license number: 3794280056729] 
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the eye (Liu & Neufeld 2001) and in the renal system (Majid et al. 2001), the effect of HP 
on NO production in bone  remains poorly characterised. 
1.9.2. Primary cilia 
Primary cilia (PC) are cell membrane protrusions into the extra cellular space 
comprised of an axoneme of nine doublet microtubules encapsulated by a continuous 
membrane that is incorporated into the cell’s plasma membrane. The microtubules are 
linked to the cytoskeleton via a subset of cytoplasmic microtubules at the base of the 
doublet microtubule structure (Anderson et al. 2008). PC have been well described in a 
number different cell types including osteocytes, osteoblasts (Whitfield 2008) and 
hMSCs (Shao et al. 2012). They act as both chemical and mechanosensors, relaying 
signals for a variety of cellular functions in most tissues in the body (Christensen, 2007). 
Genetically engineered mice with a knockout of  Kif3a, an osteocyte specific protein 
required for  PC formation, show reduced bone forming ability in response to mechanical 
loading (Temiyasathit et al. 2012). More recent in vivo evidence has also shown that 
Kif3a deletion in mice results in poor integration of implants with native bone, suggesting 
that PC also play a role in osseo-integration of implants in an orthopaedic setting (Leucht 
et al. 2013). Hence PC are considered an essential organelle both in regular maintenance 
of bone and its response to external mechanical stimuli. 
 
 
 
 
 
Fig 7 
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            As discussed in previous sections, mechanical stimuli in vivo results in local 
deformation in bone matrix leading to pressure gradients and fluid flow in the canaliculi, 
hence PC could likely to experience a number of different forces. In the context of 
defining PC response to the different ‘types’ of force as defined previously, it is 
interesting highlight that the present body of literature suggests that deviatoric forces 
such as fluid shear are mainly responsible for PC mediated mechanotransduction in bone 
cells. Indeed there is strong body of evidence reporting how deformation of PC by fluid 
shear increases osteogenic gene expression (Malone et al. 2007), calcium deposition by 
osteoblasts (Delaine-Smith et al. 2014). Interestingly whilst pressure sensing has been 
reported by primary cilia in the eye (Luo et al. 2014), there appears no evidence to 
Figure 7: Structure and function of primary cilia in osteocytes.   A) Primary cilia structure. 
B) Proposed mechanism of primary cilia mediated mechanotransduction in osteocytes. Adapted 
from (K. L. Lee et al. 2010). Reprinted with permission of Springer Link [license numbers: 
3794800269031, 3794800388861]. C) Immunofluorescent staining visualising primary cilia 
(green) in MLO-A5 osteocytes using acetylated alpha tubulin antibody.   
Microtubule doublets 
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Basal body 
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suggest hydrostatic pressure sensing  by PC in bone. This may in part be down to trying 
to rationalise a mechanism by which static pressure could induce deviatoric stress on PC 
that could be translated to biochemical signals in the cell. One could speculate that if 
bone cells contain a source of compressible material, application of external hydrostatic 
pressures could generate internal fluid flows in the cell which results in transport of 
biomolecules through the PC, creating internal, as opposed to external fluid shear caused 
by extracellular fluid flow. 
However, current evidence indicates that physical deformation of PC results an influx 
of Ca
+
 through stretch activated ion channels residing on the ciliary axoneme (Figure 
7B). This has been demonstrated in renal epithelial cells   (Liu et al. 2005) and also 
osteoblasts and osteocytes (Xiao et al. 2006). A recent study also directly observed Ca
+ 
signalling through osteocyte PC using fluorescence energy resonance transfer (FRET) 
biosensors (Lee et al. 2015). However there is conflicting evidence regarding the actual 
significance of Ca
+
 influxes and mechanosensation in bone cells (Malone et al. 2007), 
and very recently in a number of different cell types isolated from transgenic mice 
expressing a Ca
+ 
flux sensitive  PC reporter construct (Delling et al. 2016).  It appears 
then that the role of PC in mediating bone mechanotransduction is diverse, complex and 
to date, poorly understood. This does however present exciting opportunities to test novel 
hypotheses using the mechanical force bioreactors, yielding valuable information on the 
nature of PC mediated mechanotransduction in bone. 
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1.9.3. Integrin receptors 
 Integrin receptors are described as trans-membrane protein structures consisting of 
heterodimers made up from α and β subunits (Rubin et al. 2006). Integrins tether a cell to 
the surrounding ECM and are involved in regulating a number of physiological 
phenomena including embryonic development (Yang et al. 1993)(Stephens et al. 1995), 
tumour progression (Reynolds et al. 2009), programmed cell death (Cardó-Vila et al. 
2003), bone resorption by osteoclasts (Teitelbaum 2000) and mechanical sensing of the 
ECM (García & García 2014). In stem cells, it now widely accepted that the mechanical 
environment of the ECM has a strong influence on stem cell behaviour (F. M. Watt; T. S. 
Huck 2013).  As such, there has been a recent revival in research studying integrins and 
their downstream effectors. Engler et al. arguable provides the most comprehensive 
evidence yet demonstrating the effect of mechanical sensing on stem cell behaviour. They 
were able to show that hMSC grown on soft substrates differentiated into neurons, 
medium stiffness promoted myogenic differentiation, and hard substrates promoted 
osteogenic differentiation (Engler et al. 2006).  Integrin’s transmit information about the 
local microenvironment through focal adhesions attached to the actin cytoskeleton 
(Nemir & West 2010). The interaction of integrins with the ECM determines the effect 
that ECM can have on cell behaviour. In the context of osteoblast function, it has been 
shown that RGD binding sites promote integrin mediated activation of focal adhesions, 
which in turn initiated increased matrix mineralisation in partially denatured collagen 
relative to intact collagen ECM (Taubenberger et al. 2010). This highlights how small 
changes in the ECM environment can have pronounced effects on tissue development due 
to the specificity of integrin mediated cell responses.  
The role of specific integrins in mediating certain cell responses such as 
differentiation in stem cells is currently not well defined. However there are a number of 
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common downstream events that occur as a result of the interaction of integrins with 
focal adhesions. In the latter case of substrate stiffness these include; actin stress fibre 
formation (Discher et al. 2005), increased cell spreading and adhesion (Yeung et al. 
2005) and nuclear translocation of transcriptional proteins that regulate stem cell 
differentiation (Dupont et al. 2011). In the case of the latter Dupont et al. demonstrated 
that the yes-associated protein (YAP) not only regulates stem cell differentiation but also 
by inducing expression of YAP, showed that it acts to override physical constraints such 
as ECM stiffness that dictate cell behaviour. 
 Since integrins act as the initial sensory mechanism of the cell to the ECM, it seems 
reasonable to postulate that external forces like hydrostatic pressure might further 
enhance integrin mediated changes in cell behaviour, similar to those observed when 
changing substrate stiffness. This hypothesis seems reasonable when we consider that 
integrin’s are able to translate the stiffness of the surrounding ECM into stiffening of the 
cell itself (Tee et al. 2011)(F. M. Watt; T. S. Huck 2013) (Figure 8). Coupled with this, it 
has been shown that both fluid flow and hydrostatic pressure increase cell stiffness in 
MC3T3 osteoblasts (Gardinier et al. 2009).  
Consideration of integrin mediated responses in cells provokes re-assessment of 
experimental design parameters when attempting to define the effectiveness of 
hydrostatic pressure for in vitro preconditioning of bone. The varied range of effects in 
cells exposed to HP reported in the literature are could due to changes in design between 
experiments, which based on current evidence, would have a profound effect on integrin 
mediated mechanotransduction. In light of this, evidence describing integrin mediated 
mechanotransduction provides us with a robust set of comparisons through which we can 
delineate the possible underlying mechanisms. Moreover, there is to date no evidence 
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detailing the mechanisms described above on different stiffness substrates in the context 
of stem cells and hydrostatic pressure.  
For the purpose of characterising mechanoactive responses in our bioreactor, the 
literature provides a platform for developing rapid, high throughput screening of events in 
cells responding to hydrostatic loading. Understanding such mechanisms could contribute 
to a deeper understanding of the interplay between mechanical stimuli, the cell 
microenvironment and their combined effect on in vitro bone formation. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 8: Cartoon representation of effect of ECM stiffness on cell sensing of the 
surrounding microenvironment. In softer microenvironment (A) (low concentration 
collagen hydrogel) cell traction forces through integrin receptors deform the ECM 
microenvironment. In stiffer microenvironments (B) (higher concentration collagen 
hydrogel) cell traction forces are instead directed through the actin cytoskeleton and 
hence change the subsequent behaviour of the cell such through events such as cell 
stiffening (Tee et al. 2011). Figure adapted from (F. M. Watt; T. S. Huck 2013). 
Reprinted with permission of Nature publishing group [licence number: 3795980655788] 
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1.10. Hydrostatic force bioreactors for bone tissue engineering 
The development of hydrostatic force bioreactors may provide a translatable platform 
to transfer knowledge of in vitro tissue engineering concepts to applicable clinical 
procedures. An evidence based understanding of what chemical/mechanical conditions 
are best suited to generate bone tissue in vitro should be combined with the appropriate 
bioreactor design that appropriately addresses both clinical and manufacturing 
requirements. A key element of bioreactor design utilises the appropriate mechanical 
stimuli, as well as a move towards an automated platform to allow a reduction in batch to 
batch variability. A clinically translatable bioreactor system should ideally be scalable 
from a manufacturing point of view. This requires the design to enable simultaneous 
culture of multiple constructs without affecting individual construct maturation. The 
study by Maxson and Burg (detailed in Table 2) utilises a bioreactor design that 
incorporates both fluid flow and HP as stimuli, allowing a combination of forces to be 
simultaneously applied whilst also replenishing media, thus eliminating human 
intervention during culture. Whilst this is a promising approach to design clinical 
translatable bioreactors, the system only allows for stimulation of a single construct at a 
time (Orr & Burg 2008). This is a disadvantage on two fronts: The first disadvantage 
from a manufacturing perspective is scalability, and from a research point of view, the 
lack of sample numbers required to generate statically relevant data from a single 
experiment. The second disadvantage is the complexity of the system. The use of 
multiple valves within a peristaltic pump configuration required for fluid flow, introduced 
air bubbles in the bioreactor chamber and interfered with HP treatment. This was 
overcome through design adjustment; however it highlights potential complications that 
can arise from using combinatorial stimuli in such systems.  
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Another similar system using media perfusion in combination with HP have 
addressed the issue of scalability, to allow multiple constructs  (Chenyu & Rei 2012b). 
However, experiments designed to delineate fluid shear and pressure were not carried 
out, making it difficult to separate the effect of HP versus fluid flow in stimulating bone 
formation. (Meyer et al. 2011) utilised a bag configuration submerged in a pressurised 
water tight vessel. Whilst this has the advantage of being in a sense ‘truly hydrostatic’, 
the engineering itself would be problematic in addressing waste accumulation in the 
sealed bags over prolonged culture. These systems provide intuitive and practical 
approaches for applying physiological stimuli in the context of design specification, and 
their use in tissue engineering constructs provides important preclinical validation data, 
as well as allowing process improvement for future designs.  However from a 
translational point of view, we seek to acquire a system that incorporates simplicity, 
experimental efficacy and scalability, thus improving the outcome for these systems in 
reaching the clinic. 
 
1.10.1. Keele/TGT hydrostatic bioreactor   
The bioreactor described in this thesis was manufactured by Tissue Growth 
Technologies, US in collaboration with Keele University, UK with the intention of 
evaluating standardized, commercially available systems for use in engineering clinically 
applicable tissue engineered bone constructs (Figure 5). The system consists of a sealable 
pressure chamber, housing a standard size tissue culture plate (6 to 384wells), which is 
connected to a compressor via a hose. Both compressor and chamber can be placed inside 
a cell culture incubator. The magnitude, frequency, waveform and duration of mechanical 
loading may be set using an in house software platform (Growthworks, TGT). Previous 
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research has demonstrates that the system yields a degree of efficacy over static culture in 
the developing chick femur, whereby HP resulted in increased bone collar volume in 
femurs cultured in Osteogenic media (Henstock et al. 2013). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 9: Schematic and pictorial representation of the Keele-TGT hydrostatic 
bioreactor. A&B) the dimensions of the compression chamber are such that they can be 
housed in a standard cell culture incubator. The thumbnuts seal the top lid to the 
chamber whilst the quick disconnect connector provides a pressure lock to maintain 
pressure during operation. C) The chamber itself houses a standard cell culture plate, 
which during operation is subjected to hydrostatic force due to compression of gas/air 
interface residing above the culture media. Cells and/or constructs then sense this force 
as it is transduced through the culture medium.  Compression is provided by a stimulator 
box housed in the incubator (D) which is linked to an external rotary oil compressor. The 
growth works software is capable of generating both static and cyclic waveforms, with 
magnitudes between 0-333kPa and frequency from 0-2Hz. 
A B 
D E
C 
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1.11.  Aims and objectives of the project 
The aim of this thesis is to evaluate the Keele/TGT bioreactor as a 
preconditioning tool for bone repair. I have discussed in some detail in the preceding 
sections of this introduction, the various structural and functional aspects of bone and its 
comprising cells and proteins. I then explored different aspects of bone tissue engineering 
and the use of appropriate animal models to investigate the mechanisms of fracture 
repair. Through this I sought to identify the advantages and disadvantages of using 
different experimental approaches and animal models which are required to generate 
research based evidence for potential therapies to address the limitations facing current 
orthopaedic gold standards.  
I then aimed to identify the mechanisms and responses of mechanical loading that 
are commonly used to evaluate the effectiveness of bioreactors for bone tissue 
engineering, and how the different design parameters make these systems suitable for 
translatable therapies. To that end, the structure of my thesis is separated into three 
experimental chapters which aim to define a strategy for evaluating the Keele/TGT 
bioreactor as a tool for preconditioning cell seeded scaffolds to be used as bone implants. 
1.11.1. Chapter 1 - Monolayer characterisation 
This chapter aims to utilise the current knowledge of literature with regard to cell 
responses to hydrostatic loading; identifying events that occur due to bioreactor 
stimulations which are considered common responses in cells, such as actin remodelling 
and nitric oxide release. Additionally I aim to understand how different magnitudes and 
frequencies of loading affect these responses. Next, I will identify novel aspects of 
mechanotransduction through the activation of YAP. I explore how different aspects of 
cell physiology and cell phenotype (stem cell or osteoblast) regulate this signalling 
pathway. Finally I aim to investigate whether tailoring the ECM environment to promote 
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YAP expression worked synergistically with hydrostatic stimulation to enhance 
osteogenic differentiation in adult stem cells. 
1.11.2. Chapter 2 - Translation from 2D to 3D, optimisation and scale up 
This chapter looks at validating the bioreactor as a hydrostatic preconditioning tool 
for in vitro bone tissue formation. I explore the differences in response to hydrostatic 
pressure in osteoblast MG-63s in 2D monolayers and 3D collagen hydrogels, to underline 
how the ECM environment changes cellular response to external mechanical stimuli. I 
then aimed to define a set of conditions in which static in vitro culture of hMSC collagen 
hydrogels best promotes bone formation. In doing so I will look at changes in the ECM 
environment such as collagen content, and understand if the spatial distribution of cells 
can produces quantifiable changes in bone formation during in vitro culture. This will 
ultimately provide an internal benchmark of static culture (no bioreactor treatment) by 
which we can compare changes due to daily loading with hydrostatic pressure. 
 
1.11.3. Chapter 3 - Developing an ex vivo fracture repair model for preclinical 
testing 
This chapter aims to develop an organotypic tissue model to study fracture repair 
using isolated embryonic chick femurs. I first detail construction of the model and then 
investigate the effect of stem cell seeded scaffolds to heal induced femoral defects. By 
comparing the effect of freshly seeded stem cell/collagen scaffolds in femurs subjected to 
hydrostatic pressure, with static cultured femurs using hydrostatically preconditioned 
stem cell/collagen scaffolds, I hope to determine if preconditioning of stem cell seeded 
scaffolds is sufficient to enhance repair in an organotypic fracture repair model. In 
developing this model, I aim to characterise a high throughput system for preclinical 
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evaluation that adheres to the 3 R’s principle but also recapitulates in vivo bone formation 
in vitro. 
Since each chapter incorporates within itself a fairly distinct set of analyses and 
protocols, the materials and methods shall precede the results section for each chapter. I 
believe this will allow the conceptual flow of results easier to follow compared with a 
self-contained materials and methods chapter, in which reference in then made to within 
each of the following chapters.  
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Chapter 2 
Monolayer characterisation 
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2.1. Introduction 
As discussed in the previous chapter, the response of cells to mechanical stimuli will 
vary according to cell type, extracellular matrix environment, the nature of mechanical 
stimulation applied and the time over which cells experience this stimulus. The 
downstream effects on cell behaviour appear to share common responses to mechanical 
stimuli which include: induction of gene expression (Ignatius et al. 2005); matrix 
synthesis (Sittichokechaiwut et al. 2010); changes in proliferation (Yan et al. 2012); and 
in stem cells, differentiation toward lineages specific to the nature of stimulus applied 
(Chenyu & Rei 2012)(Xu et al. 2015).  
OSs are widely considered to be the primary mechanosensory cells that control bone 
resorption and remodelling (Klein-Nulend et al. 2013). They have been shown to respond 
to both fluid shear and compressive loading by multiply transduction processes. One of 
these is increased production of NO,  which is thought to inhibit bone resorption by 
preventing osteoclast activity(Wimalawansa 2010). Application of cyclic pressure in OBs 
also  induces stress fibre formation in the actin cytoskeleton and is accompanied by 
increased cell stiffness (Gardinier et al. 2009).  
The Hippo signalling cascade, which involves intracellular transport of YAP/PDZ- 
binding motif (TAZ) proteins is emerging as an important regulator of cell differentiation 
due to changes in the mechanical environment of the ECM (Dupont et al. 2011). A recent 
study of  YAP/TAZ co-activation  in OBs demonstrated that fluid flow increased nuclear 
accumulation of YAP/TAZ, and was required for increased mechanosensing via 
downregulation of the Sost gene  (Kaneko et al. 2014), which itself is upregulated in 
response to prolonged unloading of bone (Lin et al. 2009). By contrast, phosphorylation 
and subsequent nuclear accumulation of YAP has been shown repress Runx2 
transcription (Zaidi et al. 2004), and thus inhibits Runx2  mediated osteogenesis in MSCs 
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(Sen et al. 2015). Another recent study showed that cyclic stretch induces actin 
tensioning, which was required for nuclear accumulation of YAP (Driscoll et al. 2015).. 
The current body of literature seems to indicate a complex, but nonetheless prominent 
role of YAP/TAZ in mechano-sensing, suggesting that YAP/TAZ signalling is sensitive 
to both cell phenotype and the nature of stimulus applied (strain, fluid flow etc). To date 
there have been no reports studying the effect of hydrostatic pressure on this signalling 
pathway. Based on the existing evidence, it is reasonable to suggest that hydrostatic 
pressure might be involved regulating this pathway in both MSCs and more committed 
OBs phenotypes. 
Understanding the initial mechanosensory events that occur using the Keele/TGT 
hydrostatic bioreactor will give valuable knowledge in appropriately implementing the 
device for osteogenic preconditioning. For example, static compressive regimes using the 
Keele/TGT bioreactor have been shown to have little additive effect on bone formation in 
the developing chick femur. By contrast, a positive correlation was present between bone 
formation and cycling frequency (Henstock et al. 2013), however the earlier signalling  
mechanisms that lead to enhanced bone formation have not been investigated.  
 The software interface of the bioreactor described in section 1 allows for a series of 
defined magnitudes and frequencies to be applied to cells. I hypothesise that applying 
hydrostatic pressure to cells using the bioreactor will stimulate NO production and I aim 
to investigate the effect of change in the loading regime on this process. I also 
hypothesise that initial mechanosensory events such as actin remodelling and YAP 
signalling might take place as a result of hydrostatic loading. By testing this hypothesis in 
two different cell types (undifferentiated MSCs and MLO-A5 late stage OBs), I can 
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determine if these signalling mechanisms vary between cells at different stages of 
osteogenic differentiation.    
Objectives 
i) Quantify nitric oxide release in MLO-A5 cells in response to pressure.  To 
determine the effect of static versus oscillatory loading on anabolic signalling 
and define changes in cell responses due to the frequency and magnitude of 
loading.  
ii) Investigate the role of the NO production and the f actin cytoskeleton in 
cells exposed to hydrostatic loading.  To determine the role of cellular actin 
in translating hydrostatic pressure to cell signal events.  
iii) Investigate changes in YAP expression during hydrostatic loading. To 
study changes in YAP expression during hydrostatic loading and determine 
the role of actin cytoskeleton in regulating this pathway. 
iv) Preconditioning of hMSC on different stiffness substrates during 10 days 
culture in osteogenic media. To determine the effect of hydrostatic loading 
on osteogenic differentiation of hMSCs and to study the importance of the 
extracellular matrix environment on translating external hydrostatic pressure. 
 
 
 
 
 
 
55 
 
2.2. Materials and methods 
2.2.1. Cell culture  
For each experiment hMSCs and MLO-A5 cells were culture under identical 
conditions unless otherwise stated. hMSCs from a human bone marrow aspirate were 
purchased from Lonza and isolated via plastic adherence and subsequently characterised 
for the relative CD markers (See Appendix Ch1). MLO-A5 cells were kindly donated by 
Professor Linda Bonewald of the University of Missouri, Kansas. Each cell type was 
stored in liquid nitrogen experiments in 10% Dimethyl sulfoxide (DMSO)(Sigma) in fetal 
bovine serum (BSA)(Biosera) until ready for use. Prior to experiments, cells were thawed 
by adding 0.5ml pre warmed (37
0
C) Dulbeco’s Modified Eagle Medium (DMEM) 
(Lonza) to the frozen cell suspension for 1 minute. The suspension was then transferred 
to 10mls pre warmed DMEM and centrifuged at 800rpm for 5mins. Cells were washed 
once in 10mls DMEM, centrifuged and transferred to tissue culture plastic at a seeding 
density of 6500 cells/cm
2
. Cells were expanded in proliferation media (PM) consisting of 
DMEM (1ng/ml glucose, w/o L-Glutamine) containing 10% fetal bovine serum (FBS), 
2% penicillin-streptomycin (Lonza), 1% Non-essential amino acids (Sigma) and 1% L-
Glutamine (Lonza). During in vitro expansion, cells were passaged at approximately 90% 
confluency. Passages were performed by washing cells once in phosphate buffered saline 
(PBS) (Lonza) followed by 5-7mins incubation at 37
0
C in 1x Trypsin (Lonza). The 
enzymatic reaction was quenched in PM and cells were centrifuged at 800rpm for 5 
minutes. Cells were then seeded in T75 flasks (Sarstedt) at the same density as before at 
6500/cm
2.  
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2.2.2. Cell seeding prior to experiments 
For experiments using the hydrostatic bioreactor, glass coverslips (Fisher 
Scientific) were placed into either 6 or 24 well tissue culture plates and subjected to 15 
minutes ultra violet (UV) sterilisation using a Bio-Rad gene linker UV chamber. 
Coverslips were coated for 1 hr at room temperature in 0.2mg/ml type-1 rat tail collagen 
(Corning) made from an (8-11) mg/ml stock solution. After incubation, the collagen 
solution was aspirated and wells were washed once in PBS prior to seeding. Unless 
otherwise stated in the results section, cells were seeded at approximately 80% 
confluencey (15,000/cm
2
 for hMSC, and 100,000/cm
2
 for MLO-A5 cells). Cells were 
seeded 24 hours prior to each experiment.  
 
 
100μm 
Figure 1.  Left) hMSC precursors characterised using surface markers: positive 
CD173, CD90, CD105; and negative CD 14, CD34, CD45, CD19, HLA – DR (See 
appendix ch1).  Right)  MLO-A5 late stage OBs.  
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2.2.3. Inhibition of  f-actin  
Disruption of actin microfilaments was achieved by treatment with Cytochalasin 
D (CytoD) (Sigma), a myotoxin that serves as a potent inhibitor of actin polymerisation. 
Cells were incubated for 60 minutes at 37
0
C in PM supplemented with 10μM CytoD. 
After incubation, cells were washed twice in PBS.  
2.2.4. Fixation  
All cells were fixed in 10% neutrally buffered formalin (Fisher Scientific). For NO 
studies, well plates were removed from the bioreactor immediately after stimulation and 
the media was collected and stored at -20
0
C. The remaining cells were immersed in 
fixative for 15 minutes at room temperature followed by 2 washes in PBS. Samples were 
stored in PBS with 1% pen-strep, 1% amphotericin B (Lonza) at 4
0
C until 
immunofluorescent staining was performed.   
 
2.2.5. Nitric oxide quantification 
Nitric oxide rapidly undergoes spontaneous oxidation into stable nitrite compounds 
under physiological conditions (Ignarro & Buga 1987). The detection of stable nitrites 
present in the media was quantified using a Griess assay (Life technologies). 150μl of 
media per sample was mixed with 150μl of Griess reagent (10μl N-(1-
naphthyl)ethylenediamine dihydrochloride, 10μl sulfanilic acid, 130μl distilled water 
(DH2O)) and incubated in the dark at room temperature for 30 minutes. Absorbance was 
measured at 548nm on a Bio-synergy 2 plate reader. Results were normalised to 
absorbance reading for fresh media and standardised against known quantities of nitrite 
containing solution. 
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2.2.6. Immunocytochemistry 
Monolayer cultures were permeabalised in 0.01% triton-X 100 (Sigma) for 15 
minutes at room temperature, followed by 2 washes in PBS- 0.1% Tween (Sigma). Cells 
were then blocked in 1% bovine serum albumin (BSA) (Fisher Scientific) for 1 hr at 
room temperature followed by two washes in PBS-0.1% Tween. Primary antibody 
incubations [, anti-human YAP mouse monoclonal (Santa Cruz Bio), anti-human 
osteocalcin mouse monoclonal (R&D systems), anti-human Runx2 goat monoclonal 
(R&D systems)]  diluted to 2μg/ml in 0.1% BSA in PBS-0.1% -tween were performed 
overnight at 4
o
C. Following primary antibody incubations, the cells were washed twice 
for 5 minutes each on a shaker in PBS-0.1% Tween. Cells were then incubated in 
respective Alexafloura 488 or 555 secondary’s (2μg/ml, 0.1% BSA, 0.1% Tween-20 in 
PBS) (Abcam) for 1hr at room temperature in the dark followed by 2 washes in PBS-
0.1% tween. Counterstaining was performed with 4',6-diamidino-2-phenylindole (DAPI) 
(Sigma) for 30 minutes in the dark to s cell nuclei. F-actin staining was performed using 
Cytopainter 555 phalloidin (Abcam) for 1 hr at room temperature in the dark. Cells on 
coverslips were mounted onto microscope slides using Vector shield mounting medium 
(Vector Laboratories).  
2.2.7. Polyacrylamide gel fabrication 
Polyacrylamide gel substrates with different stiffness’s were fabricated according to 
methods published by Tse and Engler (Tse & Engler 2010). 13mm thick glass coverslips 
were placed on a hotplate at 70
0C to allow evaporation of 250μl of 0.1M sodium 
hydroxide (NaOH)/coverslip (Fisher Scientific), until an even coating was present.  
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Table 1. Ratios of acrylamide to bis-acrylamide for substrates with different predictied  
stiffness’s.  (adapted from (Tse & Engler 2010)). 
Coverslips were then placed in a fume hood and coated with 200μl (3-
Aminopropyl)triethoxysilane (Sigma) for 5 minutes, followed by 30 seconds washing 
under running DH2O. Coverslips were transferred to square petri dishes and immersed in 
0.5% glutaraldehyde (Sigma) in PBS for 30 minutes. The solution was then removed and 
coverslips were left to dry overnight in a fume hood. Chloro-silinated glass slides were 
prepared by coating slides in 100µl dichlorodimethylsilane (Sigma) for 5 minutes in a 
fume hood. Slides were rinsed three times for 30 secs each in DH2O. Acrylamide/ Bis-
acrylamide (Sigma) ratios were prepared accordingly, yielding solutions equating to 
different stiffness substrates (Table 1).  
Polyacrylamide solutions were degassed in vacuum desiccator for 15 minutes to 
exhaust dissolved oxygen. Solutions were then mixed with 1/100 10% (wv) ammonium 
persulfate (Sigma) by volume and 1/1000 N,N,N′,N′-Tetramethylethylenediamine 
(Sigma) by volume. 25µl solutions were then pipetted onto chloro-silinated slides with 
the amino coated coverslips placed face down on top, allowing the solution to coat the 
coverslips evenly. The solutions were left to polymerise for 30minutes before removing 
polyacrylamide coated coverslips from the cholo-silinated slides. The coated coverslips 
Acrylamide (40% 
stock)(ml) 
Bis-acrylamide 
(2% stock) (ml) 
DH2O (ml) Predicted stiffness 
(kPa) 1.25mls 0.15mls 8.6mls 1±0.31kPa 
2.5mls 0.5mls 7mls 10+0.79 kPa 
2mls 2.4mls 5.6mls 40.4±2.39 kPa 
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were transferred to well plates and washed twice in PBS. Well plates were then sterilised 
overnight under UV light in a biological safety cabinet. 
2.2.8. Polyacrylamide surface functionalisation  
Substrates were functionalised according to methods described in (Tse & Engler 
2010). sulfosuccinimidyl 6-(4'-azido-2'-nitrophenylamino)hexanoate (Sulpho-SANPAH) 
(Thermo-Fisher), a protein cross-linker that covalently binds ECM proteins to the 
acrylamide surface, was used to enable cell attachment to the different stiffness in 40µl 
DMSO at 50mg/ml. Aliquots were flash frozen in liquid nitrogen and stored at -80
0
C 
until use. For surface functionalisation, sulpho- SANPAH solutions were diluted to 
0.2mg/ml in DH2O and added to wells to immerse the coverslips. Coverslips were then 
placed under 365nm UV light source in a Bio rad GenX UV chamber for 10 minutes. 
Coverslips were then rinsed twice in 50 mM HEPES before adding 0.2mg/ml rat tail 
collagen. After overnight incubation at 37
0
C, the collagen solution was aspirated and the 
coverslips were washed once in PBS and once in PM before cell seeding.  
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Figure 2.  Preparation of polyacrylamide substrates with different stiffness’s. A) 
Fabrication process of substrates with different stiffness. B) Functionalisation of 
substrates and attachment of ECM coating.   
Soft     Medium    Stiff 
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Table 2.  Magnitude and frequency of hydrostatic loading used for experiments. 
 
2.2.9. Hydrostatic regime 
The pressure regimes used in experiments were selected with the aim of observing 
changes in cell response due to magnitude and frequency during loading (see Table2). 
Experiments studying nitric oxide production, actin remodelling and (Section 2.3.1) were 
performed using PM, which was changed immediately before stimulation. This allowed 
the results in both pressure treated and static controls (no pressure) to be normalised to 
fresh media as a negative control. For osteogenic preconditioning experiments (Section 
2.3.2), PM was supplemented with 150µg/ml L-ascorbic acid (Sigma), 10
-8
M 
dexamethasone (Sigma) and 2mM sodium β-glycerophosphate (Sigma). Cells cultured in 
osteogenic media received media changes every 2 days before bioreactor stimulation. A 
small amount of evaporation was present in wells closest to the nozzle side of the 
bioreactor, which was accounted for by seeding cells in central wells of the plates and/or 
replacing equal volumes of media lost with DH2O after stimulation was complete. The 
Frequency Magnitude Cell type Analysis 
0, 1, 2Hz 200kPa MLO-A5 NO release, ICC 
1Hz 0, 50, 200, 280kPa MLOA5 NO release, ICC 
1Hz 280kPa hMSC NO release, ICC 
1Hz 280kPa hMSC Preconditioning 
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remainder of the time cells were kept under static standard cell culture conditions in a cell 
culture incubator at 37
0
C with 5%CO2.  
2.2.10. Confocal imaging 
Imaging was performed using an Olympus U-TBI 90 laser scanning confocal 
microscope, employing three channel fluorescence microscopy. Image acquisition was 
performed using Fluoview10 software and image analysis was performed using 
Fiji/ImageJ Win64 open access software (http://fiji.sc/Fiji).  
2.2.11. Quantification of fluorescence intensity 
Images were acquired under identical offset and gain settings for each separate 
experiment undertaken. Analysis of fluorescence intensity in ImageJ was used to quantify 
the mean fluorescence per unit area in each cell to assess changes in the ratio of nuclear 
to cytoplasmic retention of YAP (Figure 3). The raw intensity values for nuclear 
fluorescence were subtracted from the total cell fluorescence and the values normalised to 
their respective areas to give a fluorescence intensity/ unit area.  By dividing the 
nuclear/cytoplasmic intensity using this method for each experimental group, the relative 
change in nuclear to cytoplasmic intensity could be estimated.   
2.2.12. Sudan black B staining  
hMSCs on different stiffness substrates were incubated in 1% w/v Sudan black B in 
70% ethanol (EOH) for 10 minutes. Cell were then washed 3 times for 5 minutes each on 
a shaker in PBS before imaging using an EVOS® FL Colour Imaging System. 
2.2.13. Alkaline phosphatase activity 
Alkaline phosphatase detection was employed using a Naphthol AS-BI phosphate based 
kit (Millipore) to assess the rate of osteogenic differentiation in hMSCs seeded on 
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different stiffness substrates. Fixed cells were rinsed in TBST buffer (20mM Tris-HCl, 
0.15M NaCl, 0.05% Tween-20) and incubated in staining solution for 30 minutes away - 
from the light. Cells were rinsed once in TBST and imaged using an EVOS® FL Colour 
Imaging System. 
2.2.14. Statistical analysis 
Data was plotted and analysed in Microsoft Excel. All data point represents mean 
values ± standard error of the mean. Statistical significance was determined either by  
using a two tailed Students t-test with p<0.05 denoted statistical significance. When 
specified, statistical analyses by a two analysis of variance was performed in Origin pro 
9.0, with p<0.05 denoted statistical significance. 
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A. Random field of view B. Quantify total cell fluorescence 
C. Highlight nuclear area  D. Quantify nuclear fluorescence  
𝑵𝒖𝒄𝒍𝒆𝒂𝒓 𝒍𝒐𝒄𝒂𝒍𝒊𝒔𝒂𝒕𝒊𝒐𝒏 =
𝑰𝒏𝒖𝒄
𝑰𝒄𝒚𝒕
=
𝑭𝑰𝒏𝒖𝒄
𝑨𝒏𝒖𝒄
∗
(𝑨𝒄𝒆𝒍𝒍 − 𝑨𝒏𝒖𝒄)
(𝑭𝑰𝒄𝒆𝒍𝒍 − 𝑭𝑰𝒏𝒖𝒄)
 
     𝑵𝒐𝒓𝒎𝒂𝒍𝒊𝒔𝒆𝒅 𝒏𝒖𝒄𝒍𝒆𝒂𝒓 𝒊𝒏𝒕𝒆𝒏𝒔𝒊𝒕𝒚, 𝑰𝒏𝒖𝒄 =  𝑭𝑰𝒏𝒖𝒄/𝑨𝒏𝒖𝒄  
  
     𝑵𝒐𝒓𝒎𝒂𝒍𝒊𝒔𝒆𝒅 𝒄𝒚𝒕𝒐𝒑𝒍𝒂𝒔𝒎𝒊𝒄 𝒊𝒏𝒕𝒆𝒏𝒔𝒊𝒕𝒚, 𝑰𝒄𝒚𝒕 =  (𝑭𝑰𝒄𝒆𝒍𝒍 − 𝑭𝑰𝒏𝒖𝒄)/(𝑨𝒄𝒆𝒍𝒍 − 𝑨𝒏𝒖𝒄) 
𝑭𝑰 = 𝒇𝒍𝒐𝒖𝒓𝒆𝒔𝒄𝒆𝒏𝒄𝒆 𝒊𝒏𝒕𝒆𝒏𝒔𝒊𝒕𝒚(𝒔𝒖𝒎 𝒐𝒇 𝒈𝒓𝒆𝒚𝒔𝒄𝒂𝒍𝒆 𝒑𝒊𝒙𝒆𝒍 𝒊𝒏𝒕𝒆𝒏𝒔𝒊𝒕𝒊𝒆𝒔) 
                         
               𝑨 = 𝒂𝒓𝒆𝒂 (𝝁𝒎𝟐) 
Calculation  
Units 
Figure 3. Quantifying the nuclear to cytoplasmic ratio of fluorescence intensity (FI) in 
ImageJ. For each field of view(A), the nuclear FI (D) was subtracted from the total cell 
FI (B) and expressed as FI/unit area. Dividing the nuclear by cytoplasmic intensity 
yielded a ratio of nuclear translocation for each cell. n>40 cells  
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2.3. Results 
2.3.1.  Mechanotransduction in MLO-A5 late OBs and MSC precursors 
2.3.1.1. Effect of pressure on actin remodelling and nitric oxide 
production in MLO-A5 cells 
Cyclic pressure (Figure 4C, D&E) induced f-actin remodelling from randomly 
ordered actin filaments in statically controls and statically compressed MLO-A5s (Figure 
4A&B), to tensioned parallel stress fibres. Fluorescent quantification of F-actin (Figure 
4F) showed a significant increase in actin fluorescence in all cyclic pressure regimes, but 
not in the static compression regime. F-actin remodelling correlated with an increase in 
NO production in pressure treated cells.  Application of cyclic but not static pressure 
caused a significant increase in NO release over a 1 hr period. The rate of NO production 
(Figure 4G) was regulated by both the frequency and magnitude of loading and increased 
3.7 fold vs static controls using a 200kPa 2Hz regime (P < 0.001); 2 fold using a 200kPa 
1Hz regime (P < 0.05); and 1.4 fold at a 50kPa 1 Hz regime (P=0.3). 
 
.   
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Figure 4. Regulation of actin remodelling and nitric oxide release by hydrostatic 
pressure in MLO-A5 late stage OBs. (A-E) F-actin staining in cells exposed to different 
pressure regimes after 60minutes, n=6. F) Nitric oxide production in cells after 60 
minutes G) Image quantification of f-actin fluorescence intensity, n=3.  Scale bars = 
50μm. Error bars = standard error of the mean. **** P<0.001. **P<0.01.  *P<0.05. 
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2.3.1.2. Role of F-actin integrity during pressure mediated NO 
production 
To determine if pressure induced NO production required and intact cytoskeleton, 
MLOA5s were cultured in PM supplemented with 10μM cytoD for 1 hr before 
stimulation. The cells initially adopted a rounded morphology in response to the 
treatment which persisted during hydrostatic stimulation, but recovered after 24hrs, 
regaining morphology comparable with untreated cells. Consistent with observations 
made in Section 2.3.1.1, untreated MLO-A5s underwent f-actin reorganisation towards 
parallel stress fibres (Figure 5C). CytoD treated MLO-A5s (Figure 5 B&D) had a 
noticeable disrupted cytoskeleton, forming detached aggregates of actin filaments in the 
cell cytoplasm. Fluorescent quantification of f-actin (Figure 5F) showed a significant 
reduction in f-actin fluorescence in cells treated with cytoD. No changes were observed 
in actin organisation between pressure treated and static cultures after incubation in 
cytoD. NO production (Figure 5G) was significantly higher than untreated controls in 
cells treated with cytoD, and was comparable with levels released by pressure treated 
cells. A combination of cytoD and pressure induced NO produciton to similar levels 
observed due to cytoD treatment alone, and pressure alone.   
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Figure 5. Role of cytoskeletal integrity in pressure mediated nitric oxide release.  (A-
D) Contrast filtered images of F-actin staining in MLOA5 cells with and without 10μM 
cytoD incubation prior to loading. F) Image quantification of fluorescence intensity 
prior to loading, n=3. G) Nitric oxide production in cells after 60 minutes, n=12. Scale 
bars (top) = 50μm. Error bars = standard error of the mean. *** P<0.001.  
2-way Anova 
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2.3.1.3. Regulation of nuclear to cytoplasmic expression of YAP in MLO-
A5 late stage OBs and hMSC precursors 
The study of nuclear YAP localisation in cells responding to pressure aimed to 
establish the interaction of this pathway with hydrostatic pressure and actin stess fibre 
formation. Cyclic pressure was applied to MLOA5 cells and hMSCs to investigate 
changes in YAP expression using the same stimulation regime as before (280kPA, 1Hz, 
60 mins), to study changes in the retention of YAP in the cytoplasm and the nucleus. 
Actin remodelling in pressure treated MLOA5 (Figure8Aii) was accompanied by a 
significant increase in the nuclear accumulation of YAP versus static controls 
(Figure8B). Quantification of fluorescent intensity (Figure8C) indicated an increase in 
the accumulation of both nuclear and cytoplasmic YAP in stimulated MLO-A5s vs static 
controls, with a significant increase in fluorescence intensity in the nucleus of pressure 
treated cells versus controls. 
Consistent with previous observations, pressure treated hMSC (Figure8Dii) did not 
undergo remodelling of F-actin toward parallel stress fibres. The nuclear accumulation of 
YAP was slightly higher in stimulated cells vs static controls ((Figure8E), however the 
levels of nuclear vs cytoplasmic YAP were comparable is between control and pressure 
treated cells (Figure8F). In contrast to MLO-A5s, pressure treated hMSCs had lower 
levels of YAP expression in both the nucleus and cytoplasm compared with controls. The 
increase in nuclear/cytoplasmic YAP was attributed to a small but significant decrease in 
the retention of cytoplasmic YAP in pressure treated cells. 
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2.3.1.4. F-Actin integrity regulates nuclear to cytoplasmic expression of 
YAP 
The disruption of the actin cytoskeleton using cytoD was employed to investigate 
changes in YAP expression in MLO-A5s and hMSCs in both static and pressure treated 
cells (Figure9). Consistent with previous observations, the application of cytoD disrupted 
pressure mediated actin remodelling and intiated sequestration of YAP from the nucleus 
into the cytoplasm. Application of pressure (Figure9C, D, G, H) did not result in any 
observable differences in YAP expression in either MLO-A5 or hMSC. 
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2.3.2. Effect of substrate stiffness and cyclic pressure on hMSC differentiation during 
10 days culture in osteogenic media 
Up to this point, my experiments have identified a broad range of changes in cell 
behaviour during stimulation with hydrostatic pressure, confirming that the bioreactor can 
induce mechano-active responses in cells that are commonly observed in the literature. I 
now aimed to test of the hypothesis that the bioreactor can accelerate osteogenic 
differentiation in hMSC monolayer after 10 days in culture. Dupont et al. demonstrated 
that alterations in the differentiation potential of hMSCs are related to factors such as 
actin stress fibre formation and nuclear localisation of YAP when cells are cultured on 
different substrate stiffness’s (Dupont et al. 2011). Coupled with my findings thus far that 
show changes in the behaviour of YAP due to pressure, my hypothesis is that by 
generating an ECM environment that favours osteogenic differentiation in MSCs,  
hydrostatic pressure will act synergistically with this environment to enhance 
differentiation when compared with unstimulated controls. Since nuclear YAP expression 
is more prevalent on stiffer substrates, observing the shift in YAP localisation is a useful 
method to validate the change in stiffness of the polyacrylamide substrates. Additionally, 
I can then also study changes in YAP expression as a result of hydrostatic pressure in 
MSCs cultured on different stiffness substrates.  
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2.3.2.1. Effect of substrate stiffness on cell area and YAP expression in 
hMSCs  
hMSCs seeded on polyacrylamide gels of different stiffnesses (7500cells/cm
2
) had a 
distinct cell morphology 24hrs after seeding. Cells seeded on soft substrates had a spindle 
like morphology (Figure11 A), attributed to a decrease in cell spreading. Increasing the 
stiffness (Figure11 B&C) of the substrates significantly increased cell spreading and 
consequently cell area (Figure11 D). The increase in cell area correlated with an increase 
in actin stress fibre formation and a significant increase in the nuclear accumulation of 
YAP on stiffer substrates (Figure11E). 
 
 
 
 
 
 
 
 
 
 
 
Figure 8. Substrates stiffness regulates cell spreading and nuclear accumulation of 
YAP in hMSCs seeded on polyacrylamide substrates. (A-C)Immunofluorescent staining 
showing F-actin and YAP expression in hMSCs seeded on different stiffness substrates. 
C) Cell area on different stiffness substrates, n>40. D) Ratio of nuclear to cytoplasmic 
YAP in hMSCs seeded on different stiffness substrates, n>40. Scale bars = 50μm.  
****P<0.0001 determined by one way analysis of variance.  
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2.3.2.2. Effect of cyclic hydrostatic pressure on YAP expression in hMSC 
seeded on different stiffness substrates  
Cells seeded on different substrates stiffness’s were exposed to cyclic pressure to 
investigate changes in YAP expression during hydrostatic loading. The regulation of 
nuclear to cytoplasmic YAP in response to loading was dependant on the stiffness of 
underlying substrate, with soft substrates (Figure 13 Ai) inhibiting both nuclear and 
cytoplasmic YAP expression after loading, and stiffer substrates, Figure 13 Aii&iii) 
increasing the expression of both nuclear an cytoplasmic YAP during loading. Nuclear to 
cytoplasmic retention of YAP (Figure 13D) showed no statistically significant 
differences between static and pressure treated cells with respect to substrate stiffness. 
Analysis by a two way anova revealed there was no significant difference in nuclear YAP 
intensity in response to hydrostatic pressure or a change in substrate stiffness. However 
there was a significant interaction between pressure and stiffness with respect to nuclear 
YAP intensity, which can be seen by a reduction in nuclear YAP intensity in response to 
pressure on soft substrated, and an increase in nuclear YAP intensity on stiffer substrates 
in response to pressure. By contrast, analysis by two way anova on cytoplasmic YAP 
intensity showed that whilst the effect of pressure alone was not significant, there was a 
significant difference in cytoplasmic YAP intensity due to substrate stiffness. The 
interaction between pressure and stiffness with respect to cytoplasmic YAP was also 
significant. Overall these results suggest that the change in nuclear YAP localisation was 
determined primarily by substrate stiffness and not hydrostatic pressure. Furthermore, the 
two way anova’s suggest that this effect was primarily due to a reduction in cytoplasmic 
as YAP intensity as substrate stiffness increases. 
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2.3.2.3.  hMSC morphology after 10 days culture in osteogenic media 
Cells proliferated during the 10 day culture period in all experimental groups but 
developed different morphologies depending on the stiffness of the underlying substrates. 
Soft substrates progressed from spindle shaped morphology (Figures 11&12), to rounded 
island morphology (Figure 13A). Stiffer substrates (Figure 13B-D) retained spread 
morphology with actin stress fibres becoming more prominent as stiffness increased. In 
contrast to day 1, where YAP was localised in the nucleus, by day 10 YAP was almost 
exclusively found in the cytoplasm. 
 
 
 
 
 
 
 
 
 
 
 
Figure 10: Substrate stiffness mediates cell spreading and cytoskeletal stress fibre 
formation after 10 days culture in osteogenic media.  Scale bars = 50μm 
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2.3.2.4. Assessment of osteogenic differentiation in hMSCs after 10 days 
in culture 
Osteogenic differentiation after 10 days was assessed by immunocytochemistry to 
detect Runx2 (discussed in Section 1.4.3), an transcription factor involved in osteogenic 
differentiation of MSCs and OCN (discussed in Section 1.4.4) a non-collagenous protein 
present that is thought plays parts in regulating bone formation. Immuno-fluorescent 
detection of OCN and Runx2 showed positive expression of both markers in all 
experimental groups (Figure 14 A-H). Runx2 expression was upregulated as substrate 
stiffness increased (Figure 14 A-D, E-H). Osteocalcin was also upregulated on stiffer 
substrates, with a higher number of osteocalcin rich nodules present in stiff and glass 
substrates vs sot and medium substrates. No clear differences in expression were noted 
between static (Figure 14, A-D) vs pressure treated (Figure 14, E-H) cells. The 
localisation of red fluorescence (Runx2) to the nucleus signified a specificity of activity 
in cells that represented binding of transcriptional Runx2 to DNA, initiating osteogenic 
differentiation. The presence of OCN in the cell cytoplasm and ECM suggested cells 
actively secreting the protein as a result of undergoing osteogenic differentiation. The co-
localisation of green and red fluorescent (appearing yellow) on soft substrates (Figure 14 
A&E) indicated a false positive signal generated by auto-fluorescent material present in 
the cells.  
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2.3.2.5. Assessment of lipofuscin formation in hMSC cultured on 
different stiffness substrates 
On softer substrates, whilst the presence Runx2 and OCN was detected (Figure 14 
A&E), the intensely stained co-localisation of green (OCN) and red (Runx2) 
fluorescence and indicated a false positive signal due the presence of auto fluorescent 
material in the cells. One potential explanation for this false positive signal was the 
formation of lipofuscins in cells cultured on softer substrates. Lipofuscins consist of auto 
fluorescent lysosomal storage bodies that accumulate in different tissues during cell 
senescence (Katz & Robison 2002). Sudan black B staining is commonly used to quench 
auto-fluorescence in tissue sections and has also been shown to be specific to lipofuscin 
formation in senescent cells (Georgakopoulou et al. 2013). Based on this, Sudan black B 
staining was employed to assess the presence of lipofuscins in cells to determine if the 
fluorescent signal in softsubstrates was due to the formation of auto-fluorescence 
lipofuscins. After staining the different stiffness substrates with Sudan black B, 
brightfield microscopy was used to assess the extent of lipofuscin formation (Figure 15). 
soft (Figure 15A&E) substrates had noticeable more nodular black deposits in the 
cellular cytoplasm compared with stiffer substrates (Figure 15 B,C,D&G), indicating 
that cells grown on the softest substrates experienced extensive lipofuscin formation after 
10 days in culture, which was likely the cause of false positive ICC signal on soft 
subrates 
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2.3.2.6. Alkaline phosphatase activity 
. ALP staining was used to assess osteogenic differentiation in MSCs seeded on 
different stiffness substrates. Bright field imaging of MSCs at day 10 following ALP 
staining demonstrated an increase in ALP positive cells as substrate stiffness increased 
(Figure 16, red). Softer substrates (Figure 16 A, E, B&F) had little to no positive 
detection of ALP, whilst stiffer substrates (Figure 16 C,D,G&H) had ALP positive cells, 
particular in nodular areas that correlated with increased OCN expression in Figure 15. 
Glass substrates showed the highest number of ALP positive cells, however neither static 
nor pressure treated cells showed a noticeable difference in ALP positive cells. This 
result suggests that pressure treatment did not enhance the osteogenic differentiation of 
hMSCs during the 10 day culture period. 
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2.4. Discussion 
2.4.1. Nitric oxide and actin remodelling  
Application cyclic pressure increased NO production in MLO-A5 late stage OBs, and was 
accompanied by remodelling of the f-actin cytoskeleton. Pressure induced nitric oxide 
production was dependant on both the magnitude and frequency of loading, with higher 
magnitudes and frequencies increasing NO production. By contrast, static compression did 
not alter NO production when compared with unstimulated controls. This suggests that cyclic 
loading regimes are required to induce cellular responses to hydrostatic pressure. Magnitude 
and frequency dependant NO production has been reported in MC3T3 OBs in response to 
fluid flow(Mullender et al. 2006). Additionally the same study also found whilst fluid flow 
increased PGE2 production, this was not dependant on magnitude and cycling frequency. It 
would be interesting in future to test PGE2 production under the regimes described in Section 
2.3.1.1 to determine if PGE2 is sensitive to different magnitudes and frequencies if 
hydrostatic pressure. This might highlight an important distinction in the response of cells to 
fluid flow and hydrostatic pressure.  
Pressure mediated NO production did not require an intact cytoskeleton, suggesting that 
the factors influencing f-actin stress fibre formation and NO production act independently 
from each other. The increase in NO production in cytoD treated cells in unstimulated 
controls suggests that while actin integrity itself not does mediate NO production in response 
to hydrostatic pressure, the underlying biochemistry that influences actin organisation and 
NO production is related. Cytochalasins are fungal metabolites that permeate the cell 
membrane and inhibit actin polymerisation, membrane ruffling and cell stiffness (Yahara et 
al. 1982). There are many different types of cytochalasin compounds, and each can induce 
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distinct responses in cells. For example cytoD has been shown to have a much stronger effect 
on increasing adenylpyrophosphatase (ATPase) activity in cells than cytochalasin B (cytoB) 
(Brenner & Korn 1980), which is also commonly used to disrupt actin polymerisation. 
McGarry et al. studied changes in flow induced NO production in MC3T3 OBs using cytoB 
(McGarry et al. 2005). In contrasts to the results in Section 2.3.1.2 which used cytoD, 
McGarry and colleagues observed a reduction in flow induced NO in cells pre-treated with 
cytoB. The same study also shows that in MLO-Y4 OSs (a later stage phenotype of MLO-
A5s (Kato et al. 2001)), cytoB treatment did not affect flow induced NO production, but 
instead inhibited flow induced PGE2 production, implying that the regulation of these 
mechanisms is unique to different cell types. Studying changes in NO in combination with 
different cytochalasin compounds could facilitate a deeper understand of the underlying 
biochemical changes in cells that determine their response to hydrostatic pressure. It is 
possible that we might observe changes in the regulation pressure induced NO production 
using different cytochalasin compounds. Furthermore, since different cytochalasins can alter 
cellular ATPase activity, we might also further elucidate the relationship between ATP and  
hydrostatic pressure,  of which the former has previously been reportedto be involved in 
pressure mediated actin stress fibre formation in OBs (Gardinier et al. 2009).  
The current body of literature suggests the effects of mechanical loading in the form of 
flow, pressure, or strain, can have broadly similar effects on cell behaviour in the context of 
actin reorganisation and NO production. However, there is a vast body of literature 
attempting to define the mechanisms that underpin these cellular processes, making it 
difficult to interpret precursor events that lead to these changes. One possible explanation for 
why NO production and stress fibre formation in section 2.3.1.1 appeared to coincide with 
each other, and then later in  section 2.3.1.2 why NO production was stimulated in the 
absence of an intact cytoskeleton,  could be through pressure mediated  release of 
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intracellular calcium stores. This mechanism has been shown to modulate the organisation of 
f-actin in OSs during cyclic pressure stimulation (Liu et al. 2010), and also in OBs 
responding to fluid flow (Chen et al. 2000). Interestingly, Malone et al. have also reported 
increased levels of intracellular calcium in OBs exposed to cytoD (Malone et al. 2007). Since 
the experiments described  in this chapter show an increase in NO production in response to 
both pressure and cytoD treatment,  it could be that NO production by cyclic pressure is 
associated with the release of intracellular Ca
+
 stores, which might also be responsible for 
actin stress fibre formation. However, whilst NO has been shown to correlate with calcium 
signalling in OSs during fluid flow (Huo et al. 2008), this relationship is not clearly defined. 
Initial calcium peaks have been shown in OSs to occur much earlier than the onset of NO 
production (Lu et al. 2012), and it has been suggested that NO instead might influence the 
induction of external influxes of Ca
+
 to replenish intracellular stores(Li et al. 2003).   Further 
work studying the effect of calcium signalling in cells during bioreactor stimulation, such as 
blocking specific Ca
+
 ion channels or depleting intracellular calcium stores prior to loading 
could improve our understanding of pressure mediated changes in cell behaviour.  
 
2.4.2. YAP expression in hMSCs and MLO-A5s in response to pressure 
The results indicated that in MLO-A5s hydrostatic pressure initiates translocation of YAP 
to the nucleus via a mechanism associated with f-actin stress fibre formation. In contrast to 
MLO-A5s, nuclear accumulation of YAP did not occur in MSCs. whilst the reason for this 
was unclear, it is possible that this was due to the lack of actin stress fibre formation in MSCs 
during hydrostatic stimulation. This was further supported by the expulsion of YAP into the 
cytoplasm during cytoskeletal disruption with CytoD in Section 2.3.1.3. This result might 
reflect a potential mechanosensory shift between MSC precursors and mature skeletal cells.  
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       The correlation between f-actin stress fibre formation and nuclear translocation of YAP 
in MLO-A5s indicated that the behaviour of YAP transport in OBs in response to hydrostatic 
pressure is different from MSCs. Whilst there is still some uncertainty as to how YAP/TAZ 
signalling regulates cell behaviour, it has been shown to be important in regulating bone 
formation both in vitro and in vivo(Tang et al. 2013).  Whilst much of the work on YAP 
expression has focussed on MSC differentiation, it is surprising that there appears to be no 
literature on the activity of this pathway in late stage OBs. When we consider that a nuclear 
translocation of YAP has been shown to depend on f actin stress fibre formation, which is 
widely reported in OBs undergoing mechanical loading, it seems reasonable to suggest that 
YAP may play an important role in the transition of OBs to mineralised OSs. One potential 
mechanism by which pressure induced actin stress fibre formation could induce nuclear YAP 
accumulation is via the Serine/threonine-protein kinases (LATS). It has been shown that 
LATS1/2 mediated phosphorylation triggers the localisation of YAP in the cytoplasm(Dong 
et al. 2007)(Zhao et al. 2007). Interestingly LATS phosphorylation has recently been linked 
with f-actin stress fibre formation, a mechanism in which actin stress fibres bind angiomotins 
targeted by LATS kinases for phosphorylation, leading to localisation of YAP into the 
cytoplasm (Dai et al. 2013) (Mana-Capelli et al. 2014). This might explain why nuclear YAP 
accumulation correlated with actin stress fibre formation in MLO-A5s. A detailed 
examination of LATS expression during hydrostatic loading could identify changes in 
phosphorylation events that lead to increased nuclear YAP in OSs but not MSC. A tempting 
hypothesis would be to test if gradual shifts in the activation of this pathway occur during 
hydrostatic stimulation as MSCs transition from stromal cells to later stage OBs. Figure 18 
summarises the cellular events that were observed following application with cyclic pressure.  
Identifying these initial events inferred that cells interpreted external hydrostatic pressure 
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Intact cytoskeleton Cytoskeletal disruption 
Disrupted F-actin YAP F-actin 
? ? 
from the bioreactor, and translated these pressures into biochemical signals; confirming that 
mechanotransduction was taking place in cells dung bioreactor stimulation.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 14. Summary of findings of mechanotransduction in MLO-A5s exposed to 
hydrostatic pressure. Upon application of hydrostatic pressure, cytoskeletal tensioning leads 
to accumulation of YAP in the nucleus.. Hydrostatic pressure also induces NO release, a 
process that does not require an intact cytoskeleton. Existing evidence infers hydrostatically 
induced NO production might be related to the rapid release of intracellular calcium stores 
during loading. 
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2.4.3. Hydrostatic preconditioning of hMSCs monolayers 
The final section of this chapter aimed to investigate if the mechanisms discussed above 
were key determinants of osteogenic differentiation in hMSC. Analysis of osteogenic markers 
Runx2, OCN and ALP showed that stiffer substrates promoted osteogenic differentiation and 
that this correlated with the initial cell area, nuclear YAP localisation, and f actin stress fibre 
formation. Whilst hydrostatic pressure altered the expression of YAP on the different 
stiffness substrates, there did not appear a consistent pattern in the behaviour of YAP 
expression due to substrate stiffness and pressure. Coupled with this, daily application of 
pressure over 10 days did not appear to enhance MSC differentiation. This suggests that in 
contrast my initial hypothesis, while stiff substrates promote nuclear accumulation of YAP 
and enhance osteogenesis relative to softer substrates, the synergistic effect of pressure did 
not improve the differentiation potential when compared with unstimulated controls.  
 The induction of osteogenic differentiation using soluble factors such as dexamethasone 
and β-glycerol phosphate is a well-established technique. There is a large body of literature 
exploring gene expression profiles at different stages of osteogenesis(Stein et al. 2004), and 
the specific expression profiles of key markers is still debated. The typical timeframe for 
differentiation of hMSC’s in osteogenic media is around 14 days, with expression of 
transcriptional runx2 between days 5 and 14 (Birmingham et al. 2012). During this time there 
is also thought to be a peak expression in ALP (Aubin 2001) before the onset of matrix 
production in the form of OCN, collagen and calcium deposition (Hoemann et al. 2009).  The 
experiments described in Section 2.3.2 showed hMSCs expressed ALP, runx2 and OCN, 
which is consistent with the literature describing early marker expression profiles during 
osteogenic differentiation of MSCs. It may be that a longer time in culture might have 
elucidated a response due to hydrostatic pressure that was not observed during the 10 day 
culture period. Additionally, a more thorough characterisation of cell behaviour such as 
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changes in proliferation, metabolite assays, or analysis of gene expression by qPCR might 
have identified mechanoactive responses that are as of yet undetermined. Whilst age related 
shifts in the response to mechanical loading have been identified in MSCs (Tan et al. 2015), 
the idea that the mechano-sensitivity might change as MSCs develop into more osteoblastic 
phenotypes has not yet been explored. Indeed the ability of OSs to sense certain mechanical 
stimuli has been shown to be fairly unique, by which it’s characteristic dendritic processes 
more effectively translate locally applied mechanical stimuli than the main cell body(Adachi 
et al. 2009).  
Aside from potential changes in the mechano-sensitivity in MSCs, it could be that the 
regime chosen for the experiments in Section 2.3.2 did not reflect physiological pressures 
MSCs experience as they undergo the initial transition into pre-osteoblasts. A recent study 
measuring pressure and shear stress in the trabecular compartment of whole porcine femurs 
during whole bone loading estimated pressure gradients of between 0.013-0.46kPa, shear 
stresses between 1.67-24.55Pa and compressive strains around 100-150µϵ (Metzger et al. 
2015).  It’s reasonable to suggest that the fluid flow or strain more positively influence the 
early stages of MSC differentiation towards pre-OBs, and hydrostatic pressures regimes such 
as the one used in Section 2.3.2 could more accurately reflect physiological loading in the 
later stages of OB differentiation. Likewise this maybe why MLO-A5s behave differently to 
MSCs in response to pressure with respect to actin reorganisation and YAP expression.  
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2.4.4. 2D vs 3D growth environments  
The study of 2D monolayers systems has long been debated with respect to designing 
growth environments that accurately recapitulate the in vivo cell niche. Coupled with this 2D 
systems complicate many aspects of clinical translation due to problems with limited 
scalability and reproducibility (Serra et al. 2012). Chondrocytes have been shown to switch 
from a rounded morphology in 3D to a fibroblast morphology in 2D, which was shown to 
alter the rate ECM production between the two systems (Lawrence & Madihally 2008). It has 
also been suggested that changes between 2D fibroblast cultures and fibroblasts cultured in 
3D collagen hydrogels exhibit differences in cell-cell signalling, cytoskeletal regulation and 
integrin mediated cell matrix interactions (Rhee 2009). It’s likely that by providing a more 
appropriate 3D growth environment for MSCs could enhancee bone forming in response to 
hydrostatic pressure. We must not however overlook the seminal contributions to the 
understanding of bone mechano-biology that have been made through investigating 2D 
environments under dynamic loading. In vitro monolayer studies of early 
mechanotransduction events can offer a high throughput screening method that is cost 
effective, and can deliver useful preclinical evaluation of the efficacy of hydrostatic pressure 
bioreactors over static cell culture.  
2.5. Conclusion 
In this chapter, I observed active mechanotransduction in cells during hydrostatic loading 
using the bioreactor system. I have identified changes in cell behaviour associated with 
different magnitudes and frequencies of loading, determining that cyclic and not static 
loading is required to initiate mechanotransduction in the form of NO production and actin 
stress fibre formation.. Finally, I employed the bioreactor to attempt to enhance osteogenic 
differentiation in hMSCs cultured on different stiffness substrates; however my results 
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suggested that bioreactor stimulation did not improve the outcome of differentiation 
compared with a static culture environment. The next chapter aims investigate the difference 
in response of 2D and 3D growth environments in OBs, and to optimise a growth 
environment that reflects a clinically relevant bone graft using hMSCs.   
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Chapter 3  
Translation from 2D to 3D: 
Optimising in vitro bone formation 
in cell seeded hydrogels 
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3.1. Introduction  
In the previous chapter I demonstrated that daily treatment with hydrostatic pressure 
did not enhance osteogenic differentiation in hMSC monolayers after 10 days in culture. I 
discussed that a longer culture period may have resulted in a greater response to 
hydrostatic pressure, due to the developing OB phenotype potentially being more 
responsive to pressure than MSC precursors.  In this chapter I will use a human MG63 
bone cell line, considered to represent an intermediate stage of differentiation (Pautke et 
al. 2004)(Czekanska et al. 2014), as a reference cell line to determine if bioreactor 
stimulation can increase the rate of in vitro bone formation. MG63s (discussed Section 
1.5.2) share many of the same phenotypic traits as primary human OBs, and also 
represent a heterogeneous cell population that is well characterised by the literature. 
Additionally, I aim to study changes in cell behaviour due the transition from 2D 
monolayers to a 3D environment, which more accurately represents the in vivo niche of 
bone tissue. I hypothesise that a transition between 2D and 3D culture environments will 
alter the MG63s response to hydrostatic pressure.  A number of studies report a disparity 
in mechanically active responses of cells between 2D and 3D environments (Cukierman 
& Bassi 2010) (Tibbitt & Anseth 2009) (Polacheck et al. 2014). Thus, insight into such 
translational mechanisms could help bridge the gap in the understanding of how 
heterogeneous cell populations respond to hydrostatic pressure between 2D and 3D 
growth environments. Additionally, defining a loading regime that positively influences 
bone formation in cell seeded constructs will be important in evaluating the efficacy the 
bioreactor when compared with a static culture environment. 
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  Recapitulating in vivo niches in vitro 3.1.1.
Recapitulation of in vivo niches to generate  tissue equivalents in vitro may lead to a 
significant step forward in advancing treatments for orthopaedic medicine(Ingber & 
Levin 2007). As discussed in Section 1.4.4 & 1.6.2, collagen type 1 represents the most 
substantial organic component of mammalian tissue, accounting for 20-30% of the 
body’s total protein content (Harkness 1961). Due to its excellent bio-compatibility and 
the ease at which its properties can for fine-tuned for different applications, collagen 
remains one of the most promising candidate biomaterials for tissue regeneration. 
Collagen’s regenerative capacity has been demonstrated in a number of different in vitro  
models, including neural tissue (Weightman et al. 2014), tendon (Lomas et al. 2013), 
muscle(Micol et al. 2011) cartilage(Hui et al. 2008) and bone (Schneider et al. 2010). 
Due to the collagen’s unique chemistry, it can be readily manipulated to serve as a drug 
delivery vehicle (Aishwarya 2008), and has proven safety and efficacy as a bone 
substitute in humans when used in combination with osteo-inductive growth 
factors(Geiger 2003).  Existing evidence demonstrates the usefulness of collagen 
scaffolds to translate 2D cell culture toward a cell microenvironment that more closely 
mimics physiological niches. Coupled with this, experiments using 3D collagen 
hydrogels can facilitate a deeper understanding of how environmental factors such as the 
ECM, affect a cells ability to translate hydrostatic pressure into biochemical responses.  
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  Defining measurable outputs for quantifying mechanically stimulated bone 3.1.2.
formation  
Utilising the appropriate forms of analysis to assess changes in the osteogenic 
differentiation of cells seems a somewhat trivial statement; however, characterising the 
level of complexity in in vivo tissues requires extensive analysis, and the increasingly 
interdisciplinary nature of BTE has introduced a vast database of analytical techniques 
that aim to quantify in vitro tissue development. It is important then to review and 
implement techniques that more adequately represent the aims of my hypothesis, that is, a 
daily cyclic pressure regime can accelerate bone formation in cell seeded 3D hydrogels. 
Computer aided imaging modalities such as x-ray micro computed tomography (µCT), 
represent a growing advance in analytical techniques which can accurately probe changes 
in the physical and mechanical environment of 3D cell seeded constructs(Baas et al. 
2010). The first publications relevant to orthopaedic research, detailed in the late 1980’s, 
used µCT to describe the structural mechanics of trabecular bone architecture (Feldkamp 
et al. 1989). The contribution of µCT since has made an astounding impact on the 
understanding of bone development, allowing the researcher to quantify temporal 
changes in the structure and density of different tissues with micrometre resolution. The 
sensitivity of µCT, coupled with its non-destructive imaging capabilities, makes it an 
excellent tool for live monitoring structural changes in pre-cultured cell seeded scaffolds. 
 Optimising the ECM environment 3.1.3.
Given the extent in which collagen is used in biomedical research, surprisingly little 
has been done to standardise methods in which scientists can stimulate in vitro tissue 
growth. Previous studies have demonstrated that the collagen content, controlled by 
adjusting the relative concentration during hydrogel fabrication, is a critical determinant 
of subsequent tissue development. Changes in collagen concentration have been 
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correlated with altered gel contraction in MSCs, as well as with changes in cell mediated 
matrix remodelling during tenogenic differentiation (Awad et al. 2000).  Interestingly, 
despite the evidence describing a strong correlation between cell seeding density and 
collagen hydrogel concentration on in vitro cartilage formation by hMSCs (Hui et al. 
2008), studies are yet to characterise the effect of these experimental parameters on in 
vitro osteogenesis in hMSCs. Furthermore, there is currently a poor understanding of how 
spatial changes dictate temporal osteogenic maturation of MSC seeded collagen 
hydrogels. The manufacturing requirements for a viable regenerative medicine therapy 
require not only adequate characterisation of cell sources and expansion techniques(Want 
& Nienow 2012) but also a rigorous demonstration of clinical relevance through process 
improvement and optimisation (Williams & Sebastine 2005). I therefore aim in this 
chapter to assess the extent of in vitro bone formation in hMSC seeded collagen gels with 
different gel concentrations and cell seeding densities. In doing so, I can define an 
optimal set of initial conditions to generate 3D bone constructs. Since the beneficial 
effect of preconditioning in the bioreactor is at present not clear, I must first define an 
appropriate set of conditions in which I can reliable manufacture hMSC/collagen 
scaffolds that represent clinically relevant bone substitutes. By generating an internal 
gold standard of static culture in hMSC/collagen hydrogels, the process of assessing the 
outcome of experiments implementing hydrostatic preconditioning could become much 
simpler. 
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Objectives 
i) Study the effect of hydrostatic preconditioning on MG63 osteoblasts 
in 2D monolayers. To determine if hydrostatic preconditioning 
accelerates bone formation in differentiating MG63’s. I aim to test the 
hypothesis that changes in cytoskeletal remodelling at the point of loading 
(reported in Section 2.3.1) reflects the cells ability to increase bone 
formation due to hydrostatic preconditioning. 
 
ii) Assess changes in the behaviour of MG63 osteoblasts in 2D 
monolayers and 3D collagen hydrogels. To determine if a 3D 
environment enhances the ability of cells to translate hydrostatic pressure 
into bone forming responses. This will also serve to determine if the 
loading regime (280kPa, 1Hz, 60 minutes) is effective for preconditioning 
3D bone constructs.  
 
iii) Define an internal ‘gold standard’ of bone tissue development in 
hMSC/collagen hydrogels after 4 weeks in static culture. To understand 
how changes in cell seeding density and collagen concentration affects 
bone formation in hMSCs after 4 weeks static culture, based on typical 
timeframes in which in vitro ostegenesis is performed using a trilineage 
differentiation assay hMSCs(Glueck et al. 2015). In doing so I aim to 
generate a reliable comparison for assessing the additional benefit of 
hydrostatic preconditioning.  
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3.2. Materials and Methods 
 MG63 experiments 3.2.1.
 Cell culture  3.2.1.1.
MG63’s stably transfected with an OCN luciferase reporter (Feichtinger et al. 
2011) were kindly donated by Dr Deniz Oeztuerk of the Ludwig Boltzmann Institute for 
Experimental and Clinical Traumatology, Austria. Cells were thawed from liquid 
nitrogen at room temperature, washed once in 10mls DMEM, centrifuged at 800rmp for 5 
minutes and transferred to tissue culture plastic at a seeding density 6500cells/cm
2. 
Cells 
were maintained in PM for 2 passages prior to each experiment undertaken. For 
monolayer experiments, cells were seeded at a density of 2x10
4
cells/well in 24 well 
plates. For 3D hydrogel experiments, MG63s suspended in PM were mixed with 
appropriate volumes of type-1 rat tail collagen, made from a stock solutions of (8-11) 
mg/ml (Corning). Hydrogels were seeded with 10
5
cells in 300µl volumes of 2mg/ml 
collagen, and kept in culture for 24 hours until stably contracted. After contraction, gels 
were transferred to 6 well trans-well inserts (Corning). 
 For the duration of the experiments: 7 days for monolayer studies; and 14 days 
for 3D collagen hydrogels; MG63s were maintained in osteogenic media (described in 
Section 2.1.9). For end point analysis, samples were fixed in 10% neutrally buffered 
formalin for 15 minutes at room temperature for monolayer samples, and for 1hr at room 
temperature for collagen hydrogels. Samples were washed twice in PBS and stored in 
PBS with 1% pen-strep, 1% amphotericin B at 40C until subsequent analysis was 
performed. 
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 Hydrostatic regime 3.2.1.2.
For each experiment undertaken, samples received one hour per day in the 
hydrostatic bioreactor. Cultures were kept in osteogenic media with media changes every 
2 days before stimulation. Evaporation in wells closest to the nozzle side of the bioreactor 
was accounted for as described in Section 2.1.9.   The remainder of the time constructs 
were kept under static standard cell culture conditions in a cell culture incubator at 370C 
with 5%CO2. The pressure regimes applied were a) 0 – 280 kPa at 1 Hz for 60 minutes 
and b) no pressure as a control. 
 Osteocalcin activity 3.2.1.3.
The expression of OCN in MG63s was quantified by taking media samples each 
day before hydrostatic stimulation.  A PierceTM Gaussia Luciferase Flash assay kit 
(Thermo Scientific, UK) was used to quantify secreted luciferase protein in the culture 
media. An auto injection protocol was employed on a bio synergy 2 plate reader. 50µl of 
flash assay solution was injected into each well containing with 50µl of sample and 
mixed for 2 seconds. A 10 second reaction time preceded the luminescence reading for 
each sample. Pressure treated samples were normalised to static controls to give a value 
representing a fold change in OCN activity.  
 Lysate preparation 3.2.1.4.
 Monolayer cultures were lysed using a luciferase cell lysis buffer (Thermo Scientific, 
UK). The media was removed and cells were washed once in PBS. 250µl of 1x lysis 
buffer was added to each well and the plate was then placed on a shaker for 5 minutes. 
The lysate was transferred to an Eppendorf tube and a further 250µl of fresh lysis buffer 
was added to the wells to gather any remaining lysate. Samples were stored at -20
o
C until 
ready for use.  MG63/collagen hydrogels were washed in PBS for 15 mins and digested 
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in 2mg/ml collagenase from clostridium histolyticum (Sigma) for 30 minutes. Samples 
were then spun down at 10K rpm for fifteen minutes, the supernatant was removed and 
the remaining pellet washed in PBS and centrifuged twice, and re-suspended in 500µl of 
1x luciferase cell lysis buffer. 
 DNA quantification 3.2.1.5.
Total DNA was measured using a Quant-iT PicoGreen assay (Thermo Scientific, 
UK). Briefly, 25ul of cell lysate was incubated in 1x PicoGreen working solution for 5 
mins at room temp, covered from light. Fluorescence was measure at 480/520nm 
excitation/emission spectrum and normalised to fluorescence values of known standards 
of DNA. 
 Total Protein 3.2.1.6.
Total protein in cell lysates was quantified using a Pierce
TM
 BCA protein assay kit 
(Thermo Scientific, UK). 25ul samples of lysate were mixed in 200ul of the kits working 
solution and incubated for 30 mins at 37
o
C. Samples were allowed to cool to room 
temperature before measuring absorbance at 562nm on a Biosynergy 2 plate reader. 
Readings were normalised against known standards of BSA diluted in DH2O and further 
normalised to the DNA content of the respective samples.  
 Collagen detection 3.2.1.7.
Collagen production in MG63 monolayers was quantified using the collagen stain 
Sirius red (Direct red 80, Sigma UK). 100ul of the cell lysate was added to a 1.5ml micro 
centrifuge tube and 0.5ml 1% w/v Sirius red S in dH20 added. The solution was incubated 
at room temperature for 20 minutes and centrifuged at 10,000 rpm for 15 minutes to form 
a pellet. The supernatant was decanted and repeat washes were performed until 
supernatant became a clear solution. The pellet was resuspended in 100ul 1M NaOH to 
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remove the bound dye. Absorbance measurements of the pellets were measured at 540nm 
using a biosynergy 2 plate reader and the values were normalised to DNA content of the 
respect samples. 
 Calcium detection 3.2.1.8.
Calcium production in MG63 monolayers after 7 days was quantified using an 
alizarin red S (A/R) based cetylpyridinium chloride extraction method (Gregory et al. 
2004). Fixed cells were stained for 30 minutes at room temperature in 1% filtered A/R. 
Repeated washing in PBS and centrifugation was carried out until unbound dye was not 
visible in the rinsing solution of PBS.  0.5mls of 10% cetylpyridinium chloride (Sigma) 
in DH2O was then added to each well and incubated overnight at room temperature to 
extract the bound dye from the samples. The cetylpyridinium chloride de-staining 
solution was then removed from each well and absorbance measurements were performed 
at 562nm using a Biosynergy 2 plate reader. Absorbance measurements were normalised 
to the DNA content of the respective samples. 
 
 X-ray micro tomography 3.2.2.
Analysis of volume and density in cell-seeded hydrogels was by X-ray micro 
tomography (μCT) using a Scanco μCT40 (beam energy: 55 kVp, beam intensity: 145 
μA, 200 ms integration time, spatial resolution: 10 μm).  Mineralisation of the hydrogels 
was assessed by calculating the volume fraction of material at different density 
thresholds. The different density thresholds are computed by averaging the linear 
attenuation coefficient for each voxel within a given hydrogel and normalising this value 
to the attenuation coefficient for water, thus obtaining the relative density in CT units. 
Samples were analysed at two density thresholds (50/1000, 80/1000) firstly to determine 
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the total size (volume) and average density of each construct following bioreactor 
stimulation, and then at higher threshold to calculate the percentage change in percentage 
volume over time in the mineralising phase.  
 Histological staining and imaging of 3D hydrogels 3.2.3.
Histological analysis of hydrogel sections was achieved by embedding whole gels 
in paraffin wax using an automated vacuum tissue processor (Kedee). 10µm sections 
were cut using a microtome, after which sections were transferred to a preheated water 
bath (40
0
C) and mounted onto polylysine coated microscope slides (Thermo Fisher). 
Sections were deparaffinised in 2 xylene washes for 5 minutes each and rehydrated in 
serial ethanol dilutions (100%, 90% 70% 50% and DH2O) for 3 minutes each. 
Mineralisation was quantified using either A/R or Von Kossa (V/K) staining to confirm 
the presence of calcium phosphate deposits. Sections were incubated in either 1% A/R or 
5% silver nitrate in dH2O for 30 minutes at room temperature. Sections were then washed 
under running tap water for 2 minutes and for V/K staining, exposed to UV irradiation for 
15 minutes in a Bio rad GenX UV chamber. Cell nuclei and cytoplasm were stained using 
Harris Haematoxylin solution and eosin for 30 secs each followed by 30 secs emersion in 
scots tap water (10g MgSO4, 1.75g NaHCO3 in 500mls PBS). Sections were mounted in 
DPX mounting medium and Imaged using an EVOS® FL Colour Imaging System.  
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 hMSC experiments  3.2.4.
 Cell culture 3.2.4.1.
Frozen vials of hMSCs were seeded into T75 flasks as detailed previously (Section 
2.5.1). hMSCs were expanded in PM (described in Section 2.2.1) until passage 5, before 
encapsulation in collagen. Collagen hydrogels of concentration (0.5-5mg/ml) were 
fabricated by diluting cells suspended in PM with appropriate volumes of stock 
concentration (8-11) mg/ml type-1 rat tail collagen.  300µl solutions were pipetted into 
non-adherent round bottom 96 well plates and left to contract for 24 hrs. Collagen 
hydrogels (1mg/ml) were also fabricated with different cell seeding densities (0.1x10
5
-
3x10
5
cells/hydrogel). After 24hrs, hMSC/collagen hydrogels were transferred to 6 well 
trans-well culture inserts. Hydrogels were maintained in osteogenic media under static 
culture conditions (37
o
C with 5%CO2) for 28 days, with media changes every 3-4 days. 
After 28 days, hydrogels were washed twice in PBS and fixed in neutrally buffered 
formalin for 1 hr at room temperature, followed by two 15 minute washes in PBS. 
Samples were stored in PBS with 1% pen-strep, 1% amphotericin B at 40C until 
subsequent analysis was performed. 
 ImageJ analysis  3.2.4.2.
ImageJ was used to quantify the average number of cells per/mm
2
 to assess the 
change in cellular distribution between the different experimental groups. 10 µm paraffin 
embedded sections were deparaffinised and stained with haematoxylin and eosin 
(described in Section 3.2.3).  The number of cells within a given area was counted on 
three separate gel sections using a cell counter plugin in ImageJ, with the corresponding 
area calibrated to measure in mm
2
. The final values were normalised to cells/mm
2
, 
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allowing for direct comparison of cellular distribution between different gel 
concentrations and seeding densities.  
 Immunohistochemistry 3.2.4.3.
 Immunohistochemistry (IHC) stating for OCN and Connexin 43 (Cx43) was 
performed on hMSC/collagen hydrogels after 28days culture. Fixed hydrogels were 
paraffin embedded, sectioned, deparaffinised and rehydrated as described in Section 
3.2.3. 10 μm tissue sections were then permeabalised in 0.01% triton-X 100 (Sigma) for 
15 minutes, followed by 2 washes in PBS. Antigen retrieval was performed by immersing 
sections in 20µg/ml pre-warmed proteinase k solution (Sigma) for 15mins at 37
o
C. 
Sections were then blocked in 1% BSA (Fisher Scientific) for 1 hr at room temperature 
before overnight incubation at 4
o
C in primary antibody solutions: anti-human OCN 
mouse monoclonal (R&D systems); and anti-human Cx43 mouse monoclonal (Santa 
Cruz Bio); diluted to 2µg/ml in 0.1% BSA in PBS with tween (0.1%). Secondary 
antibody staining was performed using an ABC immune-peroxidase method (Santa Cruz 
bio), following the manufacturer’s instructions. Secondary only antibody staining of 
tissue sections were used as controls.  
 Statistical analysis 3.2.5.
Data was plotted and analysed in Microsoft Excel. All data point represents mean 
values ± standard error of the mean. Statistical significance in MG63 experiments was 
determined in Microsoft Excel using a two tailed students T-Test. For hMSC/collagen 
hydrogels, statistical analysis was performed in Origin 9.0, employing linear fitting and 
iterative, non-linear fitting to determine relationships between size, density and 
mineralisation between experimental groups.  
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3.3. Results 
 2D cell culture 3.3.1.
 Assessment of proliferation and OCN activity 3.3.1.1.
To assess the initial mechano-response in MG63s at Day 1, cells were fixed and 
stained with phalloidin immediately after loading to assess changes in the f actin 
cytoskeleton between control and stimulated groups (Figure 1A). Similar to MLO-A5s 
described in Section 2.3.1, bioreactor stimulation induced f-actin stress fibre in MG63 
monolayers. For studies looking at the temporal effects of pressure in MG63s, cells were 
maintained in static culture for 7 days and compared with MG63s receiving daily 
bioreactor stimulation. In both static and pressure treated groups, cells became confluent 
after 3-4 days (Figure 1D). Cell number remained constant for the remainder of the 
experiment with a slight decrease in cell number by day 7. After 7 days pressure treated 
groups had slightly higher numbers of MG63s but this was not statistically significant. 
Live dead staining (Figure 1C) was employed after 7 days to assess cell viability. Daily 
treatment with pressure enhanced cell viability, indicated by an increase in dead cells 
(red) in statically cultured groups receiving pressure. 
Osteocalcin activity (Figure 1E) was normalised to represent a fold increase over 
static controls to account for the cumulative increase of secreted protein in between 
media changes, which were performed every 2 days. A second static control (Figure 1E 
grey dashed line) was used to demonstrate negligible plate to plate variability in OCN 
activity in static controls. Osteocalcin was activated transiently by pressure, with peak 
activity by day 3 (P=0.15). Activity returned to comparable levels with static controls by 
day 5 and remained comparable with static controls for the remainder of the experiment 
(day 7). 
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Figure 1. Evaluation of response of MG63 pre osteoblasts to hydrostatic pressure 
over a 7 day culture in osteogenic media. (A&B) F-actin staining in cells exposed to 
pressure regimes after 60minutes. C) Live dead staining at day 7. D) Total DNA in 
MG63 monolayers over 7 days in culture, n=3. E) Osteocalcin activity in MG63 
monolayers over 7 days in culture, n=6. Scale bars (A&B) = 50μm. Scale bars (C) = 
500μm. Error bars = standard error of the mean. ns P>0.05 
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 Assessment of extra cellular matrix production 3.3.1.2.
The rate of total protein synthesis (Figure 2A) over the 7 day period increased by 
50% in cells treated with pressure, and was significantly higher at day 5 and day 7. 
Histological staining (Figure 2B) of the wells was performed at day seven to assess for 
changes in the presence of collagen and calcium between the two experimental groups. 
Pressure treated plates had stronger visible staining in the centre of the wells for both 
collagen and calcium when compared with static controls.  Quantification of collagen 
production was performed in cell lysates to assess for changes due to pressure (Figure 
2C). The results indicated an increase in collagen production in pressure treated cells as 
early as day 3, which continued to increase until day 7, however the measured increase at 
day 7 was not statically different from static controls (p=0.11). Quantification of alizarin 
red staining reflected the observational increases in calcium, with a significant increase in 
calcium production in pressure treated cells compared with static controls (Figure 2D). 
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Figure 2. Collagen and calcium production in MG63s after 7 days in vitro culture. 
A) Total protein in MG63 monolayers over 7 days in culture, n=3. B) Histological 
staining for calcium (top) and collagen (bottom) production in MG63 after 7 days in 
culture.  C) collagen production in MG63 monolayers over 7 days in culture, n=3. E) 
Calcium production after 7 days in culture, n=3. Scale bars = 500μm. Error bars = 
standard error of the mean. **P<0.01 *P<0.05 
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 3D Hydrogels 3.3.2.
  Assessment of proliferation and OCN activity 3.3.2.1.
Cells contracted the surrounding collagen matrix after fabrication and were stable 
enough to transfer to trans-well inserts after 24 hours. DNA quantification (Figure 3A) 
showed a significant reduction (P<0.0001) in cell number between day 1 and day 3. Since 
day 1 samples were lysed before hydrogels contracted, this suggested not all cells were 
able to attach to the surrounding collagen as the hydrogels underwent contraction. Cell 
numbers did not change significantly during the experiment, with a small reduction in 
cell number observed between day 10 and day 14. Daily bioreactor stimulation had no 
effect on cell proliferation. 
OCN activity in stimulated hydrogels (Figure 3B) was significantly higher at 
days 3, 4, 6 and 7 of the experiment. The trend signified a transient expression profile, in 
which pressure increased osteocalcin activity by two fold between day 1 and day 3, and 
subsequently returned to control levels by day 5. A second peak in activity was observed 
by day 7 and day 8 with a 3 fold increase in activity compared to controls. Activity 
returned to comparable levels by day 10 and remained within close range of static 
controls for the remainder of the experiment.  
 Whole mount imaging of the hydrogels after 14 days (Figure 3C) demonstrated 
pressure treated hydrogels were smaller in size, implying MG63s contracted the 
hydrogels more when hydrostatically stimulated.  Live dead staining at day 14 (Figure 
3D) showed MG63s remained viable during the experiment, with some areas of cell death 
evident around the hydrogel periphery in both stimulated and statically cultured 
hydrogels.  
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Figure 3. Evaluation of response of MG63/collagen hydrogels s to hydrostatic pressure 
over a 14 day culture in OM. A) Total DNA in MG63 collagen hydrogels over 14 days 
in culture, n=3. B) Osteocalcin activity in MG63 monolayers over 14 days in culture, 
n=6. C) Brightfield images of MG63/collagen hydrogels after 14 days.  D) Live dead 
staining of MG63/collagen hydrogels after 14 days. Scale bars (C) = 5mm. Scale bars 
(D) = 2mm. Error bars = standard error of the mean. **P<0.01.  *P<0.05 
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 Assessment of MG63/collagen hydrogel mineralization   3.3.2.2.
µCT was employed to assess for changes in hydrogel volume and mineralisation at 
different time points during the experiment (Figure 3A-C).   Hydrogel volume (Figure 
3A) during the initial contraction phase decreased from 300mm
3
 to 17.38.±1.1mm
3
. In 
both static and pressure treated hydrogels, the rate of change in volume over 14 days was 
comparable, with pressure treated hydrogels exhibiting a longer period of contraction 
than static controls. After 14 days, hydrogels treated with pressure were 28% smaller than 
static controls and 37% more mineralised (Figure 3A). Stimulated hydrogels began 
mineralising sooner than static controls becoming significantly more mineralised at day 5 
and day 10 (Figure 3B). Hydrogels treated with pressure were significantly more dense 
at day 14 compared with static controls (Figure 3C). µCT reconstructions of the 
mineralised volume and revealed a noticeable larger volume of more dense tissue in 
stimulated hydrogels (Figure 3D).  
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Figure 4. Assessment of hydrogel mineralisation in MG63/collagen hydrogels over 14 
days in culture. A) Change in volume of MG63/collagen hydrogels during 14 days in 
culture. B) Change in percentage mineralised volume of MG63 hydrogels over 14 days 
in culture. C) MG63/collagen hydrogel density at day 14. μCT image reconstruction of 
mineralised volume in MG63 collagen hydrogels at day 14. Scale bars (D) = 1mm. Error 
bars = standard error of the mean. ***P<0.001 **P<0.01 *P<0.05 
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 Histological assessment of bone formation in hydrogels after 14 3.3.2.3.
days in vitro culture 
Histological analysis was employed to detect calcium deposition in MG63 seeded 
hydrogels to assess the extent of bone mineral formation after 14 days in culture. V/K 
staining visualised regions of calcium deposition (black). Calcium deposition was 
localised to regions occupied by cells and supported the µCT data and further showing 
that daily bioreactor stimulation increased bone formation and hydrogel mineralisation. 
Stimulated hydrogels (Figure 5D,E&F) had more positive V/K staining than static 
controls and contained cells with dendritic processes extending into the ECM (Figure 
5E). Cells in statically cultured hydrogels were also locally mineralised within the 
collagen ECM but did not show evidence of mineralised dendritic processes extending 
into the ECM (Figure 5A, B&C). 
 
 
 
 
 
 
 
 
 
Figure 5. 10μm histology sections of MG63/collagen hydrogels at day 14. Sections 
stained with Von Kossa (black) to detect bone formation. Scale bars (A&D) = 1mm. 
(B&E) = 200μm. (C&F) = 100μm 
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 Optimising osteogenic differentiation in hMSC seeded collagen hydrogels 3.3.3.
The next part of this chapter aimed to optimise the osteogenic differentiation of 
hMSC encapsulated in collagen during a 28 day in vitro culture period. In doing so I 
wanted to define an ‘internal gold standard’ with which I could compare the effect of 
hydrostatic preconditioning during this time. By comparing endpoint analysis through 
µCT and histology, I can determine if µCT readouts accurately reflect the maturity of the 
comprising tissue.  
  
 
 
 
 
 
 
 
 
 
 
 
Figure 6. Assessing the effect of collagen concentration and cell seeding density on 
osteogenic preconditioning of hMSC collagen hydrogels. 10
6
cells/ml (3x10
5
/hydrogel) 
were seeded with different collagen concentration (A, 0.5-5mg/ml). 1mg/ml collagen 
hydrogels were seeded with different numbers of cells (B, 1x10
4
- 3x10
5
cells/hydrogel). 
Hydrogels were cultured for 4 weeks under static conditions in osteogenic media before 
fixation and endpoint analysis.  
A B 
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 Hydrogel contraction and viability 3.3.3.1.
Contraction of the hydrogels was observed as soon as 1 hour after fabrication. 
Live dead staining 3 hrs after fabrication showed that cell viability is not adversely 
affected during fabrication or self-assembly of the hydrogels (Figure 7A&B). Lower 
concentration gels with a high cell seeding density (Figure 7B) contracted more rapidly 
than high concentration or low seeding density (Figure 7A). All gels were stable in size 
after 24 hours and with a small further reduction in volume observed after 28days. Higher 
concentration hydrogels initially assumed a hemisphere like morphology due to shape of 
the round bottom well in which the gels were set. After the 28day culture period, the 
hydrogels had adopted a relatively homogeneous spherical shape. After 28 days in 
culture, live dead staining was repeated in 0.5mg/ml & 5mg/ml hydrogels to assess if the 
hydrogels size and/or culture regime negatively affected the viability of encapsulated 
cells (Figure 7 A&B inset). Both low and high collagen concentrations demonstrated 
little adverse effect on cell viability after 28 days in culture.   
 
 
 
 
 
 
 
 
Figure 7:  hMSC remained viable during gel fabrication used and remained viable 
over 28days in culture.  
 
 
117 
 
 Change in volume after 28 days culture 3.3.3.2.
The volume of the hydrogels after 28days decreased linearly when the collagen 
concentration was lowered (Figure 8A&C, R
2
=0.99). The linear decrease in volume 
equated to 19.21±0.23mm
3
/mg of collagen, (R
2
=0.99). Changes in volume due to the cell 
seeding density (Figure 8B&D) could be described by a cubic fitting function (R
2
=0.52), 
however this correlation was relatively low compared to changes in collagen 
concentration. Despite this, the relationship allowed the calculation of  critical point 
values for cell seeding density, defined by the roots of the derivative of the cubic function 
(Figure 8D, x1=0.69x10
5
, x2=2.12x10
5
). These critical points represented threshold cell 
seeding densities that defined both: contractile equilibrium, past which higher cell 
numbers do not further decrease contracted volume (x1); and the threshold cell number 
(x2) needed to overcome contractile equilibrium.  Quantitation and comparison of 
changes in hydrogel volume demonstrated a much higher dependence of contractility on 
initial collagen concentration as opposed to cell seeding density.   In addition, whilst both 
parameters provide a seemingly good rate of predictability, the correlation between 
collagen concentration and volume was much stronger than the correlation between cell 
seeding density and volume. 
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Figure 8. Volume of hMSC collagen hydrogels after 28 days in vitro culture depends 
on initial collagen concentration and cell seeding density.  Whole mount imaging 
hMSC/collagen hydrogels after 28 days in culture in osteogenic media when changing 
collagen concentration (A) and cell seeding density (B). Change in volume of 
hMSC/collagen hydrogels at 28days in hMSC/collagen hydrogels when changing 
collagen concentration (C) and cell seeding density (D), n=6. Scale bars = 5mm. Error 
bars = standard error of the mean. 
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 Change in hydrogel mineralisation after 28 days in culture 3.3.3.3.
 Image reconstruction of the hydrogels (Figure 9 A&B) showed the change in 
mineralised volume due to concentration (Figure 9A, i-vi), and cell seeding density 
(Figure 9B, i-vi). 1 and 0.5mg/ml concentration gels (Figure 9A, v&vi) showed more 
heavily mineralised regions (indicated by solid grey regions) compared to higher 
concentration gels. Mineralising regions were also more noticeable in hydrogels with 
higher seeding densities, with mineralised nodules visible on peripheral regions of 
hydrogels seeded with 2x10
5
 and 3x10
5
 MSCs (Figure 9B(v&vi)).    
The rate of decrease in the percentage mineralisation of the hydrogels (Figure 
9C) with respect to an increase in concentration was could be related by an inverse power 
relationship. Hydrogel mineralisation was inversely proportional to (collagen 
concentration) 
2/3 
(R
2
=0.94). If we consider as mentioned previously that the regulation of 
volume is linearly dependant on concentration, then the above relationship infers a 
significant dependence of hydrogel mineralisation on the cell to volume ratio of the 
constructs.  
Increasing the initial cell seeding density whilst maintaining the same collagen 
concentration (Figure 9D) increased hydrogel mineralisation. The observed change in 
mineralisation due to cell seeding density followed the same relationship as the changes 
in volume, with a stronger correlation present using a cubic fitted function (R
2
=0.98). It 
should be mentioned that whilst care must be taken when attempting to correlate data sets 
with higher order polynomial functions as a predictive tool. The use of cubic correlations 
to describe changes in volume and mineralisation in this experiment supports the 
inference that the µCT readouts appear to be a reflection of the population density of 
hMSCs in the contracted hydrogels.  
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Figure 9. Hydrogel mineralisation is regulated by collagen concentration and cell 
seeding density. μCT image reconstruction of mineralised volume in hMSC/collagen 
hydrogels at day 28 showing changes in concentration from high (A, 5mg/ml, i) to low 
(A, 0.5mg/ml, vi) and when changing the cell seeding density from low (B, 0.1x10
5
, i) to 
high (B, 3x10
5
, vi). C) Quantification of mineralisation with repsectthe collagen 
concentration. D) Quantification of mineralisation with repsectthe collagen 
concentration with respect to cell seeding density.   n=6. Scale bars= 1mm. Error bars 
= standard error of the mean.  
 
 
121 
 
 Change in hydrogel density 3.3.3.4.
Hydrogel density after 28days (Figure 10) was dependant on both collagen 
concentration (Figure 10A) and cell number (Figure 10B). The rate of change in density 
due to concentration was related to the rate of change in mineralisation (Figure 10C).  
The rate of change in density due to cell number was also related to the rate of change in 
mineralisation ((Figure 10D). Consequently, plotting density vs hydrogel mineralisation 
demonstrated that hydrogel density was linearly proportional to hydrogel mineralisation 
(Figure 10C&D R
2
= 0.94, 0.99).  µCT imaging was employed to visualise the local 
density through cross sections of the hydrogels (Figure10 E&F). The colour heat map 
depicts soft tissue in blue progressing through to green and finally red, representing 
densely mineralised tissue. The difference in size made it difficult to make comparisons 
between high and low concentration hydrogels. To overcome this, µCT reconstructions 
were scaled accordingly (see inset scale bars). 0.5mg/ml collagen gels showed the 
presence of densely mineralised tissue throughout the hydrogel whereas higher 
concentration gels were considerable less dense. Reconstructions of hydrogel with 
different cell numbers showed to a lesser extent an increase in dense material in 
hydrogels with high cell seeding densities (3x10
5
cells) vs hydrogels with low cell seeding 
densities (0.1x10
5
cells).  
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Figure 10: Collagen concentration and cell seeding density regulate hydrogel density. 
hMSC/collagen hydrogel density at day 28 plotted against changes in collagen 
concentration A) and against changes in cell seeding density B), n=6. C&D) 
corresponding density plotted against percentage mineralisation of hydrogels at day 28, 
n=6. E) μCT image reconstruction of density distribution (red – blue = high density – 
low density) in hMSC/collagen hydrogels with different collagen concentrations (E) and 
different cell seeding densities. error bars represent standard error of the mean.  
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 Histological evaluation of mineralisation in hydrogels with 3.3.3.5.
different collagen concentrations 
Haematoxylin and eosin staining (Figure 11A) was used to visualise encapsulated 
hMSCs in hydrogels with different collagen concentrations. In higher concentration gels 
where the volume was also higher, hMSCs were more sparsely distributed than lower 
concentration gels.  Alizarin red (A/R) staining (Figure 11B) was used to visualise 
calcium deposition and Von Koss (V/K) (Figure 11C) staining to relate V/K localisation 
to A/R localisation. Used together they serve as a convenient and accurate method of 
assessing matrix mineralisation. Positive V/K and A/R staining was observed in point 
regions that represented encapsulated cells, implying that hMSCs became encapsulated in 
mineralised matrix after 28days. As the collagen concentration was lowered and cells 
became more closely packed. There appeared a point shift in matrix mineralisation 
between 2mg/ml and 1mg/ml hydrogels.    Above concentrations of 1 mg/ml, mineralised 
hMSCs appeared homogeneously distributed within the hydrogel. In 1 mg/ml hydrogels, 
mineralised hMSCs were heterogeneously clustered, and in 0.5mg/ml hydrogels hMSCs 
appeared heavily throughout.  ImageJ analysis was used to quantify the number of 
cells/mm
2
 for each group (Figure 11D, R
2
=0.98). The number of cells/mm
2
 decreased as 
concentration was increased. The average distribution of cells per unit area was linearly 
proportional to the change in mineralisation (Figure 11E R
2
=0.97). 
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Figure 11. : Histological evaluation of matrix mineralisation and cellular distribution 
of hMSC in collagen hydrogels with different collagen concentraitons over 28 days in 
vitro culture. 10µm Parrafin embedded sections were stained with haomatoxylin and 
eosin (A), Alizarin red (B) and von kossa (C). D) Average cell distribution plotted 
against collagen concentraton, n=3. E) Average cell distribution plotted against 
percetage of hydrogel mineralised, n=3. Scale bars =500µm and 20µm (inset). Error 
bars represent standard error of the mean.  
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  Histological evaluating of hydrogel mineralisation due to 3.3.3.6.
changes in cell seeding density 
Haematoxylin and eosin staining (Figure 12A) visualised encapsulated hMSCs in 
hydrogels with different cell seeding densities. Increasing the cell seeding density 
produced hydrogels after 28 days with a higher cell overall cell density. A/R (Figure 
12B) and V/K staining (Figure 12C) showed point like matrix mineralisation 
representing mineralised cells similar to that observed previously when changing 
collagen concentration. The increase in cell seeding density was proportional to an 
increase in cells/mm
2
 (Figure 12D, R
2
=0.93) in histological sections, and was also 
proportional to hydrogel mineralisation (Figure 12E, R
2
=0.78).  
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Figure 12. Histological evaluation of matrix mineralisation and cellular 
distribution of hMSC in collagen hydrogels with different cell seeding densities over 
28 days in vitro culture. 10µm Parrafin embedded sections were stained with 
haomatoxylin and eosin (A), Alizarin red (B) and von kossa (C). D) Average cell 
distribution plotted against cell seeding density, n=3. E) Average cell distribution 
plotted against percetage of hydrogel mineralised, n=3. Scale bars =500µm and 20µm 
(inset). Error bars represent standard error of the mean. 
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  Immunohistochemistry 3.3.3.7.
IHC was performed on 10μm tissue sections in hydrogels with a high number of 
cells/mm
2
 vs hydrogels with a low number of cells/mm
2 
(Figure 13). 1mg/ml collagen 
gels seeded with 3x10
5
 (Figure 13A) and 0.1x10
5
 (Figure 13B) hMSCs were chosen to 
allow comparison of two different cell densities, with the same collagen concentration. 
Higher concentration hydrogels (2-5mg/ml) were considered analogous to a lower cell 
seeding density (0.1-2x10
5
cells) due to the similar values obtained for the hydrogel 
mineralisation, density and number of cells/mm
2
. IHC was used to detect the presence of 
osteocalcin (Figure 13Ai&Bi) as a quality measure for matrix mineralisation, and 
connexin 43(Figure 13Aii&Bii) to determine the extent of cellular interconnectivity. 
Secondary only antibody staining was used as a control (Figure 13Aiii&Biii). 
Osteocalcin was abundant in 1mg/ml hydrogels seeded with 3x10
5
 cells, and was specific 
to regions which stained positive for A/R and V/K, suggesting mineralised areas of the 
hydrogels gels became enriched with bone matrix proteins secreted by encapsulated cells. 
The presence of connexin 43 was also confined to heavily mineralised regions, 
suggesting that closely packed differentiating hMSC form an interconnected cellular 
network of connexin channels. By contrast, hydrogels with sparsely distributed cells had 
positive staining limited to single cells or small clusters of cells which had become 
mineralised. Secondary only staining showed little to no positive staining, indicating that 
IHC labelling was specific to the targeted antibodies.  
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 Figure 13.  IHC staining of tissue sections from hMSC/collagen hydrogels at day 28. A) 
Osteocalcin (i), connexin43 (ii) and secondary only controls (iii) of 1mgl/ml collagen hydrogels 
seeded with 3x10
5
 cells. B) Osteocalcin (i), connexin43 (ii) and secondary only controls (iii) of 
1mgl/ml collagen hydrogels seeded with 0.1x10
5
 cells. Scale bars =500µm and 20µm 
(highlighted areas) 
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3.4. Discussion  
 Chapter overview 3.4.1.
The results described in this chapter evaluated the performance of the bioreactor as a 
preconditioning tool for 3D cell seeded constructs. I initially investigated the effect of a 
1hr daily loading regime (280kPa, 1Hz CHP) on two separate growth environments of 
osteocalcin reporter MG63s. The first part studied the effect of pressure on cells in 
monolayer; the second studied the effect of pressure in a 3D environment in collagen 
hydrogels. Daily application of pressure increased osteocalcin expression and accelerated 
mineralisation in both systems. 3D collagen hydrogels intrinsically provided a more 
optimal growth environment for bone formation than monolayers despite the fact both 
environments exhibiting similar responses to pressure. After 14 days in culture, daily 
treatment using the bioreactor produced hydrogels that were 28% smaller and 37% more 
mineralised. µCT, coupled with histology demonstrated increased bone formation in 
hydrostatically stimulated hydrogels. This confirmed my hypothesis that the loading 
regime defined in chapter 1 is sufficient to accelerate bone formation in 3D cell seeded 
constructs.  
The second part of this chapter looked to optimise culture conditions to generate 
tissue engineered bone constructs over a 28 day in vitro culture period using hMSC 
seeded collagen hydrogels. The study described the rate of change of in vitro osteogenic 
differentiation of hMSC/collagen hydrogels due to changes in collagen concentration and 
cell seeding density during hydrogel fabrication. Osteogenic maturation of the hydrogels 
was dependant on both the collagen concentration and cell seeding density, with low 
collagen concentration – high cell density hydrogels yielding the highest rate of bone 
tissue formation. Increasing the collagen concentration increased hydrogel volume whilst 
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increasing the seeding density decreased hydrogel volume.  Increases in hydrogel volume 
saw corresponding decreases in hydrogel mineralisation and density. Both tissue density 
and mineralised volume were linearly proportional to the number of cells/mm
2
 within the 
hydrogels, which strongly suggested the distribution of hMSC in the hydrogels was an 
important regulator of hydrogel mineralisation. Quantitative assessment of hydrogel 
mineralisation and density using µCT served as a good indicator of tissue development, 
and was supported by  IHC, whereby the presence of highly mineralised matrix after 28 
days correlated with the detection of OCN and Cx43 expression. This study enabled me 
to define a reliable set of measurable outputs for preconditioning hMSC/collagen 
hydrogels. The data can now serve as a reference point for comparing the effect of 
preconditioning regimes using the hydrostatic bioreactor.  
 2D culture of MG63 3.4.2.
MG63s are widely used as a model to study osteoblast function; however the effect of 
hydrostatic pressure on MG63 response has been understudied in recent years. Existing 
evidence does detail some interesting observations that support the results described in 
Section 3.3.1. Haskin and Athanasiou reported a heat shock like response with 
cytoskeletal disruption preceding changes in gene expression following 20 minutes 
hydrostatic pressure at 4MPa(Haskin & Athanasiou 1993). Heat shock like responses in 
MG63s undergoing hydrostatic loading were similarly observed by Kaarniranta et al. 
using a static pressure regime of 30MPa for 12 hours(Kaarniranta et al. 2000). The  Based 
on the current body of literature, this heat shock response has only been observed when 
using static compression, and has also been shown to increase production of Interleukin 
8(Kubo et al. 1998), a pro-inflammatory cytokine associated with destructive bone 
metabolism(Neidel et al. 1995). By contrast, cytoskeletal remodelling at the point of 
loading in this study demonstrated increased and not decreased bone formation due to 
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application of hydrostatic pressure. There is evidence showing applying cyclic vs static 
pressure in MG63s, alters the expression of matrix metalloproteinases (MMP’s) and 
collagen type 1 expression (Tasevski & Sorbetti 2005). Coupled with the fact that the 
previously documented literature use pressures that are orders of magnitude higher than 
used in this study, it is likely that the bone forming response in MG63s are be sensitive to 
both cycling frequency and the magnitude of pressure.  
    The results in Section 3.4.2 show that applying cyclic pressure in MG63 
monolayers initially induces cytoskeletal remodelling, which is followed by a transient 
increase in osteocalcin expression, resulting in increased production of collagen type 1 
and calcium. These findings support the hypothesis that was not confirmed in the 
previous chapter in MLO-A5s, that an increase in responsiveness to hydrostatic pressure 
might be represented by the ability of cells to undergo actin reorganisation at the point of 
loading.  
The proliferation of MG63s was unaffected by bioreactor stimulation, though the cell 
viability seemed slightly improved when compared with static controls using a live dead 
assay. It is well documented that osteoblasts and osteoprogenitors proliferate in response 
to fluid flow and  strain(Scott et al. 2008) (Lee et al. 2010). Evidence describing 
alterations in cell proliferation due to pressure is conflicting, with some studies 
suggesting increased proliferation (Zhao et al. 2015) and others decreased proliferation 
(Chenyu & Rei 2012). One study looking at the effect of hydrostatic pressures on 
proliferation of cells within bone tumours found changes in proliferation associated with 
pressure magnitude and cell type(DiResta et al. 2005), suggesting that proliferative 
responses using the Keele/TGT bioreactor  might change when using different cell types.  
Overall, the results in Section 3.3.2 were able to confirm my hypothesis that the loading 
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regime defined in the previous chapter is sufficient to accelerate bone formation when 
compared with statically cultured cells.  
 Translation from 2D monolayers to 3D hydrogels 3.4.3.
 In 2D and 3D growth environments, pressure upregulated osteocalcin activity, 
which was followed by increased matrix mineralisation when compared with static 
controls. The presence of a 3D collagenous matrix naturally provides a more suitable cell 
niche for sustained in vitro tissue development. Whilst I did not directly compare OCN 
activity between 2D and 3D environments, others have reported enhanced OCN activity 
in MG63s in 3D collagen hydrogels compared with 2D monolayers (Parreno et al. 2008). 
The same study also showed that treatment cytoD inhibited gel contraction and 
osteogenic gene expression. Parreno et al. also demonstrated that the contraction kinetics 
of MG63s in collagen hydrogels mediates bone formation through regulation of 
cytoskeletal integrity(Parreno & Hart 2009). It is reasonable to postulate that theobserved 
increase in contraction in pressure treated hydrogels was mediated by changes in 
cytoskeletal dynamics of encapsulated MG63s during loading. This hypothesis seems 
tempting when we consider the changes in cytoskeletal architecture in stimulated 
monolayers, however further investigation of cytoskeletal remodelling in 3D hydrogels 
would be needed to confirm this hypothesis. 
 An interesting finding was the transient activation of OCN in hydrogels 
over the 14 day culture period. Transient activity of osteocalcin could indicate that a daily 
stimulation regime may not be necessary to accelerate bone formation in vitro. The 
transient activation of OCN has been shown in MCT3T OBs, using a similar OCN 
luciferase reporter, reporting a peak expression in OCN at day 10 (Quarles et al. 1997). 
Quarles et al. also showed an increase in OCN in Ros12/2.8 OBs after 14 days exposure 
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to vitamin D, demonstrating how these reporter cell lines are useful for assessing the 
osteogenic activity to different treatments. It is likely that bioreactor stimulation in the 
MG63 reporters in Section 3.3.2 accelerated the transition of committed osteoprogenitors  
to mature OBs, a process which has been shown to involve a late stage transient peak in 
OCN expression (Liu et al. 2003).   
A potentially useful application of the transient activation profile would be to test 
if shorter periods of time in the bioreactor (1-3 days/week) yield the same level of bone 
formation as the 7days/week regime used in Section 3.3.2. Existing evidence has shown 
that short term mechanical loading can induce osteogenic differentiation to levels 
comparable to dexamethasone treatment (Sittichokechaiwut et al. 2010). Moreover,  
periodic stimulation followed by static resting phases of 3 or more days has also 
demonstrated accelerated matrix mineralisation  in OB seeded scaffolds over 20 days in 
culture (Sittichockechaiwut et al. 2009). Based on this, implementing the bioreactor using 
periodic stimulation regimes may yield important information on how to optimise 
efficient preconditioning profiles that minimise labour costs and human intervention.   
 Preconditioned hMSC collagen hydrogels 3.4.4.
 Hydrogel contraction 3.4.4.1.
The contraction kinetics of collagen have been well characterised over the years, 
with the general consensus agreeing on three main events that mediate the contraction 
process: The lag phase, followed by linear rapid contraction, preceding a slow contraction 
phase(Nishiyama & Tominaga 1988). Nishiyama and colleagues directly related the time 
spent in these phases to the quiescent nature of the cellular actin network, with the initial 
lag phase dictated by the elongation of actin with the surrounding ECM. Chen et al 
studied the changes in the time spent within each of these phases during fibroblast 
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mediated collagen contraction. They found they could reduce the time spent in the earlier 
two phases by lowering the concentration, or increasing the cell density (Chen et al. 
2007). The results in Section 3.3.3 might reflect changes in the time spent in the lag 
phase at different concentrations and cell seeding densities. It is reasonable to suggest 
that in lower concentration, cell dense collagen hydrogels, less time is spent in the initial 
contraction phases, allowing longer exposure of contractile quiescent cells to osteogenic 
supplements in the media.  
 Cellular distribution 3.4.4.2.
Collectively, the results in Section 3.3.3 strongly suggest that the overriding factor 
influencing the formation of in vitro bone tissue in the hMSC/collagen hydrogel system 
was the average distance between each cell within a given area. This can be seen if we 
plot distribution vs mineralisation for both seeding and concentration on the same graph 
(Figure 14). This is consistent with previous findings demonstrating the effect of seeding 
density on enhancing tissue maturation  (Holy et al. 2000)(Lode et al. 2008). Control of 
the cellular distribution was mediated by adjusting either the concentration, or the cell 
seeding density.  Previous reports have shown that changes in collagen concentration 
influence the contraction kinetics more than equivalent changes in cell seeding density 
(Nirmalanandhan et al. 2006), explaining why stronger correlations were present in 
groups with different collagen concentration as opposed to different cell seeding 
densities. It would be interesting in future to measure the volume change in higher 
concentration gels seeded with different cell seeding densities to compare any correlation 
with that observed in Section 3.3.3.2. Since the change in volume of hydrogels was more 
heavily influenced by collagen concentration, it is likely that at higher collagen 
concentrations, higher cell seeding densities would be required to establish a similar 
cubic correlation as reported Section 3.3.3.2.   Future characterisation of such processes 
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will be important from a manufacturing point of view, since increasing the size and cell 
density of the hydrogels could foreseeable alter the tissue density and hydraulic 
permeability (altering nutrient diffusion), which in collagen has been shown to have a 
significant effect on osteogenic differentiation of encapsulated MSC (Serpooshan et al. 
2010). 
 
 
 
 
 
 
 
 Non-invasive ‘scoring’ of tissue maturation 3.4.4.3.
What separates the findings in Section 3.3.3 from other similar systems in the 
literature studying collagen contraction is the predictive power of tissue maturation, 
whereby the trends in volume, density and mineralisation correlated with histological 
evaluation of tissue composition. Using µCT to identify hydrogels with different tissue 
densities, I were able to infer that in dense tissue regions, cells produced highly 
interconnected, osteocalcin rich matrix. By comparing histological evaluation of calcium 
deposition via A/R and V/K staining with ICC, I determined that only highly 
interconnected cells became embedded in osteocalcin rich, mineralised bone matrix. 
Further to this positive staining of OCN and Cx43 indicates that the hMSC/collagen 
Figure 14: comparison of cell distribution vs hydrogel mineralisation for variable hydrogel 
concentration (black), and variable cell seeding density (red). Error bars represent standard 
error of the mean, y-axis n=6, x-axis n=3.  
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system is capable of generating tissue architecture and composition similar to that of bone 
tissue in vivo. As discussed in Section 1.4.4. OCN is a non-collagenous protein found in 
bone that served a number of functions including regulation of bone metabolism (Long 
2011) and orientation of crystal lattice structure in hydroxyapatite (Hoang et al. 2003). 
Cx43 is a one of a family of connexin proteins which form gap junctions between 
neighbouring cells, and is the most common type of connexin found in bone 
tissue(Plotkin & Bellido 2013). Cx43 is believed to play an important role in 
mechanotransduction, whereby mechanical loading has been shown to open connexin 
hemichannels(Batra et al. 2012), which in turn allows the transport of signalling 
molecules between cells (Siller-Jackson et al. 2008). Deletion of Cx43 in mice has been 
shown to promote osteocyte apoptosis and bone resorption(Bivi et al. 2012), thus 
connexins are considered important in maintaining regular function in bone tissue. The 
abundant formation of such channels in lower concentration/high seeding density 
hydrogels suggests that cell distribution during in vitro bone formation is important for 
the formation of these proteins. It could indicate that such systems might respond more 
positively to hydrostatic pressure in future experiments due to biochemical responses to 
hydrostatic pressure being more effectively distributed between cells through Cx43 
hemichannels.   
 Scaling up tissue engineered bone grafts 3.4.4.4.
The correlation between collagen concentration and hydrogel mineralisation via a 
relatively simple inverse power relationship implies an interesting and useful application 
of the results of this study. By considering the relative change in cell distribution as 
concentration increases, it is possible to define parameters for hydrogel fabrication that 
could allow the size of the constructs to be scaled up without changing the resultant tissue 
properties.  
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As an example, if I use the results obtained for the cellular distribution within a 10µm 
section of tissue in Section 3.3.3.5, I can estimate the total cell population in the different 
concentration collagen hydrogels after 28 days. In doing so we find that the total cell 
number in the hydrogels is roughly the same irrespective of the initial concentration used. 
This first further supports my previous statement that the µCT readouts were a reflection 
of the population density of hMSCs.  Second, I can now in theory use this information to 
estimate the total cells/hydrogel required to generate constructs of different sizes, but 
with the same resultant tissue properties. This could allow constructs to be tailored to 
account for different size defects, whilst maintaining a level of predictable tissue 
formation. The scale up model presented in Figure 15 uses the cell distribution measured 
in the lowest concentration hydrogels gels (0.5mg/ml) seeded with the highest number of 
cells (3x10
5
cells), since this yielded the highest measured level of mineralisation. The 
estimated cell number required at larger volumes would in theory generate constructs that 
reflect the density and mineralisation of 0.5mg/ml hydrogels seeded with 3x10
5 
cells. 
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Figure 15: Proposed scale-up of preconditioned hMSC collagen bone grafts with 
comparable levels of hydrogel mineralisation. My results inferred that hydrogel density 
and mineralisation was a reflection of the population density of encapsulated cells 
(A&B), Red dots represent cells). I propose that we can scale up the size of the 
constructs without affecting the endpoint density and mineralisation of the hydrogels (C), 
by estimating the number of cells required in larger volumes to achieve a population 
density that reflects smaller, more mineralised hydrogels. Using data obtained via image 
analysis to count the number of cells/mm
2
 in a 10µm section of tissue (D, black data set), 
we can take the hydrogel volume (D, red data set) at different concentrations to show 
that the total cell number after 28days culture is roughly the same irrespective of initial 
collagen concentration (E). Based on this, we can then estimate the total cell numbers 
required to generate constructs of increasing size with the same level of mineralisation 
(F). Estimated cell numbers (F) are based on the cellular distribution measured in 
0.5mg/ml hydrogels seeded with 3x10
5
 cells. Error bars in E&F represent propagation 
of error from µCT and image analysis. 
A B C 
D E F 
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Another potential approach for scaling up the size of the constructs could be to 
consider the change in the concentration of the hydrogels after contraction. We can this 
time roughly estimate the final collagen concentrations in the hydrogels after 28days 
using the equation ViCi=VfCf with an initial seeding volume (300μl. This gives us a 
hypothetical final concentration in mg/ml for each starting concentration ranging between 
0.5-5mg/ml (Figure 16). Interestingly the change in estimated final concentration 
followed the same trend as for the hydrogel mineralisation and hydrogel density. By 
consequence, this implies that the mineralisation and density may also be linearly 
proportional to the collagen concentration in the hydrogel system. Plastically compressed 
collagen, a process which experimentally induces rapid expulsion of fluid has been 
developed extensively in recent years as a potential tissue equivalent. The theory is that 
that high collagen concentrations more accurateley mimic the physiological niche of in 
vivo tissues (Brown 2013). It has also recently been shown to enhance osteoconductivity 
of collagen in Saos-2 osteoblast cells (Liu et al. 2016). Based on this my results might 
also reflect a case where the lower collagen concentrationon before cell mediated 
contraction represents a more osteoconductive niche due to a higher final collagen 
density after 28 days in culture 
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Of course it must be stated that the inherent nature of biological variability, coupled 
with the complications that might arise from of using such high cell numbers in small 
volumes highlights the need for further work to validate this scale up method. However, 
it nonetheless presents a potential useful application of μCT for process control and scale 
up of tissue engineered constructs that has not been previously reported.   
 Targets for clinical translation 3.4.5.
A clinical relevant RM therapy will require tissue engineering protocols that 
incorporate minimal human intervention and reduction of time and labour costs. The use 
of hydrostatically preconditioned scaffolds for BTE has the potential to provide a scalable 
manufacturing platform that could address these requirements, as well as providing 
minimally invasive procedures to treat large bone defects. The success of these concepts 
will be underpinned by the performance and quality control assessment of newly 
developed methods for in vitro osteogenesis. Generally, scaffolds design concepts should 
consider; scaffold porosity and interconnectivity; surface properties that are optimized for 
cell attachment, migration, proliferation and differentiation; and a controllable rate of 
Figure 16: Comparison of estimated collagen concentration and hydrogel 
mineralisation in hMSC collagen hydrogels after 28days culture in osteogenic media 
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tissue growth and maturation  (Park et al. 2007). Basic parameters such as cell seeding 
density and hydrogel protein concentration provide the researcher with a good starting 
point to deliver the quality control outputs that will be required for developing new 
manufacturing protocols. Further to this, characterisation of quality control parameters in 
biomaterials (such as collagen) that are already approved by regulatory authorities for use 
in humans, will inevitable reduce the time taken for these procedures to reach the clinic 
(Woodruff et al. 2012). 
3.5. Conclusion 
In conclusion, this chapter demonstrated that the conditioning regime defined in 
previous chapter was suitable for preconditioning cell seeded scaffolds. I used MG63 
OBs to show as a reference cell line to increase bone tissue formation in collagen 
hydrogels using daily treatment with hydrostatic pressure.   I then developed and 
optimised an in vitro protocol for generating clinically applicable bone grafts using 
hMSC collagen hydrogels. In doing so I found that μCT analysis presented a method of 
evaluating bone tissue development that is non-destructive, and accurately reflected the 
tissue composition of native bone. By using μCT analysis in combination with histology, 
I was also able to propose a method for scaling up the size of tissue engineered bone 
grafts without compromising the maturation of the comprising tissue. The next chapter 
will aim to develop an ex vivo fracture repair model using embryonic chick femurs to test 
the hypothesis that hMSC seeded collagen hydrogels in combination with bioreactor 
stimulation can enhance the repair of a femoral defect. 
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Chapter 4 
Developing an ex vivo fracture repair 
model for preclinical testing 
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4.1. Introduction  
4.1.1. Modelling fracture repair 
The previous two experimental chapters showed that the hydrostatic bioreactor 
induces a variety of physiological changes in cells from the point of loading to changes in 
tissue maturation after a prolonged culture period in both 2D and 3D growth 
environments. The previous chapter also describes how the cell seeding density and 
collagen concentration in static cultured hMSC/collagen hydrogels dictates the density 
and mineralisation of the developing tissue over a 4 week preconditioning period. By 
defining a predictable rate of bone formation in preconditioned hydrogels I can now test 
the effect hydrostatic preconditioning in the hydrogels to determine if the bioreactor has 
an additive effect on bone tissue formation. As discussed in chapter 1, the use of animal 
models to study the fracture repair presents a preclinical testbed to validate the 
effectiveness of potential treatments, as well as making sure these treatments ultimately 
are safe for use in humans. The concept of preconditioning tissue engineered bone 
constructs prior to implantation has been explored by a number of groups in the last 10 
years. Interestingly, it has been frequently reported that an in vitro pre-culture period may 
not in fact be beneficial to the outcome of healing after implantation. Byers at el. showed 
that a 21 day preconditioned bone marrow stromal cells seeded in PCL implants showed 
a low rate of bone formation, comparable to that of empty defects, after implantation into 
rat cranial defects (Byers et al. 2006). However in the same study, this effect was rescued, 
yielding an improved outcome of healing by inducing over expression of Runx2 during 
the pre-culture period, demonstrating that by providing the appropriate cues during the 
pre-culture period, the outcome of healing using preconditioned implants can in some 
instances be improved. Lyons et al. have also suggested that extended preconditioning of 
MSC seeded implants may actually inhibit bone formation when compared with cell free 
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implants (Lyons et al. 2010), concluding that peripheral mineralisation of the 
preconditioned implants inhibits macrophage led remodelling after implantation. By 
contrast to the studies described above, MSC seeded silk implants preconditioned for 5 
weeks in spinner flasks prior to implantation were shown an increase in bone formation 
compared with undifferentiated MSCs  and acellular implants(Meinel et al. 2005). Based 
on existing evidence, whilst the benefit of static in vitro pre-culture in cell seeded 
constructs prior to implantation is not well defined, by actively encouraging the 
maturation of the implant using exogenous cues, the outcome of healing after 
implantation could potential be enhanced. 
4.1.2. Organotypic chick femur cultures 
  By exploring Muschlers and colleague’s considerations for addressing the 
challenges facing translational research in BTE (discussed in Section 1.7), the use of 
isolated embryonic chick femurs was highlighted as an appropriate tissue source to model 
fracture repair. Recently there has been a resurgence of interest in the study of ex vivo 
embryonic chick organ cultures due to their relative low cost, ease of expansion and 
isolation, and limited ethical concerns (Kanczler et al. 2012)(Roberts et al. 2012)(Smith 
et al. 2013).  A small body of literature has been documented over that last 25 years 
investigating ex vivo chick organ cultures and fracture repair (Takahashi et al. 1991, 
Lidor et al. 1987, Grant et al. 1987), however these studies aimed principally to 
determine the underlying mechanisms of fracture repair and not methods in which it can 
be enhanced. The development of reproducible, low cost and ethically sound fracture 
repair models has the potential to provide a pre-clinical test bed for a variety of different 
orthopaedic procedures. As mentioned in Section 1.7.2, a defect model in isolated chick 
femurs has been explored by Smith and colleagues (Smith et al. 2014a) (Smith et al. 
2014b). This two part study used an ECM/ alginate hydrogels loaded with PLGA micro 
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particles releasing different growth factors to enhance repair of the defect. Whilst the 
study demonstrated some success in encouraging new bone formation in the defect site, 
the integration of the implant with the native femurs appeared to be hindered by 
mineralised capping of the femurs at the implants/femur interface (Figure 1).  
 
 
 
 
 
 
 
Delayed healing in a human femoral fracture that has not received treatment soon 
after injury is referred to as a neglected non-union (Tall et al. 2014). Non unions are 
thought to arise from inadequate fixation and/or immobilisation of the fracture site 
following trauma. Many complications arise from this type of fracture such as; 
hypertrophic callus formation, where a vascularised callus is formed but union is not 
achieved, leaving an absence of mechanical stability (Said et al. 2013); atrophic non 
unions, in which bone healing capacity is depleted, forming a sclerotic and usually 
avascular environment between the long bone ends (Reed et al. 2003);  or  the formation 
of a pseudo arthritic joint, in which capping of the medullary cavities at each end of the 
fracture, results in the formation of synovial fluid within a  cartilaginous pseudo capsule 
bridging the capped femur ends(Johnston & Birch 2008).  
Figure 1. Histological sections of organotypic chick femur defect model developed by 
Smith et al. (2014) 10 µm sections stained for cartilage (blue) and new bone (red), 
showing  mineralised capping of the femurs at the femur/implant interface (black 
arrows). Scale bars = 200µm Figure adapted from (Smith et al. 2014b). Reprinted with 
permission of ELSVIER publishing group, [licence number: 3811420008926]. 
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To overcome problems that might occur from inadequate fixation in my 
organotypic model, we can look to current orthopaedic practises that employ the use of 
intramedullary nails (IMNs). IMNs are common place in orthopaedic surgery and involve 
insertion of a metal rod through the medullary cavity of long bones. IMNs provide 
support and contact guidance to heal unstable fractures(Brumback et al. 1988). IMNs are 
also used in distraction osteogenesis, a procedure employed to gradually separate bone 
segments to allow growth of new bone in the defect site(Richards et al. 1998).  
4.1.3. Design concept 
By applying the concepts from current orthopaedic practises employing IMNs, the 
issue of femur capping reported by Smith could be resolved, but also IMNs could provide 
structural stability in the fracture repair model. Since the previous chapter defined metrics 
in which I can control the size of the implants, I can also choose the appropriate metrics 
(cell number and collagen concentration) to compliment the size of the fracture site in the 
chick femurs.  
A key element to the success of the model will be the appropriate material used 
for the IMN. The IMN must be small enough to fit through the medullary cavity of 
isolated chick femurs, whilst strong enough to support the construct during culture. The 
IMN must also be biocompatible to prevent cell death due to interaction with the 
material, and be suitable for sustaining the developing osteogenic phenotype without 
introducing artefacts due to, for example material degradation. Borosilicate glass is 
commonly used to make microscope slides, glassware and microinjection needles. It is 
being increasingly used as a scaffold in BTE due its excellent biocompatibility, 
controllable degradation rate and its ability to be doped with different tissue promoting 
growth factors (Rahaman et al. 2011). The typical diameter of isolated chick femurs after 
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extraction at 11days is around 0.5-1mm thick; suggesting the diameter of the IMN should 
be in the range of 0.1-0.5mm thick. It is possible to construct rods of such thickness by 
anchoring glass capillary tubes either side of a heated coil element which is normally 
used to fabricate microinjection needles. This could allow the manufacture of IMNs 
suitable for fixation in isolated chick femurs.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2: Design concept for organotypic fracture repair model using isolated 
embryonic chick femurs. The isolated femurs are sectioned down the mid-section of the 
diaphysial shaft and separated to model a non-union fracture. The intramedullary rod is 
inserted through the marrow space, with the cell seeded implant filling the defect. The 
purpose of the rod is to prevent femur capping, as well as provide structural support to the 
finished construct during in vitro culture. 
IMN 
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4.1.4. Assessment of hydrostatic preconditioned implants in an 
organotypic non-union fracture repair model  
To determine if the bioreactor is effective in preconditioning implants to 
enhancefracture repair, we must consider the appropriate experimental design that can 
test this hypothesis. Since the bioreactor has already been shown to enhance bone growth 
in isolated femurs (Henstock et al. 2013), it seems rational to test the fracture model first 
under the same dynamic loading regime. By using undifferentiated hMSC/collagen 
implants in a dynamic environment, I can evaluate how pressure influences the 
maturation of the construct. This could represent a treatment in which stem cell seeded 
implants receive no preconditioning, but are subject to mechanical stimuli that would be 
naturally present in the fracture site due to movement. Then, by comparing 
preconditioned implants in static femurs, I can distinguish if hydrostatic precondiitoning 
of collagen hydrogels prior to implantation is sufficient to encourage fracture repair.  If 
this hypothesis is validated, it provides promising preclinical data for use of the 
bioreactor system to treat bone defects in humans. 
 
Objectives 
i) To construct and establish an organotypic femur defect model using 
isolated embryonic chick femurs. To determine the feasibility constructing 
a fracture repair model in chick femurs using a borosilicate glass needle as 
an intramedullary nail. I aim to generate structurally stable constructs that 
can be easily maintained in culture by using glass capillary tubes as IMNs to 
provide contact guidance for cells, and prevent to femur capping. 
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ii) To evaluate the effect of hydrostatic loading on fracture repair in the 
model using undifferentiated hMSC collagen hydrogels. To determine if 
the model accurately represents an in vitro fracture repair process. By 
implementing the design metrics for hMSC/collagen hydrogels from the 
previous chapter I aim to use the collagen gel system as an implant to 
encourage new bone formation in the defect using hydrostatic loading. 
 
iii) To determine if hydrostatic preconditioning of hMSC/collagen 
hydrogels prior to implantation is effective in enhancing fracture repair 
in statically cultured femur defects. To assess the effectiveness of the 
bioreactor for hydrostatic preconditioning of hMSC/collagen implants. By 
comparing the effect of dynamic loading in undifferentiated hMSC/collagen 
hydrogels vs preconditioned implants, I aim to test the hypothesis that the 
bioreactor provides a clinical translation platform for enhancing bone 
formation 
. 
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4.2. Materials and Methods 
4.2.1. Embryonic chick femur isolation  
Intact femurs were removed from freshly killed Dekalb white chick foetuses com 
(Henry Stewart & Co) after 11 days incubation in an Ova-Easy ADVANCE incubator 
from Brinsea (UK). Residual muscle and connective tissue was removed and femurs were 
washed in DMEM before being transferred to porous poly carbonate membrane inserts 
(Corning) in 6-well cell culture plates (Figure 3). 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3: Isolation of femurs from day 11 chick foetuses. All extractions were 
performed in a biological safety cabinet to ensure sterility. The chick foetus and yolk sac 
were tipped into a small dish (A), after which the foetus was quickly culled by separating 
the torso from the head.  The two legs were then carefully dissected from the torso (B) 
which was then discarded. The legs were rolled on sterile paper towels to remove 
connective muscle and cartilage tissue (C) and the femurs were carefully separated from 
the acetabulum (Hip) and lower connecting tibia. The intact femurs (D) were then placed 
in a 6 well Trans well insert (Centre) and cultured in serum free media supplemented 
with 2% pen-strep and 1% L-glutamine until defect fabrication was performed.  
A B 
C D 
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 Isolated femurs were maintained in serum free PM (described in Section 2.1.1) 
for 24 hrs prior to defect fabrication. 
4.2.2. Collagen hydrogel fabrication 
Frozen vials of hMSCs were seeded into T75 flasks as detailed previously 
(Section 2.1.1). Cell populations were expanded to passage 3 in PM (described in 
Section 2.1.1)) before being incorporated into collagen hydrogels (as described in 
Section 3.2.4.1). Hydrogels were kept in culture for 24 hours to allow for gel contraction. 
Hydrogels were seeded with 3x10
5
cells in 1mg/ml collagen solutions. Based on findings 
presented in Section 3.3.3.2, these parameters would yield hydrogel volumes of between 
2- 3mm
3
. Acellular hydrogels were fabricated by neutralising 1ml of ice cold 9.22mg/ml 
type-1 rat tail collagen (Corning) with 23µl 1M NaOH solution, and pipetting 10µl beads 
into round bottom 96 well plates using a Finntip™ Stepper Pipette (Thermo Scientific, 
UK) to ensure equal volumes were dispensed. Acellular hydrogels were incubated at 
37
o
C for 24hrs prior to the experiments and washed for 15mins in PM prior to use in 
defects to remove residual NaOH from the gels.  
4.2.3. Fluorescent tracking of hMSC/ collagen implants 
  PKH26 cell tracker (Sigma) was used to label populations of hMSCs prior to 
seeding in collagen hydrogels. The dye solution was formulated according to the 
manufacturer’s guidelines. hMSCs were then suspended in dye solution and incubated for 
10 minutes at 37
o
C before the reaction was quenched in PM. Cells were then spun down 
and suspended in media before incorporation into collagen hydrogels. 
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4.2.4. Femur defect fabrication  
The IMNs were produced using a coiled heating element designed to produce 
glass syringe needles (Narishige Scientific). The heated element stretched out glass 
capillary tubes (Sutter instruments, UK) into thin needles ~ 60-100µm in width (Figure 
4A). Construction of organotypic non-union defects was performed by first slicing the 
mid diaphysial section of the femurs using a sterile scalpel blade (Figure 4B).  Collagen 
implants were then threaded onto the borosilicate glass IMN, making sure the IMN was 
inserted through the central region of the implant (Figure 4C). One of the femur halves 
was then threaded onto the needle such that bone collar just made contact with the 
collagen implant (Figure 4D). The thicker capillary tube was then carefully removed 
from the thinner rod by breaking the glass at an appropriate length with tweezers. The 
remaining femur half was then threaded onto the opposing side of the IMN, again making 
sure the bone collar just made contact with the collagen implant (Figure 4E&F). The 
finished constructs were transferred to 6 well trans-well inserts and cultured in PM 
(described previously) for 24 hrs prior to the experiment (Figure 4G).  
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Figure 4. Fabrication of organotypic non-union defects in isolated embryonic chick femurs. Intramedullary rods were made by 
anchoring borosilicate glass capillary needles between a heated coil element used to make microinjection needles (A). Isolated femurs 
were cut with a scalpel blade through the mid diapyhsial section of the femur (B). Collagen implants were were skewed onto the glass rod 
(C) with one femur end then threaded onto the rod to make contact with the implant (C). Thicker end of the capillary tube was carefully 
removed and the remaining femur half was threaded onto the glass rod until just making contact with the implant (E&F). Constucts were 
then transferred to 6 well Trans well inserts and maintined in basal culture media supplemented with 10% FBS for 24hrs prior to 
experiments 
A B C D 
E F G 
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4.2.5. Hydrostatic regime in undifferentiated hMSC/collagen implant 
femur constructs 
Femur constructs were cultured for a period of 14 days with one hour per day 5 
days/week in the hydrostatic bioreactor using a 280kPa, 1Hz regime. Constructs were 
cultured in OM (described in Section 2.1.9) with daily media changes before stimulation.  
The remainder of the time constructs were kept under standard cell culture conditions in a 
cell culture incubator at 37
0
C with 5%CO2.  
4.2.6. Hydrostatic regime for preconditioned implant/femur constructs 
hMSC seeded collagen hydrogels (3x10
5
cells in 1mg/ml collagen hydrogels) were 
cultured for a period of 28 days prior to implantation in the femur constructs. Hydrogels 
were cultured in fresh OM and received bioreactor stimulation on given days for one 
hour.  The remainder of the time hydrogels were kept under static standard cell culture 
conditions in a cell culture incubator at 37
0
C with 5%CO2. The pressure regimes applied 
were a) 0 – 279 kPa at 1 Hz, 1day/week and b) 0 – 279 kPa at 1 Hz, 3days/week, c) 0 – 
279 kPa at 1 Hz, 5days/week and d) Static control. After 28 days preconditioning, (to 
remain consistent with findings in Chapter 3) hydrogels were implanted into the femur 
defects and the constructs were cultured under static conditions in OM for 14 days. 
4.2.7. X-ray micro tomography 
Changes in the mineralised volume and density of the defect regions were 
analysed using a Scanco μCT40 (beam energy: 55 kVp, beam intensity: 145 μA, 200 ms 
integration time, spatial resolution: 10 μm) as described in Section 3.3.2. The defect 
region was highlighted in the software and analysed at the two density thresholds 
(50/1000, 80/1000) as before to determine the percentage mineralisation of the defect 
site. Bone morphometric analysis of the defect regions was analysed at a density 
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threshold of 50/1000 to determine the change in trabecular number, trabecular thickness 
and connective density of the tissue within the defects.   
4.2.8. ALP Activity 
ALP activity was assessed during culture by collecting media samples 24hrs post 
stimulation at day 7, day 10 and day 14 days of the culture period. Media samples were 
run in triplicate for each construct and activity was detected enzymatically using 4-
Methylumbelliferyl phosphate (4-MUP) Liquid Substrate System (Sigma). 50 μl media 
samples were mixed in the same volume of substrate and incubated at room temperature 
for 30 mins. The reaction was stopped using 0.5M Ethylenediaminetetraacetic acid 
(EDTA) solution (Sigma). Fluorescence readings were measured at 360/440nm using a 
Biotech synergy 2 plate reader. Results were normalised against fluorescence readings 
from fresh OM. 
4.2.9. Histological staining and imaging 
After 14 days in culture, constructs were fixed in 10% neutrally buffered formalin 
for 2 hours at room temperature. The constructs were then washed three times for 5 
minutes each in PBS. Constructs were then embedded in paraffin wax using an automated 
vacuum tissue processor (Kedee). 10µm sections were cut using a microtome and the 
sections were then mounted and processed according to methods described in Section 
3.2.3. Mineralisation was quantified using the V/K method (described in Section 3.2.3). 
Sections were then counter stained using Harris Haematoxylin solution and Eosin (as 
described in Section 3.2.3). Sections were then mounted in DPX mounting medium and 
Imaged using an EVOS® FL Colour Imaging System.  
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4.2.10. Statistical analysis 
Results were plotted and analysed in Microsoft Excel. All data point represents 
mean values ± standard error of the mean. Statistical significance for undifferentiated 
hMSC and acellular constructs was performed in Origin 9.0, employing a two way 
ANOVA between cellular/acellular and hydrostatic stimulation groups. Statistical 
significance for preconditioned implant experiments was determined in Microsoft Excel 
using a two tailed students T-Test. 
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4.3. Results 
4.3.1. Construct stability  
As stated in Section 4.1.4. The constructs were kept in culture for 24 hrs prior to 
each experiment undertaken, during which time native chick periosteal cells rapidly 
migrated around the defect site (Figure 5). In acellular defects (Figure 5A) chick cells 
migrated into central regions of the implant as well as forming an encapsulating 
periosteum, which was easily observed due to the transparency of the implant. Periosteal 
chick cells encapsulated hMSC seeded implants; however the extent of migration of 
chick cells inside the implants themselves was unclear (Figure 5B). In both acellular and 
hMSC groups, the formation of the chick periosteum around the defect site was important 
for maintaining construct stability throughout the culture period.  
 
 
 
 
 
 
 
  
 
 
Figure 5. Migration of native chick cells into the defect site at day 1. Arrows inset 
represent regions of chick cell migration 
A B 
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4.3.2. Construct maturation 
During the 14 day culture period, the defect site underwent a considerable amount 
of remodelling. There was some initial concern in using collagen as a implant material, 
for acellular implants, due to collagens readiness to undergo cell mediated contraction. In 
spite of this concern, after 14 days in culture the implants integrated well with femur ends 
and showed little sign of cell mediated contraction that might inhibit the healing process 
(Figure 6A-D). PHK26 cell tracker was used to visualise the implanted hMSC during the 
experiments (Figure 6C). After 14 days hMSCs were observed migrating along the chick 
periosteum (Figure 6E, red cell tracker) inside the mineralising bone collar and also 
through the medullary cavity (Figure 6F). This highlighted benefit of using an IMN to 
prevent femur capping and to allow integration of the implanted hMSC with the native 
femur tissue. Empty defects (Figure 6D) sites supported by the IMN bridging the fracture 
site were used as negative controls for repair. Chick cells were observed migrating along 
the extending IMN, however very little tissue formation occurred after 14 days, 
representing a scenario of complete non-union in the organotypic model. 
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4.3.3. Effect of daily hydrostatic loading on construct viability 
To evaluate the effect of daily hydrostatic pressure on the viability of the 
organotypic model, femurs constructs containing either hMSC/collagen implants or 
acellular implants were cultured for 14 days, with and without daily bioreactor 
stimulation. After 14 days, a dual fluorescence live dead assay was performed on whole 
constructs to assess cell viability (Figure 7). In all experimental groups the femur 
constructs remained viable for the 14 day culture period, indicated by strong positive 
green fluorescence in the whole mount images (Figure 7 A, D, G&J). Some cell death 
was present in all groups, indicated by the detection of red fluorescent cells (Figure 7B, 
Figure 6: Maturation of organotypic chick femur fracture model after 14 days in 
culture. A) Femur construct length at day1 and day 14 days. B) Acellular collagen 
implant constructs at day 14. C) hMSC/collagen implant constructs at day 14. D) 
Acellular collagen implant constructs at day 14.  E)Migration of hMSCs (red) into femur 
constructs along the periosteal bone collar and into the medullary cavity (F). 
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E, H&K). No differences were observed in viability between control and hydrostatic 
treated constructs in both acellular collagen implant groups (Figure 7 A, B, C, D, E&F), 
and hMSC/collagen implant groups (Figure 7 G, H, I, J, K&L). The localisation of dead 
cells in acellular implant groups was different from hMSC implant groups. In acellular 
groups, dead cells were present almost exclusively along the femur periosteum and not at 
the femur implant interface. By contrast in hMSC implant groups, dead cells were not 
present around the periosteum but instead localised around the implant/femur interface.  
 
 
  
 
 
 
 
 
 
 
 
 
Figure 7. Whole mount live/dead staining in femur constructs after 14 days in 
culture. Live cells are shown in green and dead cells are shown in red.  
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4.3.4. ALP activity 
Media was collected from cultures throughout the experiment to monitor the ALP 
activity of the constructs (Figure 8). ALP activity was significantly higher in hMSC 
seeded constructs at days 7, 10 and 14 (p<0.05) in stimulated vs static cultured 
constructs.  ALP activity was significantly higher at day 7 and day 10, but not at day 14, 
in stimulated acellular constructs versus static acellular constructs. ALP activity in 
stimulated acellular constructs decreased between day 7 and 14 days and was comparable 
with static/acellular constructs by the end of the experiment. By contrast, activity in 
hMSC seeded constructs in both static and stimulated groups remained high relative to 
acellular constructs throughout the experiment.  
 
 
 
 
 
 
 
 
 
  
 
Figure 8. Alkaline phosphatase activity in femur constructs during in vitro culture 
with and without hMSCs present in the implants. Error bars represent standard error 
of the mean, n=4. * P<0.05 
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4.3.5. Defect mineralisation  
µCT was employed following fixation of the constructs after 14 days in culture to 
assess the extent of new bone formation within the defect site. As discussed in the 
previous chapter, by combining µCT analysis with histological evaluation for bone 
mineral deposition, we obtain strong inference as to the amount of new bone formation in 
the implants.   Whole mount imaging (Figure 9A) after 14 days demonstrated significant 
remodelling of the initial defect site. Native chick cells migrated along the periphery of 
the femur diaphysis, bridging and encapsulating the defect with a periosteal collar. 
hydrostatically stimulated constructs also appeared to have visible thicker cortices in the 
extending diaphysis (Figure9A, ii&iv) compared with unstimulated femurs (Figure9A, 
i&iii).  
Analysis by µCT of the percentage volume of mineralised tissue within the defect 
site (Figure9B) showed that both acellular and hMSC seeded defects had a higher 
percentage of mineralised volume when hydrostatically stimulated. Stimulated acellular 
defects had a 1.79 fold increase in mineralisation compared with static acellular defects 
(p=0.26), whilst stimulated hMSC defects were significantly more mineralised with a 
2.31 fold increase in mineralisation over static hMSC defects. The increase in percentage 
volume in the defect region correlated with µCT reconstructions (Figure9C), which 
revealed large areas of dense tissue in stimulated hMSC defects (Figure9C(iv)). By 
comparing μCT imaging and histological sections stained with von kossa (black) and 
eosin (pink) (Figure9D) we could confirm that calcium deposition (black) was localised 
to regions dense tissue regions (red) in μCT reconstructions. Analysis of the data set 
using a two way Anova (Figure9E) indicated that whilst the presence of the 
hMSC/collagen implants in response to stimulation did not significantly affect 
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mineralisation (p=0.13), the application of hydrostatic pressure did (p=0.004). There was 
no significant interaction between the two parameters (p=0.33).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 9: µCT analysis of chick femur constructs after 14 days. (Ai-iv)Whole mount 
imaging showing remodelling of the defect by the chick cells after 14 days. (B)Analysis 
by µCT showing an increase in defect mineralisation (indicated by red inset in A) in 
femur constructs at day 14. (C) Image reconstructions of the density distribution in defect 
sections. (D) Histological sections showing von kossa (black) and eosin (pink) staining 
non mineralised tissue. (E) Results for two a way Anova to determine the interaction 
between hMSC seeded collagen implants and bioreactor stimulation on defect 
mineralisation.   Error bars are standard error of the mean, n=4. * P<0.05 
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4.3.6. Cell morphology and trabecular analysis 
Fluorescent imaging of the actin cytoskeleton in hMSC seeded implants (A&B) 
showed a change in cell morphology between static and stimulated groups. Cells in static 
implants (Figure 10A) possessed an undistinguished morphology, typical of the 
developing hMSC phenotype in collagen. Cells in mineralised regions of stimulated 
defects (Figure 10B) possessed morphology typical of embedded osteocytes, with long 
dendritic processes protruding into the extra cellular matrix. High magnification imaging 
of histological sections (Figure 10C&D) showed marked differences in the ECM 
structure between static and stimulated implants. Mineralised regions in stimulated 
defects (Figure 10D) exhibited porous trabecular architecture, whereas the static defects 
(Figure 10C) had tissue fibrous gel structure. Quantification of trabecular morphometry 
using µCT (Figure 10E,F&G) showed a significant increase in trabecular number 
(Figure 10E, p<0.05), trabecular thickness (Figure 10F, p<0.01)  and connective density 
(Figure 10G, p<0.05) in hMSC seeded defects vs stimulated acellular and static controls. 
Stimulation alone was sufficient to increase trabecular thickness in acellular defects vs 
static controls (Figure 10F, p<0.01).  Results of a two way Anova performed on the data 
sets in (Figure 10E, F&G) revealed that the presence of cells was responsible for the 
significant increase in trabecular number in hMSC/collagen implants. The effect of 
stimulation on trabecular thickness and connective density of trabeculae was significant 
irrespective of the presence of hMSCs. In all three data sets the interaction between cells 
and stimulation was not significant (P>0.05). 
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4.3.7. 4 week preconditioning of hMSC seeded collagen hydrogels 
         4 weeks daily application of CHP was applied to hMSC collagen hydrogels 
(3x10
5
cells/hydrogel, 1mg/ml collagen concentration) to evaluate if preconditioning the 
hydrogels prior to implantation could enhance fracture repair in the femur defect model. 
Hydrogels were stimulated with CHP for periods of 1, 3 and 5 days/ week, to determine if 
the time spent in the bioreactor could be reduced without jeopardising bone formation, by 
reducing time and labour demands, a further realisation of clinical efficacy for these 
bioreactor systems might be obtained. The hydrogels were preconditioned using the same 
regime as for o undifferentiated hMSC seeded defects, and after 4 weeks were analysed 
by µCT and histology to compare tissue composition before implantation.  
 µCT analysis of the hydrogels after 4 weeks showed a significantly 
larger volume in hydrogels preconditioned for 5 days/week compared with statically 
cultured hydrogels (Figure 11 A, p<0.01). The hydrogel mineralisation and density 
(Figure 11 B&C) was within the range predicted by the optimisation data described in 
Figure 10: Cellular morphology and trabecular analysis in femur constructs after 
14 days.  A&B)  Fluorescent imaging of the actin cytoskeleton in static (A) and 
stimulated (B) implants. C&D) High magnification imaging of histological sections 
(C&D) stained with V/K and H&E showing marked differences in the ECM 
mineralisation and trabecular architecture between static and stimulated implants. 
Heavily mineralised regions in stimulated defects (D) had porous trabecular 
architecture, whereas the static defects (C) had a fibrous tissue structure. (E, F&G) 
Quantification of trabecular morphometry using µCT. EH) Results for two way anova 
for figures E, F&G, demonstrating a significant effect of cyclic pressure on trabecular 
architecture. Error bars represent standard error of the mean, n=4. ** P<0.01,            
* P<0.05 
Trabecular number 
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chapter 3, however preconditioning with CHP did not increase hydrogel mineralisation or 
density when compared with statically cultured hydrogels. µCT reconstructions of the 
hydrogels (Figure 11 D) demonstrated extensive mineralisation of the gels after 4 weeks, 
and also showed point mineralisation in cross-sectional density profiles (Figure 11E) due 
the presence of differentiated hMSCs. 10µm tissue sections stained positive for 
mineralised bone, as indicated by von kossa and alizarin red staining (Figure 11 F&G). 
No differences in calcium deposition were observed between hydrostatically 
preconditioned and statically cultured hydrogels.  
 
 
 
 
 
 
 
 
 
 
 
 
 
A B C 
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4.3.8. 2 week culture of embryonic chick femur constructs using 
hydrostatically preconditioned hydrogels  
Following preconditioning, the hydrogels were implanted into chick femur defects 
and cultured for 2 weeks in osteogenic media to determine if hydrostatically 
preconditioning of hydrogels prior to implantation was sufficient to accelerate the 
fracture repair process. Consistent with previous findings, the native chick cells formed 
an encapsulating periosteum around hMSC/collagen implant after 2 weeks in culture. 
Live dead staining (Figure 12) was performed on whole femurs to assess changes in 
femur and hydrogel viability and indicated no loss in viability in either the femurs or the 
hMSC implants. Dead chick cells formed a thin periphery on the outer periosteum in all 
experimental groups and no changes in viability were observed between statically 
cultured and hydrostatically preconditioned implants.  
 
 
 
 
 
Figure 11. hMSC/collagen hydrogels preconditioned for 4 weeks prior to 
implantation into femur constructs. (A-C) µCT data after 4 weeks showing total 
hydrogel volume (A) percentage mineralisation (B) and hydrogel density (C). (D&E) 
Image reconstruction of hydrogels showing mineralised volume (D) and crossectional 
density (E) of the hydrogels after 4 weeks. (F) 10µm sections of formation by von kossa 
to assess bone formation in the hydrogels after 4 weeks. Sections correspond to cross-
sectional density reconstructions. error bars represent standard error of the mean, n=3. 
Scale bars = 500µm   
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4.3.9. Assessment of defect mineralisation 2 weeks post implantation 
The femur constructs were then analysed by µCT to quantify the volume of 
mineralised tissue in the collagen implants. The results were plotted against µCT data of 
the hMSC/collagen hydrogels prior to implantation to assess the rate of change in 
mineralisation. Surprisingly, after 14 days in culture, all experimental groups underwent a 
significant decrease in mineralisation of the hMSC/collagen implants (Figure 13A). The 
mineralisation of the implants in the femur constructs was comparable between 
experimental groups, with approximately a 4 fold decrease in hydrogel mineralisation 
after 2 weeks. Hydrogel density was also significantly lower in all post implantation 
hydrogels (Figure 13B) and did not change significantly between static and 
Figure 12. Bright field imaging and live dead staining of whole femurs constructs 
at day 14 in culture. 
170 
 
hydrostatically preconditioned groups. µCT density reconstructions (Figure 13C) of the 
defect regions correlated with histological analysis of 10µm tissue sections (Figure 13D), 
showing a reduction in the amount of positive Von Kossa staining in the implants when 
compared with hMSC/collagen hydrogels prior to implantation.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 13. Comparison of implant mineralization by µCT and histology before 
implantation and after 2 weeks culture in chick femur defects. A) Percentage 
mineralisation and density B) of hMSC/collagen hydrogels before and after implantation 
into chick femur defects. C) µCT density heat map image reconstructions of the defect site 
after 2 weeks in culture, pink arrows (inset) represent IMN. D) 10µm tissue sections of 
the defect site after 2 weeks stained with von kossa (black) for bone formation and 
countered stained eosin (pink) to represent non mineralised tissue. Error bars represent 
standard error of the mean. n=4. Scale bars (bottom) = 500µm ****P<0.0001, 
***P<0.001, **P<0.01, * P<0.05 
 
A B 
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4.4. Additional observations 
After establishing in Section 3.3.2 that the precondition regime was sufficient to 
increase the rate of bone formation in MG63 collagen hydrogels, the pre-conditioned 
hydrogel experiment was performed prior to optimisation of the seeding parameters in 
Section 3.3.3. The results of this experiment whilst not optimal in terms of the model 
design provided an interesting contrast to the results described in Sections 4.3.7, 4.3.8 
and 4.3.9. The seeding parameters for this experiment were set at 100,000 hMSCs per 
1mg/ml collagen hydrogel, and the hydrostatic pressure regime was identical to the 
preconditioning regimes described previously, which stimulated hMSC/collagen 
hydrogels for different numbers of days of the week using a 280kPa, 1hz regime for 1 
hour per day. The key difference between the experiments was the stock concentration of 
collagen and the protocol used to fabricate the hydrogels.  
The use of collagen hydrogels as a growth environment for cells is a widely 
established technique and generally follows a common set of protocol. Much of the 
literature, and indeed many manufacturer’s recommendations describe a stock 
concentration (typically 3-5mg/ml) diluted to a working concentration in a cell 
suspension in 10xDMEM and PBS, after which the solution is neutralised with 1M 
NaOH. The protocol described in this thesis, differed in that cell suspensions in regular 
DMEM supplemented with 10% FBS were diluted to a working concentration from a 
higher stock concentration of collagen (9.81mg/ml) without the addition of NAOH. The 
protocol allowed cell mediated self-assemble of the collagen hydrogels, which was 
typically complete 24hrs after fabrication.  The addition of NaOH reported in the 
literature is to neutralise the acidic environment present in collagen/acetic acid solutions 
of lower stock concentrations (3-5mg/ml), which induces polymerisation of the hydrogel. 
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By using a higher starting concentration of collagen (8-11mg/ml), the relative volume of 
acetic acid-media was such that neutralisation with NaOH was not required.  
The initial studies for preconditioned hMSC/collagen hydrogels utilised the 
standard protocol from the literature, which requires neutralising the cell/collagen 
solution in 10xDMEM (made from a stock of 3.61mg/ml) with 1M NAaOH (23ul/ml 
working solution). Comparing the results from these experiments showed that the NaOH/ 
low stock fabrication, and the self-assembly/high stock fabrication methods yielded very 
different endpoint results (Figure 14), which in turn had an effect on the outcome of 
hydrogel mineralisation after implantation into the chick femurs.  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 14. Effect of fabrication method on contraction and mineralisation of 
hMSC/collagen hydrogels after 28 days in OM. A)Total volume at day 1,7 and 28. B) 
Percentage mineralisation after 28days. C) μCT image reconstruction after 28days in 
using self-assemble fabrication from high stock concentraitons (8-11mg/ml) (top) and 
NAOH neutralisation in low stock collagen hydrogel fabrication (3-5mg/ml) (bottom) 
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4.4.1. 4 week preconditioning of hMSC seeded collagen hydrogels 
fabricated using low stock concentration collagen 
Live dead staining of the hydrogels (Figure 15A) demonstrated that cells 
remained viable for the 4 week preconditioning period in all experimental groups. 
Analysis by µCT visualised the mineralised volume (Figure 15B) of the different 
preconditioned hydrogels. Quantitative analysis was performed to determine the change 
in volume over the 4 week preconditioning period (Figure 15C), the total hydrogel 
volume at 28days (Figure 15D) and the percentage mineralisation of the hydrogels at 28 
days (Figure 15E). 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 15: hMSC/collagen hydrogels fabricated from low stock concentration, 
preconditioned for 4 weeks prior to implantation. A) Live dead staining at day 28 in 
hydrogels preconditioned for different numbers of days per week. B) µCT images 
showing mineralised volume of the hydrogels at day 28. C,D&E) µCT data showing the 
volume of hydrogels over the 4 week preconditioning period (C), hydrogel volume at Day 
28 (D) and hydrogel mineralisation at day 28 (E). **P<0.01, * P<0.05 
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 Hydrogels contracted significantly during the first 7 days in culture, and there on 
continued to contract gradually to about 5-10% of their original volume. Compared with 
statically cultured hydrogels, preconditioning for either 1 or 5 days per week had a 
significantly effect on cell mediated contraction and resulted in lower volume hydrogels. 
Interestingly hydrogels preconditioned for 3 days per week did not contract significantly 
more than statically cultured hydrogels. The mineralisation of the hydrogels after 4 weeks 
was between 1-2% of their total volume and did not vary significantly between 
experimental groups.  Compared with statically preconditioned hydrogels described in 
Section 3.3.3.3, hydrogels fabricated using a low stock concentration showed a 15-20 
fold reduction in percentage mineralisation.  
4.4.1. 2 week culture of embryonic chick femur constructs using 
hydrostatically preconditioned hydrogels fabricated from low stock 
concentration collagen 
Following the 4 week preconditioning period, the hMSC/collagen hydrogels were 
implanted into the femur defects and cultured for a further 2 weeks as described in 
Section 4.2.6. After the two week culture period, the femur constructs were fixed and 
analysed by µCT to assess the changes in implant mineralisation. Whole mount imaging 
of the constructs (Figure 16A) showed the implants large size relative to the implants 
described in Section 4.3.8. Contraction of the hydrogels in all experimental groups 
continued after implantation into the femur defects. Static hydrogels, and hydrogels 
preconditioned for 1day/week contracted a further 40% of their pre implantation volume, 
whilst hydrogels preconditioned for 3&5days/week contracted a further 50% their pre 
implantation volume (Figure 16D).  
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After two weeks culture, analysis of the defect region by µCT showed 
mineralisation on peripheral regions of implants that received hydrostatic 
preconditioning. Mineralisation was particularly prominent on the peripheral regions of 
Figure 16: Comparison of implant mineralization by µCT and histology before 
implantation and after 2 weeks culture in chick femur defects. A) Wholemount imaging 
of constructs after 2 weeks in culture. B) µCT images showing mineralised volume of the 
defect region after 2 weeks in culture.C) µCT images showing cross sectional density of 
the defect after 2 weeks in culture. (D) Comparison of defect volume for preimplantation 
hydrogels, and after two weeks culture in femur defects. (D) Defect mineralisation 
before implantation, at 1 day and 14 days culture in femur defects (E).Error bars 
represent standard error of the mean. n=5. **P<0.01, * P<0.05. 
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defects receiving a 5 day/week treatment compared with 1&3days/week, or statically 
preconditioned hydrogels. Cross sectional density sections of the implants (Figure 16C) 
showed peripheral mineralisation in implants preconditioned for 1&5days/week, with 
mineralisation most prominent in 5days/week groups. Quantification of the percentage 
defect mineralisation (Figure 16E) showed a significant increase in defect mineralisation 
after 14 days in implants preconditioned for 1, 3 and 5 days/week versus statically 
preconditioned implants. Preconditioning the hydrogels for 5 days/week yielded the 
highest level of mineralisation, with an average 34.4% of the defect mineralised. 3&1 
days/week preconditioning resulted in 20.2% & 19% of the defects mineralised, whilst 
static preconditioning resulted in an average 13% of the defect mineralised.  
4.5. Discussion 
4.5.1. Chapter overview 
In this chapter I aimed to evaluate the hydrostatic bioreactor as a tool for 
hydrostatically preconditioning hMSC/collagen hydrogels to be used as bone grafts for 
fracture repair. By hydrostatically stimulating the hydrogels for a different number of 
days each week, I hypothesised that we could enhance the amount of new bone formed 
after implantation into a chick femur defect. The first part of the chapter sought to 
establish and characterise an organotypic fracture repair model. The model consisted of 
induced fracture in embryonic chick femurs, grafted with hMSC seeded collagen 
hydrogels, and utilised a borosilicate glass capillary needle to represent internal fixation 
using an IMN.  
 Initially I found that the presence of the IMN provided good structural stability to 
the constructs, allowing ease of fabrication whilst also guiding chick periosteal growth 
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which bridged the defect during culture. I also observed rapid migration of native chick 
cells into acellular collagen implants as soon as 24 hrs after defect fabrication, which 
continued for the 2 week culture period and formed a dense periosteum bridging the 
defects in both acellular and hMSC seeded implant groups. Migration of hMSCs during 
culture was monitored using a fluorescent cell tracker and demonstrated integration of 
hMSCs with the chick bone collar, along the chick periosteum, and into the medullary 
cavity. I then employed live/dead fluorescent staining to demonstrate the constructs 
remained viable for the 2 week culture period.  
By studying the effect of pressure on the femur constructs using undifferentiated 
hMSCs in collagen, I found that daily bioreactor stimulation in combination with hMSCs 
in the implants, increased bone formation in the defects when compared with statically 
cultured or hydrostatically stimulated constructs without hMSCs. I then used a 
fluorescent cell tracker to show that cells embedded within the porous trabecular ECM of 
stimulated implants assumed a more osteocytic morphology compared with cells in the 
less mineralised statically cultured implants.  These initial results first demonstrated that 
the organotypic femur constructs could recapitulate certain aspects of fracture in the 
context of bridging of the fracture site, and increased bone formation under experimental 
conditions. Second, they provided a useful comparison for then assessing the extent of 
new bone formation in hydrogels receiving hydrostatic preconditioning prior to 
implantation in the femur constructs.  
I then proceeded to hydrostatically precondition hydrogels for 4 weeks prior to 
implantation into the femur defects.  hMSC/collagen hydrogels were stimulated for 1,3 
and 5 days/ week with statically cultured gels used as a control. After 4 weeks, analysis 
by µCT showed that whilst the hydrogels collectively mineralised in a manner similar to 
that described in Section 3.3.3, there was no difference in hydrogel mineralisation and 
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density between the different preconditioning groups. A small but significant increase in 
volume was observed in hydrogels stimulated for 5 days/week compared with statically 
cultured hydrogels. Preconditioned hMSC/collagen hydrogels were then implanted into 
femur defects and cultured for 2 weeks, and maintained their viability during culture. 
Interestingly, µCT analysis after 2 weeks indicated that the mineralisation of the implants 
decreased during culture in the femur defects. No differences were observed between 
static and hydrostatically preconditioned implants, with an approximate 4 fold decrease in 
implant mineralisation in across the experimental groups after 2 weeks implanted in the 
femur constructs. 
The final part of this chapter examined experimental results from hydrostatically 
preconditioned hydrogels using non optimised seeding conditions, and compared them 
with hydrostatically preconditioned hydrogels manufactured using the optimised seeding 
conditions described in Section 3.3.3. The 2 week preconditioning period showed that 
daily bioreactor stimulation enhanced the contraction of the hydrogels by encapsulated 
hMSCs, resulting in smaller volume hydrogels compared with static preconditioning. 
However, the overall mineralisation of the hydrogels was far lower than hydrogels 
cultured under the same conditions using the optimised seeding conditions. In contrast to 
the results described in Section 4.3.9, mineralisation of the hydrogels following 
implantation into the femur defects increased, with hydrogels receiving hydrostatic 
preconditioning prior to implantation being significantly more mineralised than statically 
preconditioned hydrogels after a two week culture period.  
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4.5.2. Cell migration 
The organotypic model described in this chapter aimed to recapitulate the in vivo 
fracture repair process in vitro. If we look back to chapter 1 in which the stages of 
fracture repair are detailed, we can compare the stages of fracture repair with 
observations from this study, and assess to what extent we have successfully recapitulated 
an in vivo repair process. First it must be stated that this model differs considerable from 
an in vivo repair process due to the lack vascular and immune systems that would initiate 
inflammation and neovascularisation of the fracture site. Despite this, the invasion of 
fibroblastic periosteal chick cells into the defect region was extensive and occurred 
almost immediately after the defect was created. The invasion of chick cells occurred 
from both epiphyseal and distal femur ends and eventually formed a periosteum that 
encapsulated the defect site entirely. Histological sections of acellular implants showed 
chick cells to a lesser extent also migrating into central regions of the implant. For hMSC 
seeded implants the number of migrating chick cells into the implant would likely be less 
due to the increase in collagen density in cell seeded vs acellular hydrogels(Wu et al. 
2014). The invasion of chick cells from both epiphyseal and distal ends to bridge the gap 
could indicate the presence of directional cues that guide migration across the long axis 
of the femur. Some reports have has indicated preferred directional growth from the 
epiphyseal end of the femur when using explanted proliferative zones developing femurs 
as implants (Smith et al. 2013). In this study, whilst a directional preference of migration 
was not observed from either distal or epiphyseal end of the femurs, the system still 
provides a useful model for future study of the migration patterns of native periosteal 
fibroblasts cells into a fracture site. Further to this, recent developments in transgenic 
chick embryos with fluorescent proteins could elucidate what signalling events are 
important in governing invasion of periosteal fibroblasts into a fracture site.  
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The migration of hMSCs into the medullary cavity, as well as into the chick bone 
collar was an interesting and unexpected observation. The in vitro migratory capacity of 
MSCs has been shown to increase toward the presence of a variety of chemokines and 
growthfactors (Ponte et al. 2007). Based on this, it’s possible that signalling molecules 
from the femurs encouraged migration of the hMSCs from the hydrogels into the femur 
tissue. However, it is likely that these observations simply reflected random migration of 
MSCs from the defect site into the femur. In either case, this result presents interesting 
future opportunities to study how changes in the local cell envornment (i.e. from collagen 
hydrogels to a more physiological bone niche) determine changes in cell behaviour. For 
example, evidence indicates that Wnt signalling regulates the invasion capacity of 
hMSCs(Neth et al. 2006). It has been widely demonstrated that wnt signalling also plays  
an important role in embryonic chick development(Wilson et al. 2001)(Anakwe et al. 
2003), and more specifically in developing chick limbs (Kawakami et al. 
2001)(Hartmann & Tabin 2000). Hence a useful future study could be to investigate the 
changes in Wnt mediated signalling events such as β-catenin activity in MSCs as they 
migrate from the defect site into the medullary cavity of the femur. 
4.5.3. Use of internal fixation 
The presence of an intramedullary rod in the form of a borosilicate glass capillary 
tube represented a crucial aspect of success in the model. As mentioned previously the 
presence of the rod made fabricating the constructs relatively easy, allowed them to be 
handled in culture. Importantly the presence of the rod did not adversely interact with the 
either hMSCs or native chick tissue. The rod also appeared provided contact guidance for 
cells bridging the defect, (Figure 9D iv). In humans, IMN’s are commonly used for 
treating femoral shaft non unions (Ricci et al. 2009). They have also proved successful in 
treating neglected femur shaft non unions (Tall et al. 2012). In terms of recapitulating the 
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fracture repair processes, the incidence of femur capping reported by Smith el at. (Smith 
et al. 2014a)(Smith et al. 2014b) might represent a scenario of neglected non-union due to 
inadequate fixation. The use of the IMN in the form of a boro-silicate capillary needle in 
this chapter thus overcame this issue, and demonstrates the usefulness of fixatives for 
improving the performance of organotypic fracture repair models. Further to this, it 
would be interesting to establish plate fixatives in this model, as well as studying the 
implant femur interface and its effect on biological tissue such as changes in localised 
fibrosis and/or mineralisation. One study suggests that increases pressure during 
physiological total hip replacement implants can exert fluid flow on cells at the implant 
bone interface (Alidousti et al. 2011). If this were present in our system we might expect 
to see changes in mineralisation in cells around the IMN due to changes in fluid flow in 
these regions 
4.5.4. Effect of hydrostatic pressure on undifferentiated hMSC/collagen 
implant femur constructs 
Daily hydrostatic pressure significantly increased bone formation in the defects 
whereas no evidence was found that the presence of hMSCs affected bone formation. 
This was qualitatively confirmed by comparing µCT sections profiling the density 
distribution and corresponding histological sections, demonstrating bone mineral deposits 
within these dense regions. The reduction in defect mineralisation in stimulated acellular 
defects supports my observations from the previous chapter which describe cell density 
dependant mineralisation of collagen hydrogels. Interestingly, stimulated hMSC/collagen 
implants showed a gradient of mineralisation in the implants from the periphery toward 
the centre. Since it was observed that chick cells formed a periosteum that encapsulated 
the defect, it could be that cell signalling from the chick cells to hMSCs in the defect 
enhanced hMSC differentiation and production of mineralised bone matrix. This could 
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explain why a gradient of mineralisation was observed from the peripheral regions of the 
defect toward the centre (Section 4.3.5 Div). In future experiments it would be useful to 
characterise if the increase in bone deposition in stimulated hMSC seeded defects was 
due to hMSCs, native chick cell migrating into the defect, or a combination of  both. If 
the latter case were so it might be useful also to characterise the heterogeneity of the 
chick cell population around the defect to determine if cell-cell communication by 
specific bone cell phenotypes influences hMSC differentiation. This in turn could provide 
useful information on the benefits of different co-culture models to encouraging 
osteogenic differentiation of MSCs.  
4.5.5. Trabecular architecture 
 The analysis by a two way ANOVA in Section 4.3.6 indicates that hydrostatic 
loading of the femurs constructs was the primary stimulus for cell based remodelling of 
trabecular architecture in the defects. It is generally accepted that bone architecture is not 
preprogramed in genes and the ability of cells to produce a bone matrix that allows 
minimal weight with suitable strength is determined by external mechanical 
stimuli(Huiskes et al. 2000). The results in this chapter appear to be consistent with 
studies that have investigated dynamic loading, in which hydrostatic stimulation 
encourages the formation of thicker and more numerous trabecular architecture (Rubin et 
al. 2002). Interestingly, many of these studies have employed dynamic stimulation on the 
assumption that physical deformation of the microenvironment is conducive to bone 
formation. The hydrostatic bioreactor is assumed to apply static loading, where the force 
is mediated through increasing the external fluid pressure around cells. It appears then 
that regardless of the nature of force applied (static or dynamic), its effects on trabecular 
architecture are broadly similar. It may of course be the case that the microenvironment 
in the model is not static. Without further experimentation, we cannot rule out the 
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possibility of different pressure gradients existing between the surrounding culture media 
and the internal structure of the cultured femurs. Indeed different pressures are found to 
localise in different regions of femurs themselves(Gurkan & Akkus 2008). Computational 
modelling of bone organ cultures has also suggested that externally applied hydrostatic 
forces produce significant shear stress at the calcified/noncalcified interface and further 
concluded that hydrostatic compression resulted in local shear stresses in the ossifying 
bone centre(Wong & Carter 1990). There is also some experimental evidence confirming 
this computational hypothesis, in which anabolic responses in bone rudiments exposed to 
intermittent hydrostatic pressure undergo shear stresses at different tissue interfaces 
within the explant(Burger et al. 1992).   However in a more recent finite element model 
of hdystatic pressure in explanted bone rudiements, the authors dispute this claim, 
suggesting that the increase in pressure on cells might instead result in a change in the 
chemical potential of water in cells themselves, resulting in an equilibration of ions 
across the cell membrane that lead to cell signalling events (Tanck et al. 1999).   
4.5.6. Preconditioned implants 
The premise behind using the bioreactor in a clinical setting was based on the 
hypothesis that it could be used to hydrostatically precondition cell seeded implants.  By 
accelerating the rate at which the tissue matures in vitro before implanting it into the 
patient, I aimed to improve the outcome of healing at the injury site.  Whilst in this thesis 
I was able to produce mineralised collagen hydrogels containing MSC’s in static culture, 
when implanted into the chick femur model, a reduction in the value mineralisation was 
observed after 2 weeks. This could indicate a period of bone resorption in the implants 
during this time. The natural process of bone resorption involves the release of acid 
phosphatase by osteoclasts. As discussed in chapter 1, osteoclast progenitor cells are 
multi nucleated macrophages generally thought to derive from haematopoietic stem cells 
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(Boyle et al. 2003). It could be possible that an active population of chick osteoclasts 
reside in the femurs themselves and could have contributed to the decrease in implant 
mineralisation during culture. However, an early study on in vitro chick femur cultures by 
Roach showed virtually no bone resorption during culture due to a lack of mature 
osteoclasts at day 14 of development(Roach 1990). Since the model uses femurs 
extracted at an even early time point (day 11), and the femurs do not yet show any signs 
of vascularisation, it seems unlikely that a mature population of chick osteoclasts was 
present in  sufficient numbers demineralise the implants.  It is possible that cell secreted 
collagenases could have caused the reduction in mineralisation in the femurs.  Significant 
remodelling of the defect sight was observed in Section 4.3.6, which could have been in 
part mediated by chick cells secreting collagenases in response to ascorbic acid 
(D&apos;Angelo et al. 2000).  If this were the case then, it’s reasonable to suggest that 
collagenases secreted by native cells induced degradation of the preconditioned implants. 
Since hMSCs in the preconditioned implants had already undergone differentiation prior 
to implantation, their ability to lay down new bone matrix to mineralise the defects was 
likely far lower than the undifferentiated hMSCs used in the first part of this study. 
As discussed in the introduction of this chapter, the reduction in mineralisation of 
preconditioned implants has been reported by a number of groups  (Boyle et al. 2003, 
Lyons et al. 2010, Castano-Izquierdo et al. 2007). A study by Lutolf et al. showed that 
successful bone healing in rat cranial defects using collagen based implantss was 
dependant on cell invasion of the implants via integrin and matrix metalloproteinase 
dependant mechanisms(Lutolf et al. 2003). A summarised view of the results in this 
chapter appear to be in agree with the hypothesis that cell invasion of the implants is 
important for encouraging new bone formation. In undifferentiated hMSC and acellular 
collagen implants, chick periosteal cells were able to invade the implants and mediate 
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mineralisation in the defect site, possible influencing the differentiation of neighbouring 
hMSCs with soluble factors. This effect was also present in hydrostatically 
preconditioned implants using non optimised seeding parameters. Since the hydrogels did 
not mineralise and had a relatively low density after the 4 week preconditioning period, 
chick cells were able to invade and mineralise the defect. Supporting this hypothesis was 
the peripheral mineralisation similar to that observed in undifferentiated hMSC/collagen 
implants. The effect of 5days/week hydrostatic preconditioning in suboptimal seeding 
conditions, reduced the overall volume of the constructs by about half that of statically 
culture hydrogels. This lower surface area may have influenced the observed increase in 
defect mineralisation in preconditioned hydrogels, since chick cells would have taken less 
to proliferate and encapsulate the defect site before laying down new bone matrix.   
4.6. Conclusion 
In this chapter, I designed and constructed an organotypic model of fracture repair 
using isolated embryonic chick femurs. The model enabled the investigation of 
implanting hMSC/collagen hydrogels into femur defects to encourage bridging and repair 
of the fracture site. I tested the use of undifferentiated hMSCs/collagen hydrogels against 
hydrostatically preconditioned hMSC/collagen hydrogels on the premise that hydrostatic 
preconditioning of the hydrogels prior to implantation in the defects could enhance repair. 
I found that daily application of pressure over a 2 week period on entire constructs 
containing undifferentiated hMSC/collagen hydrogels enhanced the rate of repair. There 
were no differences in hydrogel mineralisation prior to implantation between statically 
cultured and hydrostatically preconditioned hydrogels. Further to this, the mineralisation 
of preconditioned hydrogels was nearly 4 times less than the same hydrogels analysed 
before implantation. By contrast, hydrostatically preconditioned hydrogels with non-
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optimised seeding conditions were poorly mineralised prior to implantation, which 
allowed chick cells to begin mineralising the defects during the 2 week culture period. 
In conclusion, the results from this chapter demonstrate the importance of a 
combination of hydrostatic pressure and cell invasion of the implant material in driving 
bone formation in an organotypic fracture repair model. This provides us an excellent 
platform for future studies in which we can elucidate the underlying biological 
mechanisms that control this process. 
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Chapter 5 
General discussion and future work 
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5.1. Summary of hypotheses 
The aim of this thesis was to develop and validate a hydrostatic force bioreactor for 
applications in bone tissue engineering. My approached to address this was to evaluate 
the bioreactor as a clinical translation platform to hydrostatically preconditioning 
mesenchymal stem cell seeded scaffolds. In doing so, I aimed to establish if such systems 
could one day be implemented to overcome limitations in orthopaedic practises which 
employ temporary fixatives and/or autografts. My hypothesis was that by providing a 
suitable growth environment for adult stem cells, I could generate tissue engineered bone 
grafts in vitro that would be suitable to treat non-union fractures. I aimed to prove a level 
of preclinical efficacy that would demonstrate the usefulness of these systems in 
translating bone tissue engineering from the lab to the clinic.  
To evaluate preclinical efficacy, I first wanted validate that the bioreactor induced 
changes in cell behaviour, and that these changes were consistent with the current body of 
literature reporting cellular responses to hydrostatic loading. Second, I aimed to establish 
if the bioreactor was effective in accelerating the rate of bone formation in cell seeded 
scaffolds, which represents a viable route to generate tissue engineered bone grafts. In 
addressing the second aim of this thesis, I focused heavily on the environmental factors 
that influence stem cell behaviour in collagen type 1 scaffolds. The final part of this 
thesis aimed to establish an organotypic preclinical model that accurately recapitulates 
the process of fracture repair, whilst also overcoming the ethical concerns of using live 
animal models.  
Ultimately, in exploring these facets of bone tissue engineering, I wanted to define a 
logical approach to determine the efficacy of hydrostatic force bioreactors as translational 
tools in the field of regenerative medicine. 
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5.2. Outcome of initial hypotheses 
The outcome of my initial hypotheses is that whilst the bioreactor is very useful from 
a research point of view, the system in its current form may not be appropriate for 
preconditioning hMSC/collagen hydrogels to be used as bone implants. Despite changes 
in the contraction of hydrostatically preconditioned hydrogels in Section 4.4, I have drawn 
this conclusion based on two main experimental findings: 
 Mature osteogenic phenotypes (late stage osteoblasts) and MSC precursors responded 
differently to hydrostatic loading in the bioreactor, with late stage osteoblasts 
responding in a way that is more consistent with the current literature describing 
mechanotransduction in cells.  
 Committed osteoblast phenotypes (MG63s) responded to hydrostatic loading in 
monolayers and 3D collagen scaffolds by producing more bone matrix than static 
controls. Whilst I succeeded in generating mineralised bone matrix in MSC seeded 
collagen scaffolds after 4 weeks, the addition of daily hydrostatic loading did not 
increase the rate of bone formation.   
5.3. Addressment of outcomes 
There could a number of reasons why hydrostatic loading did not enhance mineralisation of 
the MSCs/collagen hydrogels, and it may be that with further experimentation we might find the 
bioreactor can indeed enhance osteogenic differentiation and bone formation by primary human 
stem cells. First we must consider that the experiments using MSCs were performed from a single 
donor. It has been known for a period of time now the osteogenic potential of MSCs from 
different donors is highly variable (Phinney et al. 1999). It may that  screening of different donors 
in our bioreactor system could determine if the bioreactor can in fact enhance bone formation in 
MSCs. Coupled with this, bone marrow derived stem cells within a single donor contain a 
heterogeneous population of cells. This population can be isolated into homogeneous populations 
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that carry different levels of potency with respect to specific differentiation potentials (Boxall & 
Jones 2012). It might be that different populations of adult stem cell carry different levels of 
‘osteogenic potential’ with respect to their response to hydrostatic loading. This could therefore 
warrant testing the response of MSCs characterised to and isolated to express particular surface 
markers such as Stro-1 or SSEA-4(Feng-Juan lv et al. 2014). Another potential argument could 
be that whilst collagen provided a suitable environment for MG63s to respond positively 
to pressure, it may not have been adequate for generating responses in hMSCs. Further 
studies in different material scaffolds might elucidate a bone forming response in hMSC 
due to bioreactor stimulation that was not observed using collagen scaffolds.  
Aside from these considerations, it could be that MSCs are not as responsive to hydrostatic 
pressure as more differentiated phenotypes. This was a common theme throughout this thesis. In 
chapter 2, late stage OB MLOA5 cells were more responsive than MSCs to hydrostatic pressure. 
In chapter 3, pre-osteoblast MG63s encapsulated in collagen were more responsive to hydrostatic 
pressure than MSCs encapsulated in collagen, described in chapter 4. Coupled with this, in 
chapter 4 we also saw what appeared to be a gradient of mineralisation from the outside toward 
the centre of our stimulated femur defects containing what were initially undifferentiated MSCs. 
This implied that the response of chick cells to hydrostatic pressure (which has been 
demonstrated previously (Henstock et al. 2013)) influenced the differentiation of the implanted 
MSCs. Whilst there is an extensive body of literature documenting the interaction of OSs, OBs 
and MSCs in the context of stem cell differentiation, surprisingly little has been done to 
characterise changes in the functional responses of cells to hydrostatic loading as they undergo 
differentiation. That is to say, if we differentiate a mesenchymal stem cell into an OB and then 
into an osteocyte, what are the changes in its response to hydrostatic loading?  
Current evidence describes changes in the cytoskeletal network and correspondingly 
resistance to cytoskeletal disruption  in MSCs as they undergo differentiation toward a more 
osteoblastic phenotype (Rodríguez et al. 2004)(Yourek et al. 2007). Since in chapter 3 we saw 
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changes between MSCs and late stage osteoblasts (and also MG63 osteoblasts like cells in 
chapter 4) in their ability to undergo cytoskeletal modelling, it’s not unreasonable to hypothesise 
that a potential mechanosensory mechanism could be underpinned by changes in the cytoskeletal 
as cells differentiate. It would not be difficult to test this hypothesis in future experiments. Recent 
advances in differentiation protocols of MSCs to osteocyte phenotypes (Thompson et al. 2015) 
could allow us to determine if changes in the cell cytoskeletal during osteogenic differentiation 
dictate their ability to respond to hydrostatic loading.  
5.4. Drawing parallels in the results 
Although as discussed above my initial hypothesis was not confirmed, throughout the body 
of this research there existing distinct commonalities in the results that yield some interesting 
discussion points. The first commonalty was the effect of substrate stiffness on ALP activity in 
Section 2.3.2.6 and collagen concentration dependant changes in bone formation in Section 
3.3.3.3. It has been shown that increases in concentration of acellular collagen hydrogels is 
proportional to changes in hydrogel stiffness via a power law relationship (Yang et al. 2009) with 
an exponent value ~ 0.67, the same relationship and also exponent value of that found in Section 
3.3.3.3c. This implies that increases in collagen concentration in my hydrogel would see 
corresponding increases in hydrogel stiffness, thus increasing bone formation. We could expand 
this idea to incorporate changes in cell density and stiffness, since if MSCs are mineralising their 
surrounding matrix and they are closer together as a result of cell density, then the overall 
stiffness of the construct would increase, potentially creating a positive feedback mechanism. It’s 
reasonable to postulate that had ALP staining of the hydrogels been done, we would have 
observed both concentration and cell density dependant increases in ALP staining due to an 
increase in ECM stiffness. Interestingly Yang et al cite earlier theoretical models which predict 
concentration dependant changes in the stiffness of semi flexible polymers solutions, a 
consequence of which is the formation of liquid crystal phases above certain critical 
concentrations (Morse 1998)(Khokhlov 1978) (see Section 5.6 and Appendix Ch2). 
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5.5. Pre-clinical research potential of the bioreactor 
5.5.1 High throughput screening 
Since the response of osteocytes to hydrostatic loading is thought to be one of the 
mechanisms that regulates bone homeostasis, it’s reasonable to suggest that changes in 
their response to mechanical loading occur as they transition from a healthy to an 
osteoporotic phenotype. One study indicates an interaction between the Sost gene and 
Wnt signalling to be responsible for regulating osteocyte response to mechanical stimuli 
(Lin et al. 2009), which might suggest changes in this pathway in cells from healthy and 
osteoporotic donors. Others have pointed towards the shape of osteocyte in determining 
their mechanosensitivity, with rounded morphologies producing higher levels of NO than 
flat morphologies (Bacabac et al. 2008), implying the ECM environment of osteocyte 
lacuna may play a part in determining osteocyte mechanosenstivity. However, there is 
evidence challenging this hypothesis,  whereby no significant differences were observed 
in osteocyte lacuna size and shape between healthy and osteoporotic bone tissue 
(McCreadie et al. 2004). Aside from the uncertainty in the literature regarding 
mechanosenstivity in osteocytes, we can infer that hydrostatic bioreactor described in this 
thesis could provide a screening platform to study changes in mechanosensitivity in cells 
isolated from different disease states. Since the bioreactor houses standard tissue culture 
plates (which are commercially available in sizes of 6-384 wells), it could allow rapid and 
high throughput study of changes in for example NO production between healthy and 
osteoporotic bone cells. Additionally, the system could also be used to identify drug 
compounds designed to restore function to diseased cell phenotypes, generating valuable 
preclinical data for the development of pharmacological strategies to treat osteoporosis.  
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5.5.2. Leaning from developmental systems 
In chapter 4, whilst I did not delineate whether new bone in stimulated hMSC/collagen 
defects was produced by chick cells or MSCs (or both), it highlights the need for biomimetic 
niches in vitro that incorporate not just an appropriate cell matrix environment, but also mixed 
populations of cells that complement their behaviour in the context of enhancing tissue formation. 
This concept is already well established in the literature through the development of co-culture 
models, which is in some respects is what the organotypic model in chapter 4 represents. One 
potential advantage in considering the fracture repair model as a form of co-culture is the 
flexibility in the design of the model. This enables us to further study of how developmental cues 
from the embryonic femur determine the behaviour of adult human MSCs.  
I discussed in chapter 1, there are inherent difficulties in translating animal models into 
humans due to interspecies differences. Since in our fracture repair model we are using human 
cells in an animal model, we can provide direct evidence of interspecies translation that could 
help us understand what factors are important in driving bone formation in mesenchymal stem 
cells. As an example, organotypic chick femurs can be isolated at a range of different 
developmental stages, each of which exhibit different expression levels of markers associated 
with skeletal development (collagen type I/II, Stro-1) (Kanczler et al. 2012). Based on this, using 
the organotypic fracture repair model, we could test changes in the differentiation potential of 
human MSCs due to cell signalling from chick skeletal cells at different stages of development. In 
addition, it has also been demonstrated that chick femurs produce more bone at later stages of 
development in response to hydrostatic pressure (Henstock et al. 2013). Firstly this observation 
supports our previous hypothesis that more mature osteogenic phenotypes more effectively 
translate hydrostatic pressure into bone forming responses.  Second, by studying the changes in 
cell signalling from chick cells due to hydrostatic loading at different developmental stages, we 
could identify candidate signalling events that enhance hydrostatically induced osteogenic 
differentiation of human MSCs. Thus by combining organotypic developmental models with 
adult stem cells from humans, we may be able to overcome the translational problems associated 
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with interspecies differences, whilst also adhering to the three R’s principle, generating more 
ethical robust preclinical evaluation of bone tissue engineering strategies.  
5.6. The ECM environment 
Another recurring theme in the experimental outcomes of this thesis was the importance 
of an ECM environment that more closely recapitulates the native bone niche. This was seen in 
chapter 2, whereby a stiff ECM was required to allowing MSCs to undergo osteogenic 
differentiation. In chapter 3, providing the appropriate ratio of ECM and cells allowed MSCs 
generate a densely mineralised matrix environment that was rich in proteins typically found in the 
native bone niche. Moreover, this process had a high rate of predictability, in which the physical 
amount of collagen present in the ECM determined the mineralisation and density of the 
hydrogel, and also the distribution of the encapsulated cells. What was particularly interesting 
about this process was first the linear dependence of bone formation on the cellular distribution, 
and secondly the end point collagen concentration of a low vs high initial concentration. Lower 
starting concentrations resulted in much higher final concentrations with a densely packed cell 
matrix structure, resulting in more mature bone tissue formation by MSCs over 4 weeks.  
As mentioned previously, a common observation throughout this thesis was that small 
changes in the ECM environment had a large impact on the development of the resultant 
tissue. This would likely have impacted too on a cells ability to respond to hydrostatic 
pressure. Based on this, I believe that in order to elucidate a maximal output response 
from hydrostatic force bioreactors such as the one described in this thesis; we must ask, 
what are the environmental factors that most effectively allow stem cells to undergo 
osteogenic differentiation in vitro? Based on the evidence reported by the literature, 
coupled with the evidence presented in this thesis, I propose that an appropriate ECM 
environment to initiate differentiation and bone formation in MSCs should provide. 
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 The appropriate soluble factors and signalling molecules that induce 
differentiation of MSCs, of which the correct combination of factors should be 
based models studying developmental bone niches. 
 Environments that accurately recapitulate the change in spatial, 
conformational and mechanical properties of the ECM as cells undergo the 
transition from MSC precursor to encapsulated osteocyte. Biphasic scaffolds 
being developed for osteochondral repair might represent a fulfilment of this 
requirement.   
 Environments that accurately recapitulate the change in protein and mineral 
concentration of the ECM as cells undergo the transition from MSC precursor 
to encapsulated osteocyte.  
 
If these goals can be achieved in the future, then applying hydrostatic pressure using 
bioreactors systems might provide the appropriate forms of stimuli as MSCs undergo 
osteogenic differentiation. For example in an ideal biphasic scaffold, we might picture 
higher levels of strain being exerted in one area of the scaffold, containing less committed 
bone cell phenotypes (the stem cell pool). Then by contrast, lower levels of strain and 
higher levels of hydrostatic pressure and/or fluid flow being exerted in areas of the 
scaffold containing more differentiated cell phenotypes such as osteoblasts and 
osteocytes.  Due to the nature of biphasic scaffold systems, application of a single 
external force would result in multiply forms of mechanical stimuli to cells in different 
regions of the scaffold (Figure 2A).  
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The concept of biphasic scaffolds containing gradient niches might one day allow 
truly biomimetic tissue equivalents to be grown in vitro, enabling the researcher to 
elucidate how the cell-matrix environment influences mechanically induced turnover of 
bone.  
Figure 2B represents one potential avenue for addressing the problem of generating 
hierarchical tissue structures. Figure 2B, whilst is not detailed in the main body of this 
thesis (see appendix ch2), was the result of attempting to address the standardisation 
issue encountered with collagen hydrogels discussed in Section 4.4. It became apparent 
that the behaviour of collagen type 1 at very high concentrations (>50mgs/ml) was 
Figure 1. A) Cartoon representation of a biphasic scaffold concept. B) Production of 
lamellar arrangements of collagen type 1 that mimic osteon architecture.  
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remarkable different to the behaviour at commercially available concentrations (3-
11mg/ml). At these higher concentrations, the self-assembly process of collagen adopts 
liquid crystalline phase behaviour, resulting in architectures that mimic the hierarchical 
structure of bone.  Consequently this may also imply that the lamellar structure of bone 
and indeed many other tissue structures are the result of a similar physiochemical 
process. To that end, one aspect of future work that will follow on from this thesis is to 
explore the underlying mechanisms that control this process. By attempting to more 
closely mimic the architecture of native bone, it is hoped a deeper understanding can be 
obtained of how the ECM environment governs a cells response to mechanical forces 
such as hydrostatic pressure.   
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Figure 1: Certificate of analysis for hMSC Donor
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 Figure 2: Characterisation of hMSC surface markers by flow cytometry and immunocytochemistry. Immunofluorescent images courtesy of 
S.Moise. Negative control represents a cocktail antibody stain  for negative surface markers CD14, CD34, CD45,CD19 and HLA.  
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 Figure 3. Trilineage differentiation of hMSCs after 28 days in vitro culture in different media compositions. Scale bars = 200µm 
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Appendix 
Chapter 2 
Self-assembling supramolecular 
collagen scaffolds for applications in 
tissue engineering 
(The contents of this chapter have been accepted for publication in ACS Biomaterials 
Science and Engineering, March 2016)  
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Introduction 
The ability to generate hierarchical tissue structures in vitro might one day allow 
researchers recreate truly biomimetic cell niches in a dish. This could enable detailed 
study of how topographical cues within the extracellular matrix influence cell behaviour. 
Understanding these mechanisms could greatly improve our ability to engineer functional 
tissue equivalents that can be used to treat a diverse range of acute and/or pathological 
abnormalities.  Liquid crystallinity in biopolymers such as collagen has provided 
scientists with inference as to the formation of anisotropic structures in tissue such as 
bone
1
, skin
2
 and cornea
3
. Observations of liquid crystallinity in collagen are typically 
observed in concentrations higher than 50mg/ml, far in excess of commercially available 
concentrations and hence limiting the ability of the researcher to readily study these 
interesting properties. Previous reports have successfully utilised liquid crystal phase 
formation in collagen to generate ordered substrates to support cell growth
4,5
. However, 
current methods in the literature lack the benefit of simplicity and/or standardisation that 
is required to permit these materials to become common place in the lab. Furthermore, no 
one has yet shown distinct levels of liquid crystal phase formation from a single solution 
of collagen.   In this report we describe three simple cost effective methods to produce 
aligned collagen substrates to serve broad range of tissue engineering applications. Each 
method is fully scalable and requires only the very basic lab equipment, allowing rapid 
fabrication of collagen substrates that mimic the hierarchical structure of native tissues.  
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Materials and methods 
Substrate fabrication  
2ml stock concentrations of rat tail derived collagen (9.31mg/ml, BD biosciences) were 
dialysed overnight against either 30% or 50% PEG-400(sigma) in 500mM acetic acid. 
The dialysis procedure was performed in 3ml capacity dialysis cassettes (thermos-fisher). 
The final concentration was estimated by volume at 50-60 mg/ml (30%PEG) and 80-
90mg/ml for (50%PEG) (Figure 1A&B).  
Method A 
Method A (Figure 1, method A) used a 50% PEG dialysis buffer and required careful 
removal of the viscous collagen ‘frame’ from the dialysis cassette, which was then 
transferred to a petri dish. The petri dish was placed in an ammonia chamber (consisting 
of a square petri dish lines with paper towels soaked in concentrated ammonium chloride 
(Fisher scientific)) overnight to induce polymerisation in the substrate. The collagen 
frame was templated, with templates then transferred to phosphate buffered saline (PBS) 
in well plates and stored at 4
o
C until ready for use. 
Method B  
 Method B could be performed in both 30% and 50% PEG solution to dialyse the 
collagen. After removal of the collagen from the cassette, the frame was placed into an 
Eppendorf tube and heated to 50
0
C to reduce the viscosity of the collagen. The solution 
was drawn into a hypodermic syringe needle (29G) and placed upright in the fridge for 30 
minutes. The collagen was then extruded onto glass slides into long fibres of strongly bi-
refringent collagen. The slides were placed in an ammonia chamber overnight (as before) 
and stored in PBS at 4
o
C until ready for use. 
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Method C  
Method C could be performed with either 30% or 50% PEG solution to dialyse 
the collagen. Solutions were heated to 50
o
C (as before) to reduce viscosity and pipetted 
dropwise onto either glass coverslips or microscope slides. The solutions were covered 
and placed in the fridge for 30minutes before adding a neutralising buffer (equivalent 
1M-HEPES) to immerse the collagen (Figure1 method C). Samples were left overnight 
at room temperature to evaporate the immersing buffer. The samples were then placed in 
the ammonium chamber for a further 4 hours before washing briefly in distilled water and 
subjection to 15minute UV sterilisation prior to cell seeding.  
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Figure 1: Fabrication of anisotropic collagen substrates from a single solution of high 
concentration collagen.   
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Cell culture 
Mesenchymal stem cells were isolated via plastic adherence from a human bone 
marrow aspirate and maintained in cultured in proliferation media consisting of DMEM 
(1ng/ml glucose, w/o L-Glutamine (Lonza) containing 10% foetal calf serum (Biosera), 
2% penicillin-streptomycin (Lonza), 1% Non-essential amino acids (Sigma) and 1% L-
Glutamine (Lonza). Prior to seeding onto collagen substrates, cells were labelled with a 
PKH26 fluorescent tracker (Sigma) according to the manufacturer’s instructions. For 
osteogenic differentiation of MSCs, cells were maintained in proliferation media 
supplemented with 150µg/ml ascorbic acid (Sigma), 10
-8
M dexamethasone (Sigma) and 
2mM sodium β-glycerophosphate (Sigma). Experiments were terminated by fixing 
samples in 10% neutrally buffered formalin (Fisher) for 15 minutes at room temperature.       
Histology  
After fixation, cell nuclei were stained using Harris haematoxylin solution 
(Sigma) for 30 seconds followed by 30 secs emersion in Scots tap water. Cell cytoplasm 
was stained using Eosin, immersing samples for 30 seconds followed by brief washes in 
DH2O. The Von kossa method was employed to detect bone formation using 5% silver 
nitrate (sigma) in DH2O. Samples were washed thoroughly in DH2O before immersion in 
silver nitrate solution for 30 minutes, followed again by thorough washes in DH2O. 
Samples were then exposed to 90mjoule UV irradiation for 15 minutes in a Bio rad GenX 
UV chamber. 
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Immunocytochemistry 
Immunocytochemistry was performed by blocking non-specific binding using 
1%BSA (Agilent) in PBS for 1 hr at room temperature. Primary antibody staining was 
performed overnight at 4
o
C using human Osteocalcin monoclonal antibody (R&D 
systems) diluted to 2μg/ml in 0.1% BSA in PBS-0.1% -tween. Samples were then 
incubated in Alexafluora 488 or (2μg/ml, 0.1% BSA, 0.1% Tween-20 in PBS) (Abcam) 
for 1hr at room temperature in the dark. Nuclear staining was performed with 4', 6-
diamidino-2-phenylindole (DAPI) for 15 minutes at room temperature in the dark.  
Tissue sample preparation  
Dissected pig cornea and chicken tendon were fixed in neutrally buffered formalin 
before paraffin embedding using an automated vacuum tissue processor (Kedee). 10µm 
sections were cut using a microtome, with sections transferred to microscope slides. 
Sections were then deparaffinised in xylene and rehydrated in serial ethanol dilutions in 
dH2O. Sections were mounted onto slides with coverslips using DPX mounting medium 
(Sigma) prior to imaging. 
  
Imaging 
Confocal imaging of the samples was performed using an Olympus U-TBI 90 
confocal microscope, employing either reflectance mode, or using standard fluorescence 
mode. Polarised light microscopy was performed using a Brunel SP300 polarising 
microscope. Samples were places between cross polarisers and images were captured 
using an inverted digital camera (Nikon). Whole mount fluorescence imaging was 
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performed using a Leica Mz10F dissection microscope. Histologically stained samples 
were imaged using an EVOS® FL Colour Imaging System. 
Raman spectroscopy 
Raman spectra for collagen substrates fabricated using ‘Method A’ were taken on 
a DXR Raman microscope (Thermo scientific) using a 532nm laser. Raman spectral 
mapping was performed using an Olympus TH4-200 10x objective through a 50μm 
pinhole aperture. Spectra from a total of 252 points were obtained over an area of 
2.6x0.8mm with a summed average of 10 spectra/point. Spectral analysis was performed 
using an Omnic Specta software platform.   
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Results  
Method A 
 Alignment of the substrate using Method A was heterogeneous within the films. 
The central region of films (Figure 1, method A) was around 50µm thick and possessed 
anisotropic fibre arrangements. By contrast, the much thicker frame around the collagen 
films did not possess obvious anisotropic fibres, suggesting surface boundary conditions 
play an important role in guiding alignment. Further supporting this hypothesis was the 
presence of more pronounced anisotropy in regions localised to boundary conditions 
introduced by the formation of air bubbles (Figure 2C&D). The induction of collagen 
alignment by stress cues was supported by observations made under polarised light in 
viscous solutions prior to polymerisation of the substrate in ammonia vapours. By 
applying a local stress cues using tweezers (Figure2 Bi) we observed through cross 
polarisers strongly birefringent patterns representing the local alignment of collagen. 
After the stress cue was removed, the solution returned to its original state (Figure 2Bii). 
The substrate morphology and the comprising cells labelled with PKH26 could be 
monitored live in culture using confocal microscopy (Figure 2E).  hMSCs cultured on 
the substrates underwent osteogenic differentiation after 14 days culture in osteogenic 
media This was demonstrated by Von Kossa staining, showing the formation bone 
nodules on the substrate (Figure 2F, black granules) and by immunocytochemistry at 
day 14, which showed differentiating hMSCs secreting osteocalcin into the surrounding 
ECM (Figure 2F inset). 
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Figure 2: Macroscale collagen films possessing anisotropic fibre arrangements support 
the growth and differentiation of hMSCs. A) Multiple templated films of collagen could 
be obtained from a single dialysis cassette; in this case the template yielded circular films 
with a 1cm diameter. C) Cross polarised imaging of high collagen concentrations in 
solution show typical birefringence patterns,  which when subjected to stress cues (Bi) 
induces local alignment of collagen (arrow inset),Which was diminished after removal of 
the stress cue(Bii). D) Birefringence in the templated films represented areas of 
anisotropic ordering between surface boundaries created by bubble formation during 
dialysis. E) Both substrate morphology (blue) and the comprising cells (red) could be 
monitored in live culture, and underwent osteogenic differentiation after 14 days (F). 
Black granules represent bone nodule formation and inset shows production of 
osteocalcin by hMSCs.   
ii) i) 
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Method B 
The production of aligned collagen fibres using method B required high a collagen 
concentration (obtained in 50%PEG) yielding more homogeneous, birefringent fibres 
when compared with fibres produced using 30% PEG (Figure 1, Method B). After 
overnight exposure to ammonia vapours, hMSCs seeded onto the substrate aligned 
parallel to the fibre direction, which was confirmed using confocal microscopy (Figure 
3A). Interestingly, reflectance microscopy performed 1 day after cell seeding, indicated 
changes in density of collagen within individual fibres. A column of dense, aligned 
collagen was present around the periphery of the fibres, with a reduction in density 
toward the centre of the fibre (Figure 3B). hMSCs remained adhered to the fibres across 
a culture period of 7 days and retained an aligned morphology parallel to the fibre 
direction (Figure 3C-E). 
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Figure 3: Production of aligned collagen fibres using viscous extrusion to support 
oriented growth of hMSCs. A) Confocal imaging of the fibers  day 1 after cell seeding 
showed adhered hMSC  (red) aligned parallel to fiber direction (blue). B) Merged Z-
stack reflectance microscopy indicated a change in fiber density between the fiber 
boundary and central regions of the fiber. After 7 days in culture,  adhered MSCs s 
remained aligned in the direction of the fibers(inset arrows) C,D&E).  
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Method C 
Method C describes a novel application using HEPES evaporation to template the 
collagen through crystallization (Figure 1. Method C). Cross polarised imaging of the 
substrates after evaporation was complete, revealed a range of different orders, including 
regions of nested arcs (Figure4A) similar to that seen in lamellar bone
6
, as well as areas 
of distinct anisotropic banding (Figure4C). Temporal formation of different crystalline 
structures could be observed through cross polarisers, and showed rapid crystal growth 
across the substrate (see supplementary video 1). High magnification cross polarized 
images showed chiral nematic textures with helical pitch running orthogonal to the fibril 
orientation (Figure 1, method 3, i&ii). During washing with distilled water, the 
crystalline HEPES structure rapidly dissolved (see supplementary video 2), leaving 
behind the templated collagen underneath. Eosin staining of the substrates after fixation 
(Figure4B) showed the broad range of templated textures in the collagen due to HEPES 
evaporation. Higher magnification images (Figure4D&E) identify regions that were 
imaged using confocal microscopy during live culture. This enabled us to correlate the 
presence of oriented cells within the HEPES templated textures. hMSCs seeded onto 
substrates oriented themselves in the direction of banding (Figure4F&G) and showed no 
noticeable changes in viability after three days in culture.  
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Figure 4: Evaporation of 1M HEPES buffer induces unique crystalline templates in 
highly concentrated collagen. (A&C) The evaporation of 1M HEPES buffer over the 
substrates formed nested arc patterns as well anisotropic crystalline structures. During 
washing the HEPES structure rapidly dissolved (see supplementary video 2), leaving 
behind the templated collagen structure (B). Higher magnification imaging of the fixed 
substrates (D&E) identified regions that were monitored during live culture using 
confocal microscopy (F&G). 
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Raman spectroscopy of naturally aligning films 
Areas with prominent anisotropy in substrates produced using method A were 
analysed using Raman spectroscopy to assess the changes in substrate composition 
between regions assumed to be isotropic (random order and low birefringence) and areas 
containing strongly bi-refringent finger print textures (FT), assumed to be cholesteric 
phases of liquid crystal collagen. Spectral mapping of the 2800-3000cm
-1
 C-H stretching 
regions (non-specific to proteins and lipids) indicated an increase in the local 
concentration of collagen between isotropic and FT regions of the substrate (Figure 5A-
C).  The resulting textures in the naturally aligning films also changed according to the 
composition of the dialysis buffer. 50% PEG400 in 0.5Macetic acid produced workable 
films with distinct banded structures, yielding Raman spectra typical of signature region 
of collagen type 1
7
. 
 By changing the buffer to 50% PEG35000(300mg/ml in DH2O)
8
 0.5Macetic acid, 
we first observed a dramatic increase in concentration. The collagen contained within the 
dialysis membrane in this instance was very difficult to work with, and was removed in 
small quantities of film fragment. Under the polarised microscope, the films fragments 
exhibited a changes in texture compared with the PEG400 dialysis method, and in certain 
areas selectively diffracted blue light (Figure 5D, inset pictures)  the materials 
associated Raman spectra also changed relative to collagen dialysed against PEG-400 
(Figure 5D, inset red boxes). The shoulders in the 1400-1500cm
-1
 C-H region showed a 
shift in the peak centre of gravity between PEG 35000 and PEG 400 dialysed substrates. 
In the 1440-1490 Amide III region, there were slight peak shifts, as well as changes in the 
peak centre of gravity. A marked peak shift was observed in the 1000-1150cm
-1
 CH2 
deformation region, with the peak centre of gravity shifting from 1135cm
-1
 and 1059cm
-1
, 
to 1096 and 1031cm
-1
 respectively between PEG400 and PEG35000. Additionally, the 
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hydroxyproline peak centre of gravity shifted from 886cm
-1
 in PEG 400 dialysed 
substrates to 876cm-
1
 in PEG 35000 dialysed substrates.        
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Figure 5: Raman spectroscopy of naturally aligned type 1 collagen films. A) Cross 
polarised DIC of Raman mapping area showing the transition from isotropic to 
fingerprint textured (FT) collagen.  B) Bright field Raman mapping area. C) Raman map 
of 3000-2800cm
-1
 C-H stretching region showing an increase in the local concentration 
of collagen in FT regions. D) Raman spectra of collagen films showing signature region 
for collagen type 1. Changes in Raman spectra due to dialysis against PEG35000 (top) 
and PEG400 (bottom) in different regions are shown in red boxes. Inset images show 
changes in texture under polarised light according to the corresponding Raman spectra. 
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Discussion 
The results described using the natural alignment method (Method A) show that 
the presence of topographical defects in the substrates during polymerisation produces 
stably aligned collagen fibres. Coupled with analysis by Raman spectroscopy, it appears 
that the presence of topographical defects influences the local concentration of collagen 
during dialysis, resulting in heterogeneously ordered films. The change in molecular 
orientation due to increasing concentration likely represents a lyotropic liquid crystal 
phase transition. Supporting this hypothesis are changes in the resultant textures of the 
material in different dialysis buffers, a result similarly observed by Peixoto et al. who 
studied in detail the changes in molecular orientation of collagen in different solvents as 
they undergo liquid crystal phase transitions
9
.  
The shifts in the Raman peaks, and also the change in the peak intensities between 
PEG400 and PEG35000 dialysed substrates further indicate significant structural changes 
in collagen assembly as the concentration is increased. The peak shifts observed in the 
hydroxyproline region could represent alterations in collagen triple helix stability due to a 
change in the bond energy of hydroxyproline residues 
10
. Likewise, the prominent peak 
shift in the 1000-1150cm
-1
  could indicate the occurrence of a separate liquid crystal 
phase transition, whereby changes occur in the interaction of paraffinic side chains due to 
reduced water content in PEG35000 versus PEG400 substrates
11
. This hypothesis could 
be also supported by changes in the peak centre of gravity in the 1400-1500cm
-1
 region, 
indicative of paraffinic chains
12
. Deconvolution algorithms could further provide useful 
information on the underlying spectra which define the shoulder regions of these peaks. 
Collectively, the peaks shifts between the two substrates might explain the change in 
substrate texture under the microscope. It is reasonable to suggest that the lower 
concentration PEG400 system comprises of large scale anisotropic amphiphilic 
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aggregates linked by paraffinic side chains
13
, and that the more concentrated PEG35000 
system, having undergone a higher order phase transition, experienced significant 
changes in protein conformation.  The dark blue appearance of PEG35000 substrates 
under the microscope could indicate the presence pre-cholesteric liquid crystal blue 
phases. Blue phases occur in an intermediate transition of chiral liquid crystals and are 
characterised by their cuboidal packing structure, and ability to selectively diffract light 
in the visible spectrum
14
.  However, critical concentrations for blue phase liquid crystals 
have been reported to lie in between the isotropic and cholesteric phases
14
, and thus it is 
unclear that if this were the case, why lower concentration PEG400 substrates exhibit 
such prominent cholesteric banding. Despite this, our results demonstrate how useful a 
tool Raman spectroscopy can be when probing changes in molecular chemistry of 
collagen solutions as they undergo supramolecular self-assembly.  
Importantly from a tissue engineering perspective, the fabrication process did not 
adversely affect cell behaviour in the context of osteogenic differentiation of hMSCs. 
Collagen type 1 constitutes the majority of proteins found in human body, and comprises 
about 90% of the organic phase of bone tissue
15
. The ordered lamellar structure in bone is 
believed to be influenced by the formation of cholesteric phases in collagen
16
. Based on 
this, our results could well reflect the physiochemical process of hierarchical tissue 
formation under cell free in vitro conditions. It is unsurprising that we can differentiate 
hMSCs toward an osteoblastic lineage, since collagen is extensively reported to be an 
excellent growth substrate to promote bone formation
17,18,19
. The ability to control the 
orientation of collagen at the nanoscale and maintain this architecture during the culture 
and differentiation of stem cells might realise an important step forward in the production 
of biomimetic tissue equivalents. Further to this, whilst this has paper focused on the 
production of bone, the orientation in our naturally aligned collagen films is remarkable 
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similar to that seen in cornea and tendon (Figure 6). Further work to explore the 
behaviour of different cell types such as corneal stromal fibroblasts or tenocytes, could 
provide evidence for a range of tissue engineering applications for the collagen substrates 
described in this report.  
 
 
 
   
 
The results obtained using method 2 represent a simplified adaptation of methods 
described by  Kirkwood and Fuller 
4
, in which a tri axial robotic arm was used to extrude 
20mg/ml solutions of collagen onto slides, after which  ambient desiccation further 
increased concentration and induced fibrillogensis. This automated fabrication method 
has also been further adapted to manufacture bilayer transparent films for use as corneal 
substitutes
20
. Our results suggest that by using a higher starting concentration of collagen 
we can significantly reduce the complexity of the system, making the production of these 
aligned fibres far more available to researchers. However it should not be understated that 
the use of automation presents a system with a higher rate of reproducibility, and also 
reflects more accurately a process controlled manufacturing platform. (Figure 3B) 
reports a novel finding, whereby alignment using narrow channel extrusion might 
represent electrostatic interactions between the collagen and stainless steel surface of the 
needle. It is reasonable to suggest the increased alignment of the collagen molecules on 
the fibre periphery was due to interactions with the adsorbing steel surface during 
Figure 6: Cross polarised images comparing collagen orientation in type 1 collagen 
films, pig cornea and chicken tendon. 
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dynamic flow. Li and colleagues describe a similar phenomenon in molecular 
configurations of DNA in torsional flow cells, reporting changes in molecular 
deformation of DNA closer to an adsorbing glass surface
21
. Approaches to modelling 
polymer dynamics in shear flow have been reported by a number of different groups
22,23
, 
suggesting our liquid crystalline fibre production method could provide a useful 
experimental platform to validate these models.   
 The formation of cholesteric order in HEPES/collagen substrates in method C, 
infers liquid crystal phase formation driven by shear force during HEPES evaporation. 
Chung et al reported a similar phenomenon in genetically engineered viruses using an 
oscillating dip coat method 
24
.They concluded that shear force was responsible for driving 
aligned fibril formation with chiral nematic helical axis aligned orthogonal to the fibril 
direction. Our results might reflect a system where shear stress, induced by crystalline 
HEPES, orients the collagen molecules; however at this stage we do not have precise 
control of the collagen/HEPES system. It is reasonable to postulate that liquid crystal 
director growth in our collagen system could be controlled through specific 
environmental factors such as temperature, humidity or pressure. Further to this, it would 
be interesting to test the effects of different buffers on the resultant properties of the 
substrate, such as for example stiffness or optical transparency. 
The use of dialysis membranes to induce LC behaviour in collagen is widely 
established in the literature. Similar to our system, Saidi et al. used dialysis membranes to 
concentrate collagen solutions above the critical concentration required for liquid crystal 
self assembly
25
. They then neutralised the solution using PEG titration and spatially 
confined the solutions between coverslips to induce aligned fibre formation  during 
fibrillogenesis 
25
. Interestingly whilst this study was able to produce aligned collagen 
substrates, they did not report higher order chiral structures running orthogonal to the axis 
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of anisotropy. Furthermore, we could argue that similar to the comparison of method 
made with Kirkwood and Fuller, that our procedure represents a simpler and more widely 
available technique.  Coupled with this, since the alignment procedure described in 
Method A is performed in the dialysis cassettes and not using coverslips, it is easily 
scalable due to the dialysis cassettes being commercially available in a range of different 
sizes. Interestingly, the formation of a chiral axis in the substrates in method A was 
highly sensitive to the initial volume of collagen in the dialysis cassette, indicating that 
the alignment process is dependent on the degree of confinement during self-assembly.  
Alignment of collagen using dialysis has also been achieved via incorporation of 
nanocrystalline cellulose into concentrated collagen solutions 
26
 and in high concentration 
collagen type III using a using a carbodiimide based chemistry technique 
27
. Whilst 
alignment of collagen type IV using similar procedures has not to our knowledge been 
investigated, it is not unreasonable to suggest that alignment is achievable using these 
methods, particularly if we take into account early reports of liquid crystalline phases in 
collagen type IV extracted from bovine anterior lens capsules
28
. Based on existing 
evidence, together with  recent theoretical models indicating that liquid crystalline 
behaviour can accurately describe experimental assemble patterns of collagen
29
, it is 
surprising that these methods has not yet become routine in the field of tissue 
engineering. This may be in part due to the diverse and often complex set of protocols 
that are described to manufacture workable collagen substrates containing hierarchical 
assemblies. Utilising the available literature on collagen alignment to develop simple, 
rapid and cost effective protocols could make the use of self-assembled hierarchically 
ordered substrates far more available to tissue engineers. Further to this, the field of 
vibrational spectroscopy will no doubt benefit from low cost, reliable experimental 
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systems, which can accurately relate nanoscale alterations in protein conformation to 
changes in material properties.  
Conclusion 
In conclusion, by applying a broad range of basic laboratory techniques, we 
demonstrate remarkable versatility in this commonly used and widely available 
biomaterial. Using Raman spectroscopy we have also observed nanoscale conformational 
changes in protein structure that may represent distinct liquid crystal phase transitions in 
collagen.   The need for simple and cost effective fabrication of biomimetic materials will 
be important in realising clinically relevant regenerative medicine therapies. As well as 
this, a deeper understanding of the physical processes that govern anisotropic ordering in 
biopolymers could greatly improve our ability to engineer materials that mimic the 
hierarchical structure of native tissues. 
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